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ABSTRACT 
.  
Yersinia ruckeri is the aetiological agent of enteric redmouth (ERM), a disease of 
salmonids, notably rainbow trout (Oncorhynchus mykiss, Walbaum). Until the 
1990s, prophylaxis was achieved using a formalin-inactivated whole-cell vaccine of 
a motile (= flagellin producing) Y. ruckeri strain. However, outbreaks of ERM have 
since occurred in vaccinated livestock which heralded the emergence of a new 
biogroup. In addition to giving a negative result for the Voges–Proskauer (VP) 
reaction and the production of an extracellular lipase, strains responsible for the 
majority of these new outbreaks in vaccinated stock were non-motile and unable to 
produce detectable flagellin. It was the aim of this study to determine what 
protective role flagellin may have towards Y. ruckeri infection, both as a component 
of the whole-cell vaccine and as a vaccine in itself (i.e. sub-unit vaccine). 
 
Results showed that protection against bacterial challenge, either with a motile  or 
non-motile Y. ruckeri strain, was not entirely dependent on the presence of flagellin 
within the whole-cell vaccine. On the other hand, administering native flagellin (50 
µg/fish) via intraperitoneal injection (without adjuvant) resulted in excellent levels 
of protection (relative percent survival = 100%) against challenge 28 days post-
vaccination with a flagellin-producing (YR1) or flagellin-devoid (R1) Y. ruckeri 
strain. Use of recombinant flagellin (r-flagellin) as a vaccine again confirmed the 
protective properties against challenge with both YR1 and R1 strains, even at lower 
concentrations i.e. 10 µg/fish. Protection was also conferred after a relatively short 
period of time (14 days) without any detrimental effect on health or weight of the 
fish. Thus flagellin has the potential to be an efficacious, non-specific sub-unit 
vaccine for rainbow trout.  
 
Analysis of whole cell proteins by SDS-PAGE from both motile and non-motile 
isolates demonstrated that highly virulent EX5 isolates which caused disease in 
vaccinated livestock were overexpressing a 30 to 40 kDa protein. 2D SDS-PAGE 
and Maldi-tof mass spectrometry identified this protein as outer membrane protein A 
(OmpA). However, attempts to disrupt the gene encoding the OmpA protein (ompA) 
using transposon mutagenesis and PCR screening failed to isolate a mutant with a 
transposon within the gene of interest (ompA::Tn-RL27).  
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“Once you eliminate the impossible, whatever remains, no matter how improbable, 
must be the truth.”1 
 
 
In “Sherlock Holmes: A Scandal in Bohemia”1 
Sir Arthur Conan Doyle 
Scottish physician, patriot and man of letters (1859-1930) 
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TEMED N,N,N’,N’-tetramethyl-ethylenediamine 
TSA tryptone soya agar 
TSB tryptone soya broth 
UV ultraviolet 
V volt 
v/v volume to volume ratio 
WT wild-type 
w/v weight to volume ratio 
w/w weight to weight ratio 
Y. ruckeri Yersinia ruckeri 
µg microgram 
µl microliter 
µm micrometer 
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1.1 Aquaculture  
The farming of aquatic organisms, including fish, crustaceans and molluscs, often 
known as aquaculture or aquafarming, is one of the fastest growing animal-food-
producing industries in the world. Aquaculture currently provides nearly half 
(approx. 46 %) of all fish consumed by the global population and in 2008 alone was 
thought to have produced 148 million tonnes of fish (Food and Agricultural 
Organisation of the United Nations [FAO], (2010). This number includes 115 
million tonnes of fish consumed by humans. As of 2010, the human population stood 
at approximately 6.29 billion people and is estimated to rise to 10.1 billion by the 
year 2100 (United Nations. Dept. of Economic and Social Affairs. Population 
Division., 2011). This will place aquaculture under considerable pressure to produce 
the amount of aquatic food required to meet the demands of an increasing human 
population. Fish must therefore be able to grow quickly under potentially adverse 
environmental conditions (i.e. varying temperatures and water quality) with minimal 
costs to the aquaculturist, yet still produce a final product which is palatable and 
safe for consumption. An important example is rainbow trout (Oncorhynchus 
mykiss, Walbaum), which has been successfully reared in captivity for over 100 
years.  
 
1.2 Rainbow trout 
Rainbow trout is native to North America and since 1874 has been introduced to all 
continents (with the exception of Antarctica) for aquaculture and recreational 
angling (FAO, 2010). Since the commercialisation of a fish pellet diet in the 1950s, 
production of this species has increased considerably (Fig 1.1), particularly in 
Europe, North America, Japan, Chile, and Australia. In Scotland, an estimated 7,600 
tonnes of rainbow trout were produced in 2008 alone (Marine Science Scotland, 
2008). This fish species can be grown quickly over a range of temperatures and does 
not require stringent water quality. Moreover, a great deal of knowledge has been 
generated for rainbow trout regarding reproduction, genetics, immunology, nutrition 
and health. Unfortunately, with the rapid expansion of fish farming, the numbers of 
disease outbreaks have increased considerably in recent years.  
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Figure 1.1: Global production of rainbow trout (in tonnes) by aquaculture between 
the years 1950 and 2009. Data obtained from the Food and Agriculture Organization 
of the United Nations (2010). 
 
 
1.3 Diseases of rainbow trout 
Outbreaks of disease can cause significant morbidity and mortality, often resulting 
in severe financial losses for the industry. A number of fish pathogens, both 
bacterial and viral, can cause disease in rainbow trout (some topical pathogens are 
shown in Table 1.1) and have since become the basis of further research (for 
extensive reviews see Gomez-Casado et al., 2011, Walker and Winton, 2010, Austin 
and Austin, 2007, Roberts, 2001, Toranzo et al., 2005). 
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Table 1.1: Fish pathogens currently problematic for aquaculture (after Roberts, 
2001, Austin and Austin, 2007). 
Pathogen      Disease    
 
Bacterial pathogens: 
Gram-positive: 
Bacillus spp.      Septicaemia, bacillary necrosis  
Lactococcus garvieae     Streptococcosis  
(formerly Enterococcus seriolicida)       
Mycobacterium marinum Mycobacteriosis (form of fish 
tuberculosis) 
Renibacterium salmoninarum   Bacterial kidney disease (BKD) 
Streptococcus iniae      Streptococcosis   
(formely S. shiloi)          
Streptococcus parauberis    -  
 
Gram-negative: 
Aeromonas bestiarum    Ulceration 
Aeromonas hydrophila Haemorrhagic septicaemia, red  
(formerly A. liquefaciens and A. punctata)  sore disease and fin rot  
Aeromonas salmonicida    Furunculosis, ulcer disease and 
       carp erythrodermatitis  
Edwardsiella ictaluri     Enteric septicaemia of catfish
  
Edwardsiella tarda     Edwardsiellosis and redpest  
Flavobacterium psychrophilum  Cold water disease, necrotic  
(formerly Cytophaga psychrophila) myositis and rainbow trout fry 
syndrome    
Hafnia alvei      Haemorrhagic septicaemia  
Pasteurella skyensis     Pasteurellosis 
Photobacterium damselae subsp. piscicida  Pseudotuberculosis   
(formerly Pasteurella piscicida)        
Piscirickettsia salmonis  Coho salmon syndrome and 
salmonid rickettsial syndrome 
Pseudomonas anguilliseptica   Red spot and winter disease 
Salmonella enterica subs. arizonae   Septicaemia 
(= Sal. choleraesuis subsp. arizonae 
and Sal. arizonae) 
Serratia liquefaciens     - 
Serratia marcescens     - 
Tenacibaculum maritimum  Bacterial stomatitis, gill disease 
(formerly Flexibacter maritimus) and necrotic myositis  
Vibrio anguillarum     Vibriosis   
Vibrio cholerae (non-O1)    Septicaemia   
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Vibrio harveyi      Eye disease, necrotising enteritis  
(formerly V. carchariae and V. trachuri)  and vasculitis 
Vibrio ordalii      Vibriosis   
Vibrio (= Aliivibrio) salmonicida Vibriosis (coldwater) and Hitra 
disease   
Vibrio vulnificus     Septicaemia  
Yersinia ruckeri Enteric redmouth (ERM) 
Viral pathogens: 
Infectious hematopoietic necrosis virus   General viraemia 
(IHNV)  
Infectious pancreatic necrosis virus   - 
(IPNV)     
Infectious salmon anaemia virus   - 
(ISAV) 
Salmon alphaviruses     - 
(SAVs)  
Spring viraemia of carp virus    - 
(SVCV)        
Viral haemorrhagic septicaemia virus  - 
(VHSV) 
 
 
 
The establishment of disease is often multi-factorial insofar as it depends upon the 
environment, the health status of the fish, and the virulence/infective dose of the 
pathogen. Many diseases are associated with so called ‘opportunistic pathogens’ 
which maintain an endemic (= carrier) state within the environment or host, only 
causing disease following another disease process (i.e. secondary infection) or 
stressful event (Austin and Austin, 2007). Nonetheless, there are some highly 
virulent bacterial pathogens, notably A. salmonicida and V. anguillarum, which do 
not require the host to be immunocompromised (Roberts, 2001). Resurgences in 
certain diseases initially controlled with some success by vaccination, such as 
enteric redmouth disease (ERM), are becoming increasingly problematic for 
aquaculture.  
 
1.4 Enteric redmouth disease (ERM) 
ERM, sometimes known as yersiniosis, “Hagerman redmouth” or “salmonid blood 
spot”, is a bacterial septicaemia which can affect farmed salmonids, part icularly 
rainbow trout. In severe cases, ERM outbreaks can result in the loss of 30-70% of 
Pathogen   Disease    Host  Source 
 
 
Gram-positive  
  
Lactococcus garvieae    Streptococcosis   Many fish species Austrailia, Europe, Saudi Arabia, Red 
(formely Enterococcus seriolicida)        Sea, South Africa, Twain and U.S.A.. 
    
Mycobacterium marinum   Mycobacteriosis (form of fish   Many fish species Worldwide 
   tuberculosis) 
 
Streptococcus iniae    Streptococcosis   Fresh water and costal Austrailia, Bahrain, Europe, Isreal, Japan, 
(formely S. shiloi)       fish  Saudia Arabia, Red Sea, South Africa,  
         Taiwan and the U.S.A. 
 
Streptococcus parauberis  Streptococcosis   Turbot  Spain 
 
Gram-negative  
 
Aeromonas hydrophila   Hemorrhagic septicemia, red sore   Many freshwater  Worldwide 
 (formely A. liquefaciens and A. punctata) disease and fin rot.    species 
 
Aeromonas salmonicida subsp. salmonicida  Furunculosis, ulcer disease and carp   Salmonids, cyprinids Worldwide 
(formely Haemophilus piscium)  erythrodermatitis.   and marine species 
 
Edwardsiella ictaluri   Enteric septicemia of cat fish.  Catfish   Indonesia, U.S.A. and Vietnam 
 
Edwardsiella tarda   Edwardsiellosis and redpest  Fresh water species Japan, Spain and U.S.A. 
 
Flavobacterium psychrophilum   Cold water disease, necrotic myositis   Salmonids and sea  Austrailia, Europe, Japan and 
(formely Cytophaga psychrophila)  and rainbow trout fry syndrome  lamprey  North America 
 
Hafnia alvei    Haemorrhagic septicemia  Cherry salmon and  Bulgaria, England and Spain 
       rainbow trout 
 
Pasteurella skyensis   Pasteurellosis   Atlantic salmon  Scotland 
 
Photobacterium damselae subsp. piscicida  Vibriosis    Damsel fish, sharks,  Europe and U.S.A.  
(formely Pasteurella piscicida)      redbanded sea bream, 
        turbot and yellowtail    
  
 
Piscirickettsia salmonis    Coho salmon syndrome and salmonid  Salmon and sea bass Canada, Chile, Greece, Norway and  
   rickettsiel syndrome.     Scotland 
 
Pseudomonas anguilliseptica  Red spot and winter disease  Rainbow trout, cod, Finland, France, Japan, Portugal,   
        eels, black spot sea  Scotland and Spain 
        bream and gilthead 
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fish stocks (Horne and Barnes, 1999). The aetiological agent is Yersinia ruckeri, a 
bacterium originally reported in the Hagerman valley of Idaho, USA, during the 
1950s by Rucker et al. (1966). This organism has since been found within North and 
South America (Ross et al., 1966, Stevenson and Daly, 1982, Bravo and Kojagura, 
2004), Australia (Bullock et al., 1978, Llewellyn, 1980), South Africa (Bragg and 
Henton, 1986), Iran (Soltani et al., 1999), and throughout most parts of Europe 
(Davies and Frerichs, 1989, Roberts, 1983, Lesel et al., 1983, Fuhrmann et al., 1983, 
Bush, 1978, Meier, 1986, Romalde et al., 1994b). 
 
1.4.1 Susceptibility to ERM 
Even though the majority of ERM cases occur in rainbow trout, other fish species of 
commercial importance are susceptible to infection (Furones et al., 1993) (Table 
1.2). Some reports have suggested that larger fish are more prone to ERM infections, 
although size alone cannot be a determining factor (Rucker, 1966). ERM epizootics 
in healthy, vaccinated livestock are extremely rare. When disease outbreaks do occur 
they commonly result in low-level mortalities, often leading to acute, large-scale 
epizootics if chronically infected fish become stressed (Hunter et al., 1980). 
Stressors include high stocking densities, extremes in temperatures, poor diets and 
over-handling. Pollutants, such as excess ammonia, are common stressors in 
aquaculture (Austin, 1998). Fish must also be adequately vaccinated against 
different forms of virulent Y. ruckeri strains to ensure protection. Incubation times 
for this disease in naturally infected fish range from 5 to 10 days at 13-15
º
C, albeit 
dependent upon the health status of the host (Bullock and Cipriano, 1990).  
 
1.4.2 Clinical signs of ERM 
Disease associated with ERM, as recently reviewed by Tobback et al. (2007), may 
be acute or chronic depending on the size of fish. Generally, fingerling fish show 
acute cases of disease, whereas the condition can become chronic in larger fish. In 
acute form, ERM can be indistinguishable from other fish diseases, particularly for 
those infections associated with A. hydrophila and A. salmonicida (Austin and 
Austin, 2007).  
 
As the name suggests, ERM is commonly associated with haemorrhaging of the oral 
cavity, whereas an absence of this symptom cannot necessarily rule out infection 
with Y. ruckeri (Avci and Birincioglu, 2005, Rucker, 1966, Bush, 1978, Austin and 
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Austin, 2007). Some ERM symptoms are shown in Fig 1.2. Eyes may protrude from 
the ocular cavity (= exophthalmia), whereas petechial (= pinprick) haemorrhaging is 
commonly observed both externally (e.g. around the anus, fins, gills, eyes and lateral 
body) and internally (e.g. on organs such as the pancreas, liver and swim bladder). 
Skin may darken due to the development of a granular melanosis. Other physical 
signs include the inflammation of the intestine (which is often filled with a thick, 
purulent fluid) and necrosis/liquefaction of internal tissues (Rucker, 1966, Horne 
and Barnes, 1999, Avci and Birincioglu, 2005, Austin and Austin, 2007). 
Histological examination of infected material has shown the presence of an acute 
bacteraemia, particularly in vascularised tissues and in areas of petechial 
haemorrhaging (Rucker, 1966). With respect to behaviour, fish become anorexic and 
lethargic, usually swimming near the water surface or retreating to areas with slow 
currents (Busch, 1983, Rucker, 1966). Some atypical infections associated with Y. 
ruckeri merely result in fish darkening in colour and swimming near the water 
surface (Frerichs et al., 1985).    
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Table 1.2: Fish species susceptible to Y. ruckeri infections (sourced from the 
Australian Government, Department of Agriculture, Fisheries and Forestry [2008] 
Aquatic Animal Diseases Significant to Australia: Identification Field Guide). 
Common name     Scientific name 
 
Common species susceptible to infection: 
Atlantic salmon      Salmo salar 
Brown trout       Salmo trutta 
Common carp      Cyprinus carpio 
Goldfish       Carassius auratus 
Rainbow trout      Oncorhynchus mykiss 
 
Other species susceptible to infection: 
Salmonids: 
Arctic char       Salvelinus alpinus 
Brook trout       Salvelinus fontinalis 
Chinook salmon      Oncorhynchus tschawytscha 
Coho salmon       Oncorhynchus kisutch 
Cutthroat trout     Salmo clarkii 
Sockeye salmon      Oncorhynchus nerka 
 
Non-salmonids: 
Bighead carp       Aristichthys nobilis 
Burbot       Lota lota 
Channel catfish      Ictalurus punctatus 
Cisco        Coregonus artedii 
Eel        Anguilla anguilla 
Emerald shiner      Notemigonus atherinoides 
Minnow       Pimephales promelas 
Silver carp       Hypophthalmichthys molitrix 
Sole        Solea solea 
Sturgeon       Acipenser baeri 
Turbot       Scophthalmus maximus 
Whitefish       Coregonus peled, C. muksun 
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Figure 1.2: Rainbow trout (Oncorhynchus mykiss, Walbaum) exhibiting some 
clinical symptoms commonly associated with enteric redmouth disease. A: Fish 
showing signs of haemorrhaging on both the skin and eyes along with an enlarged 
stomach (= ascites) due to the accumulation of liquid. B: Fish showing signs of 
generalised necrosis/liquefaction. C: Example of haemorrhaging both within and 
around the oral cavity, thereby giving rise to the term “redmouth”. D: Trout showing 
a marked protrusion of the eyeball (= exophthalmia) caused by the accumulation of 
underlying fluids. Photographs A, C and D sourced from the Australian 
Government, Department of Agriculture, Fisheries and Forestry (2008) Aquatic 
Animal Diseases Significant to Australia: Identification Field Guide . Photograph B 
courtesy of Professor Brian Austin, Institute of Aquaculture, University of Stirling, 
Scotland, UK.  
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1.5 Yersinia ruckeri  
1.5.1 Phenotypic characteristics 
Y. ruckeri belongs to the family Enterobacteriaceae and comprise Gram-negative, 
asporogenous rods with rounded ends approximately 0.75 µm wide and 1-3 µm long 
(Ross et al., 1966), although morphology can be altered by varying culture 
conditions (Austin et al., 1982). This bacterium grows better at lower temperatures 
(e.g. 22 to 25ºC) than at higher temperatures (e.g. 35 to 37ºC). Growth may cease at 
temperatures between 35 to 37ºC when cultivating Y. ruckeri on simple media 
(Ewing et al., 1978). Bacterial cells do not possess capsules (Ross et al., 1966), 
whereas some strains are motile by means of peritrichous flagella (Davies and 
Frerichs, 1989, Ross et al., 1966). Biochemically, Y. ruckeri isolates share a number 
of common features (Ross et al., 1966, Ewing et al., 1978, Frerichs, 1993). For 
example, all strains produce lysine decarboxylase, ornithine decarboxylase and β-
galactosidase, but not hydrogen sulphide and indole (Ross et al., 1966). Moreover, 
Y. ruckeri is oxidase-negative, nitrate-reductive, and capable of fermenting glucose 
and mannitol (Ross et al., 1966, Ewing et al., 1978, Frerichs, 1993). Conversely, 
sugars such as arabinose, inositol, mannitol, rhamnose or sucrose are not fermented 
(Ross et al., 1966, Frerichs, 1993).  
 
1.5.2 Taxonomy  
This organism, originally referred to simply as the “enteric redmouth (ERM) 
bacterium”, is biochemically similar to a Serratia or Yersinia spp. than any other 
members of the Enterobacteriaceae (Ewing et al., 1978). Taking into account the 
aggregate chemical reactions given by the ERM bacterium, this organism is 
biochemically more similar to Y. pestis, Y. pseudotuberculosis and Y. enterocolitica 
(Ewing et al., 1978). With respect to DNA relatedness, which was measured by 
hybridizing genomic DNA with 
32
PO4-labelled DNA fragments, this bacterium is 
30% similar to both Serratia and Yersinia spp. Again, this suggests that the 
organism could belong to either species. On the basis of guanine-plus-cytosine 
(G+C) content, the ERM bacterium is approx. 47.5 to 48.5%, and thus more akin to 
that of a Yersinia spp. (46 to 48% G+C) as opposed to a Serratia spp. (58% G+C). 
Of interest, it was Ewing et al. (1978) who devised the name Y. ruckeri in 
recognition of its isolation by Robert R. Rucker, a researcher who spent many years 
studying redmouth disease. The final decision to place this organism within the 
genus Yersinia has nonetheless remained controversial, with some researchers 
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suggesting that the taxonomic position of this organism should be reconsidered 
(Bercovier et al., 1984, Green and Austin, 1983, Kotetishvili et al., 2005, Bottone et 
al., 2005).  
  
Although there is a dispute as to what genus the ERM bacterium should belong, the 
species is genetically homogenous in that strains sourced from a wide geographical 
area are genetically identical or highly similar (Fernandez et al., 2003, Fernandez et 
al., 2007b, Kotetishvili et al., 2005, Schill et al., 1984, De Grandis et al., 1988). 
Some researchers, such as Schill et al. (1984), have suggested that the species is 
clonal. On the other hand, Y. ruckeri strains are serologically heterogenous (see 
below) and can differ in both morphology (Davies and Frerichs, 1989, Austin et al., 
1982) and in some biochemical tests (Austin et al., 1982, Green and Austin, 1983, 
Bush, 1978, De Grandis et al., 1988, Davies and Frerichs, 1989, Davies, 1991b, 
Davies, 1991a, Davies, 1990). 
 
1.5.3 Serotyping 
Whole-cell serological typing, which includes the recognition of numerous cell 
surface molecules (e.g. lipopolysaccharides [LPS] and outer membrane proteins 
[OMPs]) by polyclonal antisera raised in rabbits against specific strains, have shown 
Y. ruckeri to be serologically diverse. The species was originally considered to be 
comprised of six serovars (I-VI) (Stevenson and Daly, 1982, Ross et al., 1966, 
Bullock et al., 1978, Ewing et al., 1978, O’Leary, 1977, Stevenson and Airdrie, 
1984, Daly et al., 1986). The single serovar IV isolate was later removed from the 
species as it was most likely to be Hafnia alvei (De Grandis et al., 1988). Later, 
using a combination of slide agglutination tests and immunoblots against antigenic 
determinants (e.g. OMPs and LPS), Romalde et al. (1993) grouped the species 
within four serotypes (O1-O4) (Table 1.3). Serotype O1 was sub-divided into two 
groups; serotype O1a (= serovar I) and serotype O1b (= serovar III). Serovar III 
isolates were included within the serotype O1 category since they are serologically 
identical to that of a serovar I (Romalde et al., 1993). Similarly, serotype O2 (= 
serovar II) was split into three groups (serotype O2a, O2b and O2c), while serotypes 
O3 and O4 are comprised of serovar V and VI isolates, respectively. 
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Table 1.3: Relationship between serotypes, subgroups and serovars of Y. ruckeri 
(after Romalde et al., 1993, Tobback et al., 2007). 
New serotype New subgroup Serovar Designation 
 
O1   a   I  Hagerman 
   b   III  Australian 
O2   a, b, c   II  Oregon 
O3   NA   V  Colorado 
O4   NA   VI  Ontario 
 
NA = Not applicable 
 
 
The bacterial species can be broadly subdivided into two biotypes depending on 
their ability to produce a phospholipase and demonstrate motility (Davies and 
Frerichs, 1989). Thus, biotype 1 (= BT 1) isolates are positive for both motility and 
phospholipase activity (i.e. Tween 20/80 degradation), whereas biotype 2 (= BT 2) 
strains are negative for both phenotypes. 
 
Another classification system is one proposed by Davies (1990) based upon the 
reaction of heat-stable O-antigens with antisera raised in rabbits against inactivated 
whole-cells. Out of 127 isolates sourced from North America and Europe, five O-
serotypes (O1, O2, O5, O6 and O7) could be distinguished. Davies et al. (1991b) 
also differentiated Y. ruckeri strains by electrophoretically separating OMPs by 
molecular weight using sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE). Isolates were shown to have a 36.5 or 38 kiloDalton (kDa) heat 
modifiable protein and a peptidoglycan-associated protein with a molecular weight 
ranging between 36.5 and 40.5 kDa. These workers were subsequently able to 
identify clonal groups of Y. ruckeri using a combination of serotyping, biotyping 
(BT 1 or 2) and OMP-typing (Davies, 1991a). Hence, serotype O1 strains could be 
categorised into six clonal groups, two of which (group 2 and 5) being 
predominately associated with ERM in rainbow trout.     
 
Whereas sorbitol-positive serotype II (= serotype O2b) strains have been found to 
cause disease in brook trout (Salvelinus fontinalis) and Atlantic salmon (Salmo 
salar) (Cipriano et al., 1986), they were believed to be confined to North America 
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and the Baltic countries (Stevenson, 1997). However, isolates of this nature have 
since caused disease in non-vaccinated rainbow trout reared in Spain (Romalde et 
al., 2003).     
 
Serotype O1 “Hagerman” strains (= serovar O1a) are highly pathogenic strains for 
rainbow trout and are the most commonly isolated. These isolates are unique in that  
they lack the ability to ferment the sugar sorbitol (Ross et al., 1966). Serotype O1 
“Hagerman” strains were broadly considered to be motile and capable of producing 
a lipase, thereby placing these strains within BT 1. Still, the biotyping of 
“Hagerman” isolates is a topical area for research and one open for further 
discussion (Section 1.19) 
 
1.5.4 Molecular typing  
Whereas serology, morphology and biochemical reactions have proven useful in 
typing different Y. ruckeri strains, they are unable to directly compare the genetic 
relatedness between isolates. Some molecular techniques used to study Y. ruckeri 
include dot-blot DNA hybridizations (De Grandis et al., 1988), multi-locus enzyme 
electrophoresis (Schill et al., 1984), multi-locus sequence typing (Kotetishvili et al., 
2005) and ribotyping (Garcia et al., 1998). An interesting study by Wheeler et al. 
(2009) using pulsed field gel electrophoresis (PFGE), a technique whereby genomic 
DNA is digested with a restriction enzyme (in this case NotI) and separated on an 
agarose gel, can be used to differentiate strains. Of the 160 Y. ruckeri isolates 
studied by PFGE, which were sourced from a wide geographical range, 44 profiles 
or “pulsotypes” could be distinguished. Using PFGE in combination with techniques 
outlined by Davies (1991a) revealed that serotype O1 isolates, which caused ERM in 
both the US and Europe, represented a sub-group of similar pulsotypes. In this 
respect a combination of methods, including both molecular (e.g. PFGE) and 
serological, can be powerful tools in studying Y. ruckeri epidemiology.    
 
1.5.5 Plasmids 
A comprehensive study of Y. ruckeri plasmids using 183 isolates, sourced from a 
wide geographical range, was undertaken by Garcia et al. (1998). The majority of 
these strains (89.13%), irrespective of their geographical origin, carried a large 
plasmid with an apparent size of 75-MDa. Furthermore, this plasmid was confined to 
strains belonging to serotype O1. As noted by Garcia et al. (1998), the presence of a 
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large plasmid within serotype O1 isolates is not a new feature of this pathogen 
(Degrandis and Stevenson, 1982, Toranzo et al., 1983, Stave et al., 1987, Guilvout 
et al., 1988, Romalde et al., 1993). In addition to harbouring the 75-MDa plasmid, 
the majority of strains were also found to possess a plasmid of approx. 12.5 MDa 
(Garcia et al., 1998), again a feature observed by other workers (Degrandis and 
Stevenson, 1982, Stave et al., 1987, Romalde et al., 1993). On the other hand, some 
Y. ruckeri strains (including those belonging to serotype O1) do not possess 
plasmids or only carry plasmids with very low molecular weights (Degrandis and 
Stevenson, 1982, Stave et al., 1987, Romalde et al., 1993, Garcia et al., 1998).  
 
Since Y. ruckeri belongs to the genus Yersinia, and as the majority of virulent 
serotype O1 strains carry the 75-MDa plasmid, work initially focused on relating 
this plasmid to those associated with virulence in other Yersinia spp. (Degrandis and 
Stevenson, 1982, Stave et al., 1987, Guilvout et al., 1988). For example, using 
restriction mapping of plasmids with the enzyme BamHI and Southern 
blotting/hybridization, Guilvout et al. (1988) established that the 75-MDa plasmid 
was not related to the 42-47 MDa plasmid harboured by some Yersinia spp. (e.g. Y. 
pestis, Y. pseudotuberculosis and Y. eneterocolitica).  
 
Still, a potential role for this 75 MDa plasmid in virulence cannot be ruled out since 
the majority of pathogenic serotype O1 Y. ruckeri strains harbour this plasmid. 
Mendez et al. (2009) showed that the 75-MDa plasmid has some sequence identity 
to the type IV secretion system found within the Y. ruckeri chromosome. To what 
extent this identity extends has still to be determined since work by Mendez et al. 
(2009) primarily focused on the type IV sequence encoded within the Y. ruckeri 
genome.    
 
1.6 Y. ruckeri pathogenesis 
Bacterial pathogens, both for fish and higher animals (e.g. humans), use specific 
macromolecules or “virulence factors” to establish infection and disease. This can 
broadly include molecules associated with bacterial survival outside the host; 
movement and attachment; invasion of host tissues; evasion of the immune system 
and aiding systemic spread (Fig 1.3). Whereas each stage of infection and disease 
can be considered separately, it is important to note that this is a continuous process 
and that any one feature of virulence could be applied to different stages of disease. 
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Compared to other fish pathogens (e.g. A. hydrophila and V. anguillarum), little was 
known about the molecular basis of Y. ruckeri pathogenicity until very recently. It is 
possible that this lack of research was due, in part, to the successful development 
and commercialisation of a vaccine (Section 1.17.1). However, recent vaccine 
failure (Section 1.19) and a sporadic increase in ERM outbreaks has led to a number 
of excellent studies, as reviewed by Fernandez et al. (2007a), regarding Y. ruckeri 
pathogenicity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Diagrammatic representation of the four main stages of Y. ruckeri 
pathogenicity in vivo. This involves bacterial transmission and survival in the 
environment (1); attachment and adherence to host tissues (2); infection and 
systemic spread (3); and shedding of bacterial isolates into the environment (4). See 
text for details.  
 
 
1.7 Transmission and survival 
Y. ruckeri is thought to be spread by direct contact (= horizontal transmission) 
between infected and asymptomatic carriers (Rucker, 1966). Although the spread of 
this disease to different fish farms is generally considered to be through the import 
of infected fish (Austin, 2007), cases of ERM have occurred on fish farms which had 
not recently received new livestock (Bullock et al., 1978). Bush and Lingg (1975) 
were able to recover the bacterium from the internal organs of asymptomatic fish 
and suggested that up to 25% of the rainbow trout population could be carrying this 
1 
4 
3 
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organism within the lower intestine. What is more, the majority of fish surviving 
ERM infections become carriers of the bacterium. While movement of 
asymptomatic livestock can contribute to the spread of ERM, it is possible that other 
animals such as birds, wild fish, invertebrates and even humans may act as vectors 
(Willumsen, 1989). Hunter et al. (1980) found that stressing carrier fish can result in 
an increase in the periodic shedding of Y. ruckeri within faeces, which might persist 
for some time even after disease has subsided (Rodgers, 1992). This is likely since 
the occurrence of ERM is generally associated with stressed or overpopulated 
livestock. The ability to transmit Y. ruckeri from the parent to the offspring (= 
vertical transmission) is questionable since only Sauter et al. (1985) has recovered 
Y. ruckeri from non-fertilized Chinook salmon eggs.  
 
Whereas asymptomatic carriers are evidently a major source of infection, Y. ruckeri 
can remain viable for long periods of time within the aquatic environment. For 
example, bacterial cells can survive for at least 3-4 months in sediment or waters 
with salinities of 0-20%o (Thorsen et al., 1992) and have been confirmed to grow in 
vitro under very low saline conditions (< 9.0%o) (Altinok and Grizzle, 2001). 
Additional evidence suggests that stressed and/or nutrient-starved Y. ruckeri cells 
may enter a state of non-culturable dormancy, yet still retain virulence and 
infectivity (Romalde et al., 1994a). It is possible that the ability of this bacterium to 
survive for long periods of time within the environment might explain why ERM 
outbreaks have occurred on sites which had not recently received new livestock 
(Bullock et al., 1978). 
 
Environmental isolates of Y. ruckeri are also capable of forming biofilms, probably 
with the aid of flagellin or pili, on materials commonly associated with fish farms 
(e.g. wood) (Coquet et al., 2002a, Coquet et al., 2002b). Susceptibility assays to 
oxolinic acid demonstrated that sessile cells (those involved in biofilm formation) 
display a stronger resistance to this antimicrobial compared to  their planktonic 
counterparts. In this respect, biofilms may persist within water tanks even after 
treatment and thus be a likely source of recurring infections (Coquet et al., 2002b). 
Proteomic analysis of OMPs by Coquet et al. (2005) from immobilised and 
planktonic cells identified a number of differentially expressed proteins, including 
some involved in motility and metabolism.   
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1.8 Adherence and invasion  
Attachment and adherence is usually considered to be the first stage in invading the 
host and establishing infection. Romalde and Toranzo (1993) found that most Y. 
ruckeri strains are moderately adhesive to the salmon cell line CHSE-214. Similarly, 
Kawula et al. (1996) demonstrated that a Y. ruckeri strain was highly invasive for 
fathead minnow (FHM) epithelial cells, yet less so for other cell lines. However, 
probing the Y. ruckeri genome via Southern blotting with gene sequences which are 
commonly associated with adhesion/invasion in other pathogenic Yersinia spp. (e.g. 
inv from Y. pseudotuberculosis and ail from Y. enterocolitica) did not detect any 
genes with significant sequence identities (Kawula et al., 1996). 
 
Recently, in vivo and in vitro studies have established that the gills, particularly gill 
mucus, are major sites of attachment for Y. ruckeri cells (Tobback et al., 2009, 
Tobback et al., 2010a).  Moderate levels of bacteria were also found within skin and 
gut tissues shortly after infection, particularly within intestinal crypts, indicating that 
bacteria can survive the first line of host defences (Tobback et al., 2009). Moreover, 
a highly virulent isolate for rainbow trout in vivo (Tobback et al., 2009) was later 
shown to be highly adhesive in vitro for gill mucus compared to other isolates 
(Tobback et al., 2010a), proposing a possible link between virulence and attachment. 
Further investigation by Tobback et al. (2010b) established that attachment/invasion 
of gill and gut tissue was not significantly different between virulent and avirulent Y. 
ruckeri strains. Consequently, attachment/invasion is not a determining factor of 
virulence.  
 
Treating bacterial cells with proteases (e.g. pronase and trypsin) and salts which are 
known to distrupt membrane polysaccharides (e.g. sodium metaperiodate) 
significantly hindered cell adherence to gill mucus and cultured cell lines, while 
having little effect on cell viability (Tobback et al., 2010a). Thus, it is likely that 
both proteins and carbohydrates (e.g. glycoproteins and lectins) have a role in Y. 
ruckeri attachment.  
 
1.9 Systemic spread 
In addition to detecting a high number of bacteria attached to the gills shortly after 
infection, Tobback et al. (2009) also observed a large bacterial load within the gills 
themselves. Since the gills are highly vascularized, it is likely that bacteria 
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disseminate throughout the underlying capillaries (= septicaemia), eventually 
leading to colonization of internal organs. Using a green-fluorescent protein (GFP) 
tagged Y. ruckeri strain in vivo, Welch and Weins (2005) established that internal 
organs such as the kidney, spleen and peripheral blood have large bacterial loads 
following infection. 
 
1.9.1 Resistance to serum-mediated killing 
Tobback et al. (2010a) discovered that a highly virulent Y. ruckeri strain was present 
in large numbers within internal organs at 72 h post-infection, whereas bacterial 
numbers for an avirulent strain declined over several days post-infection and did not 
induce any mortality. It is likely that virulent strains are able to evade the fish 
immune system, resulting in a severe septicemia/necrosis of internal organs which 
eventually leads to host death. Tobback et al. (2010a) showed that virulent strains in 
vivo (Tobback et al., 2009) were resistant to serum-mediated killing in vitro 
(Tobback et al., 2009), whereas avirulent strains in vivo (Tobback et al., 2009) were 
all serum sensitive in vitro (Tobback et al., 2010a). Both studies are in agreement 
with earlier work by Davies (1991c) which demonstrated that virulent serotype O1 
Y. ruckeri strains (clonal groups 2 and 5) were resistant to the bactericidal effects of 
non-immune rainbow trout serum, whereas the majority of avirulent strains were 
serum-sensitive. Later, Haig et al. (2011) confirmed that virulent serotype O1 
isolates, which belong to both biotypes and are virulent for rainbow trout, were 
resistant to non-immune (naïve) rainbow trout serum (PNRTS) and non-immune 
(naïve) Atlantic salmon serum (PNASS).  
 
Although serotype O1 is usually considered to be the most virulent serotype for 
rainbow trout, Y. ruckeri may exhibit host tropism (i.e. specific strains which cause 
disease in a specific host species) insofar as some serotype O2 isolates are 
pathogenic for chinook salmon (Onchorynchus tshawytscha) and brook trout 
(Salvelinus fontinalis), but not rainbow trout (Cipriano et al., 1986, Cipriano and 
Ruppenthal, 1987, Davies, 1991c, Haig et al., 2011). There are nevertheless some 
exceptions to the notion that all virulent Y. ruckeri isolates are resistant to serum 
mediated killing and vice versa (Haig et al., 2011, Davies, 1991c). For instance, a 
serotype O2 isolate which was moderately pathogenic for both trout and salmon in 
vivo was sensitive to both PNRTS and PNASS mediated killing. Similarly, a 
serotype O1 isolate which was resistant to PNASS and PNRTS mediated killing was 
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highly virulent for salmon, but not for trout (Haig et al., 2011). Hence, while serum 
resistance is important for virulence, it is nevertheless clear that other important 
features contribute to the establishment of disease.  
 
It is also worth noting that research on understanding the precise mechanism by 
which Y. ruckeri can resist serum mediated killing is currently very limited. An early 
study by Furones et al. (1990) identified a heat-sensitive factor (HSF) which was 
produced by virulent serotype O1 strains, but not avirulent isolates. It is possible 
that the HSF, which was considered as lipid in nature, could contribute to serum 
resistance. Nonetheless, this is only speculative and requires further investigation. 
The aforementioned 75-kDa plasmid (Section 1.5.5), which is harboured by most 
serum-resistant serotype O1 isolates (Guilvout et al., 1988, Davies, 1991c, Garcia et 
al., 1998), may also be linked with serum resistance. This area should be researched 
further to gain a greater understanding of serum resistance.    
 
1.9.2 Survival within macrophages 
Like other fish pathogens, Y. ruckeri has the ability to survive and persist within 
trout macrophages, both in vitro and in vivo (Ryckaert et al., 2010a). Visualizing 
infected macrophages (0 to 24 h post-infection) indicated that bacterial cells were 
present within phagocytes as autophagocytic vacuoles where they were able to 
divide and proliferate. Interestingly, no fusion with macrophage lysosomes and 
bacteria-containing vacuoles was observed, suggesting that internalized bacteria 
prevent lysosome-mediated killing. Further, internalizing Y. ruckeri by trout 
macrophages did not induce apoptosis, suggesting that this pathogen does not result 
in cell death. 
 
Virulent Y. ruckeri isolates are known to stimulate a respiratory burst by fish 
macrophages shortly after infection (Stave et al., 1987). Ryckaert et al. (2010a) 
illustrated that reactive oxygen species (ROS) production peaked at 3 h post-
infection and was nearly undetectable at 5 h post-infection in vitro. Nonetheless, a 
virulent strain of Y. ruckeri was able to withstand ROS-mediated killing in vitro 
since bacterial numbers continued to increase within trout macrophages after 6 h 
post-infection. Ryckaert et al. (2010a) proposed that detoxifying enzymes such as 
the superoxide dismutase and catalase, which are produced by serotype O1 strains 
(Horne and Barnes, 1999), could prevent phagocytic killing of internalized bacteria. 
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Additional in vivo analysis by Ryckaert et al. (2010a), which is in agreement with 
data previously obtained by Welch and Wiens (2005), showed that during the early 
phase of infection the majority of bacterial cells are extracellular. Bacteria then 
move to become predominately intracellular after the first week of infection. The 
majority of intracellular bacteria were located within head kidney macrophages 
(Ryckaert et al., 2010a).   
 
Ryckaert et al. (2010a) suggests that the ability of Y. ruckeri to invade macrophages 
could shield against other cell-mediated and humoral immune responses (e.g. 
lysozyme). Similarly, macrophages are highly phagocytic and long-lived, meaning 
that they may offer long term protection against the host immune system.   
 
1.10 Extracellular products (ECPs) 
Extracellular enzymes or products (ECPs) are secreted by bacterial pathogens to 
facilitate colonization, aid host cell killing, evade host immune systems and utilize 
nutrients via the breakdown of macromolecules (e.g. proteins). These enzymes 
commonly include amylases, proteases, haemolysins, lipases and phospholipases. 
Work by Romalde and Toranzo (1993) established that Y. ruckeri isolates, 
irrespective of serotyping or virulence, produce moderate levels of ECPs with 
haemolysin, protease, phospholipase and amylase activities. Administering ECP 
preparations by injection showed that these enzymes are highly toxic for fingerling 
rainbow trout; causing signs of necrosis, haemorrhaging and darkening of the skin. 
On the other hand, LPS was not toxic to fingerling trout since purifying and 
injecting these molecules did not cause any mortalities.  
 
Since the publication of work undertaken by Romalde and Toranzo (1993), single 
enzymatic components of the ECPs have been studied in greater detail, particularly 
those relating to proteolytic and haemolytic activities (Secades and Guijarro, 1999, 
Fernandez et al., 2002, Fernandez et al., 2003, Fernandez et al., 2004, Fernandez et 
al., 2007b).  
 
1.10.1 Extracellular protease Yrp1 
After protease activity was detected in crude ECP extracts (Romalde and Toranzo, 
1993), Secades and Guijarro (1999) varied culturing conditions to determine what 
effect this may have on protease (= caseinolytic) activity. Their results indicated that 
CHAPTER 1: INTRODUCTION    
20 
 
protease production/activity was under catabolic repression. For example, 
caseinolytic activity increased when grown in peptone or nutrient broth (NB), but 
was significantly reduced when grown in the presence of casamino acids, 
carbohydrates (e.g. glucose) or ammonium chloride. Proteolytic activity was also 
higher at the average temperature of infection (e.g. 17-20
º
C) when compared to 
cultures grown at higher temperatures (e.g. 25
º
C). After purifying native 
extracellular protein, Secades and Guijarro (1999) found that caseinolytic activity 
was due to a single 47 kDa alkaline (near pH 8 optimum) Mg
2+
 dependent 
metalloprotease which is unstable at temperatures above 42
º
C (i.e. cold-adapted). 
What is more, some Y. ruckeri strains do not produce this protease, thereby allowing 
strains to be classified as positive (Azo
+
) or negative (Azo
-
) for caseinolytic activity.  
 
Further genetic studies by Fernandez et al. (2002) found that the Y. ruckeri protease 
gene, termed yrp1 (Yersinia ruckeri protease 1 gene), encodes a protein which 
shares a high level of homology to a serralysin metalloendopeptidase. Furthermore, 
DNA sequencing showed that the yrp1 gene was next to a cluster of genes (yrpD, 
yrpE and yrpF) involved in the secretion of the Yrp1 protease by means of a type I 
secretion system. A putative protease inhibitor (inh) encoding gene was also shown 
to be near the yrp1 gene. To determine the role that the Yrp1 protease has in 
virulence, site-directed null mutations were introduced into the yrp1 or yrpE genes. 
Although these mutants were able to grow in nutrient broth, no proteolytic activities 
were found in the supernatant, nor was the extracellular protease detectable when 
analysed on a 1D-SDS-PAGE gel. Pathogenicity for both mutant strains was also 
severely reduced, with LD50 values for both mutant strains nearly two orders of 
magnitude higher than that of the parent strain. These results confirm a role of the 
Yrp1 protease in establishing disease.  
 
Pertaining that the extracellular protease Yrp1 is secreted by the Y. ruckeri 
bacterium in vivo, Fernandez et al. (2003) endeavoured to determine what fish 
matrix or muscle proteins this enzyme may be able to degrade. Proteolytic assays 
showed that the Yrp1 protease can hydrolyse a wide range of tissue associated 
proteins, including fibronectin, gelatin and, to a lesser extent, type I collagen, 
fibrinogen and laminin. With the use of yrp1::lacZ fusions, it was shown that 
expression of this gene was higher at 18
º
C as opposed to the optimum growth 
temperature of this bacterium (i.e. 28
º
C). Expression levels for this protease were 
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higher in the gills and intestine, and as suggested by the authors, degradation of 
laminin at these sites may aid systemic spread and invasion of tissues. Furthermore, 
hydrolysis of basal laminin could cause pores to form within capillary blood vessels, 
resulting in the leakage of blood through micro-haemorrhages. This might account 
for the so-called “redmouth” symptom associated with ERM.  
 
Although Azo
-
 strains of Y. ruckeri contain the genes necessary to produce the Yrp1 
protease (Fernandez et al., 2003), they do not produce the protease in vivo or in 
vitro. Whereas yrp1 and yrpE mutants were severely reduced in virulence towards 
trout (Fernandez et al., 2002), they could still cause some signs of disease. It is 
plausible that other ECPs, such as the extracellular haemolysin/cytolysin identified 
by Romalde et al. (1993), may work synergistically with the Yrp1 protease in 
breaking down host tissues and aiding systemic spread.   
 
1.10.2 Extracellular haemolysin YhlA 
Work by Fernandez et al. (2004) using in vivo expression technology (IVET) 
identified a putative gene with a high level of identity to a Serratia-type haemolysin. 
Further analysis of this locus identified the presence of two genes, yhlB and yhlA, 
which were found to be co-transcribed from a common promoter to make the yhlBA 
operon (Fernandez et al., 2007b). The yhlB gene encodes a 561 amino acid protein 
which is possibly located at the outer membrane and involved in both the secretion 
and activation of the extracellular haemolysin. The second gene, yhlA, encodes a 
protein with a high sequence identity to a Serratia-type pore-forming toxin. 
Transcriptional analysis of the yhlBA operon indicated that expression was higher at 
lower temperatures (i.e. 18
°
C) and when grown in iron-limiting conditions, a feature 
not dissimilar to the expression of the yrp1 protease gene (Fernandez et al., 2003, 
Fernandez et al., 2004). Additionally, yhlA or yhlB mutants were severely reduced in 
their virulence for fish, with LD50 values 10 to 100-fold higher than that of the 
parent strain. Cytotoxicity for the yhlA mutant was likewise reduced compared to the 
wild-type strain, thus confirming the cytotoxic effects of this enzyme. To determine 
if the yhlBA operon is a conserved feature of the Y. ruckeri genome, 12 
environmental isolates from a wide geographical area were analysed by PCR to 
amplify the genes of interest. All strains tested showed the presence of this operon, 
again confirming the homogenous nature of this bacterial species (Section 1.5.2). As 
proposed by Fernandez et al. (2007b), the pathogen may use the YhlA enzyme to 
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lyse erythrocytes, thus resulting in the release of intracellular proteins which are 
bound to iron (e.g. haemoproteins). 
 
1.11 Iron-acquisition and siderophore production 
Iron is an essential requirement for most bacterial fish pathogens to proliferate 
within the host. Although the YhlA haemolysin is used by the pathogen to release 
intracellular haemoproteins (Fernandez et al., 2007b), other methods associated with 
iron scavenging and acquisition have been described for this bacterium. Romalde et 
al. (1991) demonstrated that Y. ruckeri can grow under iron-limiting conditions and 
that strains sourced from a wide geographical range representing different serotypes 
produced phenolate siderophores. Strains were also shown to have a number of 
OMPs which were inducible under iron-limiting conditions, yet repressed when iron 
was available in sufficient quantities (Davies, 1991d, Romalde et al., 1991). In 
addition to identifying genes involved in the excretion of YhlA, Fernandez et al. 
(2004) located genes involved in siderophore-mediated iron uptake. One of these 
genes, named rupA, shared significant identity (52%) to a TonB-dependent receptor 
from the plant pathogen Erwinia chrysanthemi. Other genes identified include those 
involved in catechol siderophore (ruckerbactin) biosynthesis (rucC); ruckerbactin 
secretion (rucS); periplasmic binding of iron-associated ruckerbactin (rupB) and its 
transport to the cytoplasm via an inner membrane permease (rupDGC and exbB). 
Gene expression was upregulated when the bacterium was grown in iron-limiting 
conditions or when grown at lower temperatures. Thus gene expression was not 
dissimilar to that of other virulence related genes (e.g. yrp1 and yhlA) insofar as 
temperature and iron availability were influencing factors. Introducing mutations 
within the rucC or rupG gene significantly hindered growth in vitro and reduced 
virulence, particularly for rucC mutants which had LD50 values of at least 100-fold 
higher than that of the wild-type strain. Evidently, like other fish pathogens, the 
ability to acquire iron in vivo is important for Y. ruckeri pathogenesis.  
 
1.12 In vivo expression technology (IVET) 
In addition to identifying the catecholate siderophore ruckerbactin, and the 
extracellular YhlA haemolysin/cytolysin (Section 1.10.2), other in vivo-induced 
genes have been identified using IVET by Fernandez et al. (2004). For example the 
ivi Y. ruckeri clone iviXII, which exhibited a reduction in virulence towards trout 
(Fernandez et al., 2004), has since been studied in detail by Mendez et al. (2009). 
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This mutant carried a DNA insertion within a group of putative genes with a shared 
identity to a type IV exporter. More specifically, these sequences had a significant 
identity (35 to 58%) and near identical structure to the traH-I-J-K-C-L-M-N operon 
(tra operon) located on the pADAP plasmid of Serratia entomophila. Interestingly 
the G+C content of the loci was 53.6%, a value which is slightly higher than that 
reported for the cumulative genome of Y. ruckeri (47 to 48%), suggesting that it was 
acquired from another bacterial species via horizontal gene transfer. Thus it is 
possible that the putative tra locus within the chromosome of Y. ruckeri was 
acquired from S. entomophila (Mendez et al., 2009).   
 
Using a traI isogenic mutant (traI::pIVET8) in an in vivo competition assay with the 
parental strain, Mendez et al. (2009) established that the traI mutant was attenuated 
in its ability to grow within the fish. Yet growth in vitro under laboratory conditions 
was not altered compared to the parent strain. Expression analysis of the Y. ruckeri 
traI promoter confirmed that expression was higher at lower temperatures (i.e 18
°
C), 
but severely repressed when grown in complex and/or nutrient rich medium. As 
outlined by Mendez et al. (2009), facultative intracellular bacteria such as 
Legionella pneumophila require an intact type IV export system to survive 
intracellularly. Given that the type IV excretion system in Y. ruckeri contributes to 
growth in vivo, it is possible that these genes may have a role in intracellular 
survival. Further investigation with regard to the role of this type IV secretion 
system in intracellular survival would be interesting, particularly in light of recent 
research on this pathogens ability to survive intracellularly (Section 1.9.2).   
 
In addition to possessing a type IV secretion system, it should be noted that Y. 
ruckeri carries a putative type III secretion system (TTSS) within the genome 
(Gunasena et al., 2003). Nonetheless, its role in virulence has yet to be determined.  
 
Another in vivo-induced clone (Y. ruckeri 150RiviIX) described by Fernandez et al. 
(2004) containing a partial ORF with significant homology to a TctC protein of the 
tripartite tricarboxylate transporter family was later investigated by Navais et al. 
(2011). In this study, an operon involved in the transportation of citrate was 
identified and named as (Yersinia citrate transporter) yctCBA. This operon was 
expressed at higher levels (i.e. 3.5 fold increase) when cells were incubated in media 
supplemented with citrate, yet repressed in the presence of glucose. Expression was 
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also higher at the temperature of infection (i.e. 18ºC) as opposed to the optimum 
growth temperature (i.e. 28ºC). Whereas the yctCBA operon does have a 
physiological role in the uptake of citrate, it does not contribute to virulence as LD50 
values were not significantly different between the yctC mutant or wild-type Y. 
ruckeri 150R strain.  
 
1.13 Signature tagged mutagenesis  
Dahiya and Stevenson (2010b) used signature tagged mutagenesis to identify genes 
which are required for persistence and survival within rainbow trout. Out of 1056 Y. 
ruckeri mini-Tn5 signature-tagged mutants, 25 were unable to survive within 
rainbow trout and were significantly reduced in virulence. All mutants of interest 
were able to grow and survive in vitro, suggesting that the mutations possessed by 
these strains altered their ability to invade tissues and survive. One of these mutants 
appeared to possess a mutation in the tight adherence locus (Tad) which encodes 
bundle-forming pili. As discussed by Dahiya and Stevenson (2010b), the Tad locus 
was previously found by Fernandez et al. (2004) to be expressed in vivo. Thus, 
bundle-forming pili may be required for the initial attachment and invasion of host 
epithelial cells, eventually leading to the systemic spread of the bacterium.   
 
Mutations in other genes associated with the bacterial surface which could 
contribute to bacterial attachment were also identified by Dahiya and Stevenson 
(2010b). One of these mutants (termed F1-2) carried a mutation within a gene 
relating to O-antigen biosynthesis which could, in turn, contribute to the production 
of LPS. Preliminary analysis of LPS profiles by researchers on both the parent and 
mutant (F1-2) strain suggests that there are little (if any) in the way of differences 
between them.  
 
A second Y. ruckeri mutant strain (termed C6-1) carried a mutation within a 
homolog of znuA, a gene which encodes a periplasmic protein (ZnuA) involved in 
the high-affinity zinc transporter ZnuABC. In a similar manner to iron (Section 
1.11), zinc is an essential element for survival and can often affect the expression of 
virulence-related genes. Later, Dahiya and Stevenson (2010c) showed that a Y. 
ruckeri isolate carrying a deletion in the znuABC locus (∆znuABC) was severely 
reduced in virulence compared to the wild-type strain in vivo. Additionally, this 
mutant had nearly 150 to 350-fold lower infection loads in the kidney compared to 
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the parent strain after 5 days post-challenge. However, the ∆znuABC Y. ruckeri 
strain was not significantly altered in growth compared to the parent strain when 
cultured in zinc-limiting conditions in vitro, suggesting the presence of more than 
one zinc transporter.  
 
A third STM Y. ruckeri mutant (termed F2-4) which was reduced in virulence 
towards rainbow trout (Dahiya and Stevenson, 2010b) has since been characterised 
in detail by Dahiya and Stevenson (2010a). This mutant strain had a transposon 
insertion within a putative UvrY homolog of a two-component system (TCS) known 
as BarA-UvrY.  Dahiya and Stevenson (2010a) determined that the F2-4 mutant was 
sensitive to H2O2 mediated killing and significantly reduced in its ability to 
invade/survive within epithelial EPC cells. Also, fewer cells of the F2-4 mutant were 
isolated from the kidney compared to the parent strain after 24 h post-infection. 
Authors suggested that a reduction in the number of mutant bacterial cells within the 
kidney could be due to lower invasion capabilities and a heightened sensitivity to 
oxidative stress (i.e. H2O2-mediated killing of phagocytic cells).  
 
1.14 Environmental factors 
It is evident that the expression of some virulence factors is higher at lower 
temperatures and when free iron availability is low. A recent study by Haig et al. 
(2011) recognized that the temperature of infection can alter the virulence of 
pathogenic strains. For example, a pathogenic serotype O1 Y. ruckeri strain was 
highly virulent (74% mortality) for Atlantic salmon using bath exposure at 16°C, yet 
significantly reduced in virulence at 12°C (33% mortality). Similar results using a 
virulent serotype O5 isolate as the challenge strain was also observed by Haig et al. 
(2011). Albeit tempting to assume that the expression of virulence genes (e.g. yhlA, 
yrp1 and rucC) might be elevated at 16°C as opposed to 12°C, other contributing 
factors such as quorum sensing may have a role in establishing disease. 
 
1.14.1 Quorum sensing  
The ability to regulate virulence gene expression with respect to bacterial cell 
density via quorum sensing (QS) has become an interesting field of study for a 
number of pathogenic bacteria, including those harmful for fish (Natrah et al., 
2011). QS is a form of cell-to-cell communication through the recognition of small 
signal molecules, commonly acylated homoserine lactones (AHLs), by two-
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component systems which ultimately regulate some bacterial phenotypes (i.e. those 
associated with virulence). In addition to understanding virulence phenotypes with 
respect to bacterial density/AHL concentrations, identifying so-called quorum 
sensing inhibitors (QSIs) may prevent disease outbreaks and become an alternative 
to antimicrobial treatments. This is an attractive method for controlling Y. ruckeri 
infections since this organism has a broad resistance to antimicrobials commonly 
used in aquaculture (Section 1.16). Preliminary analysis by Bruhn et al. (2005) 
showed that Y. ruckeri produces moderate amounts of AHLs, specifically an N-3-
oxo-octanoyl homoserine lactone (OOHL) and N-3-octanoyl homoserine lactone 
(OHL). What is more, these AHLs are detectable from fish tissues infected with Y. 
ruckeri, suggesting an in vivo role for QS. 
 
Y. ruckeri can produce a wide range of AHLs, including eight detectable analogues 
from over three different AHL classes (Kastbjerg et al., 2007). The most 
predominant AHL produced by Y. ruckeri is 3-oxo-C8-HSL (Kastbjerg et al., 2007). 
In an attempt to determine what role QS may have in regulating virulence, Kastbjerg 
et al. (2007) endeavoured to relate Yrp1 protease production with different AHLs 
and QSIs. However, after testing different AHLs or QSIs at various concentrations 
under different culturing conditions, production of the extracellular protease was 
generally not altered by these chemicals. In this respect, preliminary data implies 
that this virulence factor was not under QS regulation. This is currently the only 
published study to date which attempts to correlate QS to virulence phenotypes of Y. 
ruckeri.  
 
Genes potentially involved in Y. ruckeri quorum sensing were identified by 
Temprano et al. (2001) by constructing a genomic library from a virulent Y. ruckeri 
strain in E. coli and streaking against Chromobacterium violaceum to test for the 
production of violacein. This is a dark, purple pigment which is produced by C. 
violaceum and is indicative of AHL production. One of the E. coli transformants, 
which stimulated violacein production, was shown to possess a genomic Y. ruckeri 
fragment containing two open reading frames (ORFs) with shared homology to 
genes encoding the LuxR/LuxI protein family. The first Y. ruckeri ORF, termed 
yruR, encoded a predicted protein of 247 amino acids (aa) and shared significant 
homologies to that of a transcriptional activator originally identified in V. fischeri. 
The second ORF (termed yruI) encoded a predicted protein of 217 aa which is 
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potentially involved in AHL synthesis. Even though these genes proved useful in 
detecting Y. ruckeri in a PCR reaction, their role in virulence was not deduced. It 
would be interesting to construct mutations within the yruR/yruI genes to determine 
if this has any effect on pathogencicty in vivo. Nonetheless, the identification of 
AHL production by Y. ruckeri in vivo implies that QS has a role in virulence (Bruhn 
et al., 2005).    
 
1.15 Diagnosis and detection of Y. ruckeri   
Given the number of symptoms associated with ERM (Section 1.4.2), and since 
some fish may be asymptomatic carriers of disease, diagnosis cannot be based on 
clinical symptoms alone. Other methods of identification and detection must 
therefore be used. 
 
1.15.1 Bacteriological and serological detection 
Fish are usually killed to recover Y. ruckeri. Non-lethal methods such as faecal 
analysis (Hunter et al., 1980, Rodgers, 1992, Busch and Lingg, 1975) and kidney-
biopsy (Noga et al., 1988) are available for diagnosing rare and/or valuable fish.  
Generally, the organism can be recovered from infected tissues and organs (e.g. 
kidneys) and cultured on a variety of growth media including tryptone soya agar 
(TSA) (Stevenson and Daly, 1982); nutrient agar (NA) (Secades and Guijarro, 
1999); brain heart infusion agar (Arias et al., 2007); Columbia blood agar (Gibello 
et al., 2004) and MacConkey agar (Gibello et al., 1999). Selective media are 
available for culturing Y. ruckeri (Furones et al., 1993, Waltman and Shotts, 1984), 
although they are not routinely used in diagnostics (Dr D. Austin, Heriot-Watt 
University, personal communication).   
 
When culturing Y. ruckeri on TSA and NA at 20-28
º
C for 48 h; raised, circular and 
opaque colonies of 2 to 3 mm in diameter develop (Ross et al., 1966, Bullock et al., 
1978). Biochemical characteristics discussed earlier in Section 1.5.1 can be used to 
identify the pathogen. The commercialisation of biochemical test kits, such as the 
API 20E rapid identification system, has significantly improved the ease of 
diagnosis. Still, API 20E test strips may be unable to differentiate Y. ruckeri from 
some other enterics, namely Hafnia alvei (Austin et al., 2003). Serological methods, 
such as an enzyme linked immunosorbent assay (ELISA) (Austin et al., 1986) and 
an immunofluorescence antibody technique (IFAT) (Smith et al., 1987) have been 
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developed to recognise some Y. ruckeri isolates. As outlined by Bullock and 
Cipriano (Bullock and Cipriano, 1990), polyclonal antibodies cannot react with all 
known serotypes. Thus negative or weak reactions with antibodies cannot 
necessarily rule out the possibility of Y. ruckeri. For instance, Austin et al. (2003) 
showed that polyclonal antisera raised in rabbits against inactivated Y. ruckeri cells 
agglutinated only weakly with isolates sourced from fish showing signs of ERM. It 
was only when molecular methods, such as the sequencing of 16S ribosomal RNA 
(rRNA) was performed, that strains were in fact identified as Y. ruckeri. 
 
1.15.2 Molecular methods of diagnosis and detection 
Although bacteriological and serological methods can be used to identify Y. ruckeri, 
these methods are often laborious, costly and time consuming. Alternatively, 
polymerase chain reaction (PCR) can be used to rapidly and specifically identify Y. 
ruckeri, both in artificially and naturally infected tissues, using primers which target 
non-conserved rRNA sequences (Altinok et al., 2001, Gibello et al., 1999). Other 
molecular methods of detection include multiplex PCR (Del Cerro et al., 2002, 
Altinok et al., 2008, Onuk et al., 2010), reverse-transcriptase PCR (Wilson and 
Carson, 2003, Glenn et al., 2011, Keeling et al., 2012), infrared spectroscopy 
(Wortberg et al., 2012) and a highly sensitive loop-mediated isothermal 
amplification (LAMP) assay (Saleh et al., 2008). The latter test, which was 
optimised to amplify the Y. ruckeri QS genes yruR/yruI described by Temprano et 
al. (2001) (Section 1.14.1), is of particular interest in that it is fast and does not 
require extensively trained personnel or specialist equipment. In principle, only a 
water bath and a set of primers are required to perform a LAMP reaction. Whereas 
molecular based methods have advanced considerably within the past 20 years, it is 
worth noting that they are not usually used as standalone methods of diagnosis. 
Generally, a combination of both molecular and more traditional diagnostic methods 
(e.g. biochemical tests) are used for identification (Austin et al., 2003).  
 
1.16 Treatment and control methods 
Once ERM occurs in livestock, the options for treatment are somewhat limited. As 
outlined by Austin and Austin (2007), antimicrobials such as quinolones and 
sulphamerazine (Rucker, 1966), tribrissen and tiamulin (Bosse and Post, 1983), 
potentiated sulphonamides (Bullock et al., 1983), and oxolinic acid (Rodgers and 
Austin, 1983) have been used with some success to alleviate ERM symptoms. The 
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use of antimicrobials is often a contentious issue since it has led to the development 
and spread of antibiotic resistance genes (Degrandis and Stevenson, 1985, Gibello et 
al., 2004). Antimicrobials aside, there are very few other alternatives but to impose 
movement restrictions and cull infected livestock when disease occurs. Prophylaxis 
in aquaculture is often considered to be more important than treatment, with a 
number of preventative measures now available to avert disease (Austin and Austin, 
2007).  
 
1.16.1 General prophylaxis 
As with many opportunistic fish pathogens, the occurrence of ERM is usually linked 
with immunocompromised livestock due to inadequate husbandry (i.e. high stocking 
densities and unsanitary waters) (Austin and Austin, 2007, Tobback et al., 2007). 
Reducing stocking densities, sterilizing equipment (e.g. ponds and utensils)  and 
practising good feeding regimes can considerably reduce the likelihood of disease 
outbreaks. Selective breeding of fish, with a focus on increasing the efficiency of the 
host’s innate immune system, has also been considered to decrease host 
susceptibility to Y. ruckeri infection (Austin and Austin, 2007). A notable study by 
Hadidi et al. (2008) demonstrated that a larger spleen significantly increased 
resistance to challenge with Flavobacterium psychrophilum, but not to Y. ruckeri, 
suggesting that resistance is pathogen-specific. Although unsuccessful in terms of 
protecting against ERM, it is nevertheless a step forward in determining factors 
associated with selective breeding and increased resistance to Y. ruckeri infection.   
 
1.16.2 Probiotics and immunostimulants 
In addition to adequate husbandry and feeding regimes, probiotics have been 
successfully used in aquaculture or in an a laboratory environment to prevent ERM 
(Abbass et al., 2010, Kim and Austin, 2006, Brunt et al., 2007, Raida et al., 2003, 
Capkin and Altinok, 2009, Sica et al., 2012). Probiotics are broadly defined as 
“living microorganisms which when administered in adequate amounts confer a 
health benefit on the host" (FAO; World Health Organization). For example, 
supplementing rainbow trout feed with Carnobacterium spp. (e.g. C. divergens and 
C. maltaromaticum) increased resistance to challenge with a highly virulent Y. 
ruckeri strain (Kim and Austin, 2006). Fish treated with these probiotics had 
significantly heightened phagocytic activity for head kidney macrophages and 
increased lysozyme activities for serum and gut mucus. Hence, it is possible that 
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probiotics stimulate the innate immune system, thereby priming the host against 
bacterial infection. Probiotics may also be beneficial for the host insofar as they 
could produce inhibitory compounds and/or compete with the pathogen for nutrients 
and adhesion sites (Tobback et al., 2007).   
 
In addition to probiotics, administering other compounds in the diet can have a 
positive effect on health and/or elicit immunostimulatory effects which may be 
beneficial in combatting Y. ruckeri infections. These include algal extracts 
(Gioacchini et al., 2008, Sheikhzadeh et al., 2012), vitamins (Furones et al., 1992), 
oestrogens (Wenger et al., 2011), and β-mercaptoethanol treated yeast cells 
(Tukmechi et al., 2011). An interesting study by Ryckaert (2010b) showed that a 
non-lethal heat shock (NLHS) for platyfish (Xiphophorus maculatus) increased the 
production of heat shock proteins (HSPs) which could stimulate the immune system 
and increase survival against challenge with Y. ruckeri. When recombinant HSPs 
from E. coli were administered to fish, in addition to NLHS, levels of survival after 
challenge slightly increased (20%). For bacterial HSPs to be an economically viable 
vaccine, further research must be carried out before it can be applied on an industrial 
scale.  
 
Overall, though good husbandry in combination with other non-specific techniques 
(e.g. probiotics) can significantly reduce the possibility of an ERM outbreak, 
sporadic cases still occur due to the endemic nature of Y. ruckeri. This necessitates 
the development of more specific methods (i.e. vaccines) in an attempt to prevent 
outbreaks of disease. 
 
1.17  Vaccines 
Vaccine development has become crucial in recent years for preventing many fish 
diseases, including ERM (Stevenson, 1997). The nature of vaccines are varied and 
can broadly include inactivated whole cells, live attenuated bacteria, purified protein 
sub-units, and recombinant (DNA/protein) vaccines. Nonetheless, the application of 
a formalin-inactivated whole cell (= bacterin) vaccine has generally prevented ERM 
with some success.  
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1.17.1 Bacterin vaccines 
Work to produce a successful bacterin vaccine can be linked back to the work of 
Ross and Klontz (1965). These workers found that orally administering phenol-
inactivated bacterial cells mixed with feed resulted in high levels of protection (90% 
survival) against challenge with a virulent Y. ruckeri strain. Later studies 
demonstrated that inactivated preparations can be administered to fish either orally, 
by injection, immersion (fish are bathed in a diluted preparation), showering, 
spraying, and via anal intubation (Ross and Klontz, 1965, Anderson and Nelson, 
1974, Cossarini-Dunier, 1986, Johnson and Amend, 1983a, Johnson and Amend, 
1983b). Although injection is superior for conferring protection against artificial 
challenge with Y. ruckeri (Johnson and Amend, 1983a, Vignuelle, 1990, Anderson 
and Nelson, 1974), this method is impractical for large-scale vaccinations and is 
generally reserved for large and/or valuable fish (Austin and Austin, 2007). 
Nevertheless, McCarthy and Anderson (1982) showed that vaccinating fish against a 
sorbitol-negative serotype I Y. ruckeri isolate widely cross-protected against 
challenge with other serotype I isolates. Vaccinating fish with a sorbitol-negative 
serotype II strain (Cipriano et al., 1986), or indeed a serotype I isolate, protected 
fish against challenge irrespective of serotypes (Cipriano and Ruppenthal, 1987). 
 
It is worth noting that although the bacterin vaccine has generally offered a high 
level of protection against ERM, it has recently failed to protect against an emerging 
strain of Y. ruckeri (Section 1.19). A new formulation of inactivated bacteria is now 
commercially available which offers some level of protection against this new strain. 
Still, outbreaks of this kind will inevitably occur again in vaccinated fish, thereby 
necessitating the development and/or improvement of next generation vaccines.  
 
1.17.2 Attenuated vaccines 
The use of attenuated bacteria as a vaccine is believed to have a number of benefits 
over traditional bacterins as they elicit a stronger cell-mediated response (Marsden 
et al., 1996) and can mimic natural infection (e.g. express stress-related proteins), 
yet not lead to the diseased state. Temprano et al. (2005) developed a live, 
attenuated Y. ruckeri vaccine by insertionally inactivating the aroA gene via allelic 
replacement with a DNA fragment containing a kanamycin resistance (Km
R
) marker 
(aroA::Km
R
). The aroA gene, which encodes the enzyme 5-enolpyruvylshikimate-3-
phosphate synthase, is essential for producing chorismic acid in vivo, a prerequisite 
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for synthesizing p-aminobenzoic acid, aromatic amino acids and folate. Actually, 
aroA::Km
R
 Y. ruckeri mutants were significantly attenuated in virulence for fish and 
were not recoverable from organs 48 h post-vaccination. Intraperitoneal (i.p.) 
vaccination with this mutant also conferred excellent protection against challenge 
with the wild-type Y. ruckeri strain (RPS = 87.5-93.75%). Although the DNA 
insertion within the aroA gene was deemed stable, use of an attenuated vaccine is 
often met with some criticism for fear of reverting back to virulence (Austin and 
Austin, 2007). Moreover, recombinant bacteria of this nature can be shed from 
vaccinated fish and thus result in environmental contamination (Vivas et al., 2004). 
It should also be noted that stigma surrounding live vaccines, even if they are 
deemed safe for use, is often still met with criticism in the aquaculture industry 
(Professor B. Austin, Stirling University, personal communication). 
 
1.17.3 Protein sub-unit vaccines 
Fernandez et al. (2003) investigated the immunogenicity of the extracellular 
protease Yrp1 (Section 1.10.1) by heat-inactivating the enzyme (= toxoid) and 
administering to fish as a vaccine. Initial results suggested that i.p. injection of this 
toxoid gave excellent protection (95% survival) against Y. ruckeri infection. 
Although not directly stated by the author, the challenge strain (Y. ruckeri 150) was 
previously shown to be an Yrp1 producing (Azo
+
) isolate (Secades and Guijarro, 
1999). Should protection be correlated to the production of an anti-Yrp1 antibody, it 
is therefore plausible that this vaccine may not confer protection to challenge with 
an Azo
- 
strain. Even so, this is the first (and currently only) toxoid to successfully 
protect against Y. ruckeri infection when used as a vaccine and thus merits further 
attention. For instance, cloning/overexpression of the yrp1 gene might allow the 
toxoid to be produced on a large scale, although this is only speculative and 
undoubtedly requires further investigation.  
 
1.17.4 Recombinant vaccines 
This area of vaccine development has been negligible for ERM. Most DNA vaccines 
have been researched for conferring protection against fish viruses. For example, 
trout vaccinated with plasmid DNA encoding the viral haemorrhagic septicaemia 
virus (VHSV) or the infectious haematopoietic necrosis virus (IHNV) glycoprotein 
genes, were relatively protected against VHSV or IHNV challenge. In contrast, fish 
were not significantly protected against challenge with Y. ruckeri (Lorenzen et al., 
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2002). It is likely that specific anti-viral mechanisms are involved in conferring 
protection against viruses which cannot protect against bacterial pathogens.  
 
As of 2012, there is currently no recombinant protein or DNA based vaccine 
described within the literature which successfully protects against ERM.  
 
1.18 Immune response to Y. ruckeri infection 
It is likely that the development of new vaccines will depend on a greater knowledge 
of the fish immune system and how the host responds to bacterial infection. Like 
terrestrial vertebrates (e.g. humans), fish possess both a non-specific (= innate) and 
adaptive immune system, which may be broadly categorised as being cellular or 
humoral in nature. However, despite an extensive amount of research, features of the 
fish immune system which aid in preventing the development of ERM are still 
speculative; it is likely to involve both an innate (below) and adaptive immune 
response (Section 1.18.2).  
 
1.18.1 Innate immune response  
The innate immune system is usually considered to be the primary defence of fish 
against pathogens (Ellis, 2001). Indeed, this aspect of the fish immune system is 
thought to be extremely important in preventing fish pathogens. Unlike an adaptive 
immune response, the innate immune system is non-specific (i.e. not dependent upon 
the distinct recognition of molecules associated with any one pathogen) and is 
usually very fast in responding to infection. Research to date has shown that Y. 
ruckeri infection can result in the upregulation of genes which encode proteins 
related to an innate immune response. These generally include cytokines (e.g. TNF-
a, IL-1β, IL-8, IL-10 and IL-22); Toll-like receptors (e.g. TLR5); acute phase 
proteins (SAA, hepcidin, transferrin and precerebellin); antimicrobial peptides (e.g. 
cathelicidin-2); nitric oxide synthase; mannose binding lectins and complement 
factors (e.g. C3, C5 and factor B) (Chettri et al., 2012, Ruangsri et al., 2012, Bridle 
et al., 2011, Monte et al., 2011, Raida et al., 2011a, Diaz-Rosales et al., 2009, Raida 
and Buchmann, 2009, Harun et al., 2011, Evenhuis and Cleveland, 2012). 
Vaccinating fish against formalin-inactivated bacterial cells similarly resulted in the 
upregulation of genes related to innate immunity (Raida and Buchmann, 2008a, 
Raida and Buchmann, 2007). However, the majority of these studies concerning the 
response of the fish innate immune system to Y. ruckeri were performed over a 
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relatively short period of time (0 to 3 months); thus the long term immunological 
responses to bacterial infection following vaccination, or a previous encounter with 
this bacterium, cannot be determined from these data. This would probably concern 
the adaptive immune system, of which its role in protecting against ERM has only 
recently been approached within the published literature.   
 
1.18.2 Adaptive immune response 
An adaptive immune response towards Y. ruckeri was first noted by Raida and 
Buchmann (2008b). This study showed that genes involved in innate immunity (e.g. 
IL-1β) were up regulated in naïve fish following Y. ruckeri infection. After 35 days 
post-challenge, trout surviving the primary infection were re-infected with the 
bacterial pathogen. Unlike the primary infection whereby mortality reached 37%, 
only 7% of fish that were re-infected with the pathogen died. Bacterial clearing was 
also increased within the spleen of re-infected fish, although the expression of genes 
related to innate immunity had decreased to levels not dissimilar to that of control 
fish (i.e. fish not challenged or vaccinated). This was considered by the authors to be 
indicative of an adaptive immune response (Raida and Buchmann, 2008b).  
 
More recently, Deshmukh (2012) advocated that vaccine-induced protection against 
Y. ruckeri over a longer period of time (4 to 8 months) involves an adaptive immune 
response. What is more, Raida et al. (2011b) showed that plasma antibodies against 
Y. ruckeri increased after 8 and 12 weeks post-vaccination. This level of antibody 
production was also correlated with levels of protection, hence indicating that an 
adaptive immune response is involved in conferring protection. Taking results by 
Raida et al. (2011b) into consideration, it is likely that the role of the adaptive 
immune system will become a topic of further research in the near future. 
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1.19 EX5: a new problem for aquaculture 
In 1991, it was reported that a site in southwestern England had suffered a severe 
loss of vaccinated rainbow trout. When researchers arrived at the farm, fish were 
found to be severely overstocked in unsanitary waters (Professor B. Austin, 
University of Stirling; personal communication). In fact the situation was so 
uncontrollable that the fish farm in question was later closed. The aetiological agent 
of disease was later attributed to a bacterium with similarities to both Hafnia alvei 
and Y. ruckeri. Correctly identifying the bacterium initially posed a problem insofar 
as strains were non-motile, phospholipase negative and positive for the Voges-
Proskauer (VP) reaction; phenotypes which were not usually attributed to Y. ruckeri 
(Austin et al., 2003). Nevertheless, sequence analysis of 16S rRNA encoding genes 
confirmed that isolates were in fact Y. ruckeri (100% homology). Strains of a similar 
nature have since caused disease in vaccinated livestock throughout Europe and the 
USA (Strom-Bestor et al., 2010, Wheeler et al., 2009, Arias et al., 2007, Fouz et al., 
2006). 
  
The non-motile nature of some Y. ruckeri strains was not previously unknown 
(Davies and Frerichs, 1989), although the majority of disease outbreaks up until the 
1990s were attributed to traditional “Hagerman” (= biotype 1 [motile], serotype O1) 
strains. Whereas Austin et al. (2003) considered these strains to be part of a new 
biogroup, others considered them to be biotype 2 (= non-motile) serotype O1 
isolates (Arias et al., 2007, Davies and Frerichs, 1989, Strom-Bestor et al., 2010, 
Fouz et al., 2006, Wheeler et al., 2009, Evenhuis et al., 2009, Welch et al., 2011, 
Welch, 2011). All workers thus far agree that the non-motile isolates belong to the 
serotype O1 as they are unable to ferment sorbitol (Arias et al., 2007, Davies and 
Frerichs, 1989, Austin et al., 2003, Fouz et al., 2006, Evenhuis et al., 2009) and 
agglutinate slightly better with polyclonal antibodies raised against serotype O1 
cells compared to serotype II (Austin et al., 2003). LPS from these strains also react 
with antiserum raised against serotype O1 when used in an immunoblot (Fouz et al., 
2006). In addition to being non-motile, reoccurring isolates causing disease in the 
vaccinated host share a number of biochemical features which differ from the 
original “Hagerman” strains. 
  
Terminology can often be misconstrued when referring to different Y. ruckeri 
strains, particularly when standardisation has yet to be accepted by researchers. 
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Hence for the purposes of this study, non-motile strains with phenotypes outlined in 
Table 1.4 will be collectively known as “EX5”. The origina l motile isolates will be 
collectively referred to as “serotype O1”. Although the author accepts that so-called 
“EX5” strains belong to serotype O1, they do not match the original definition of 
this serotype (i.e. motile, phospholipase positive and VP negative). Therefore, when 
the term serotype O1 is used in this study it refers to the original “Hagerman” strain 
in Table 1.4. 
 
 
Table 1.4: Biochemical and phenotypic comparisons between two biotypes of Y. 
ruckeri (after Austin et al., 2003). 
    Biotype 1 (O1) Biotype 2 (EX5) 
 
Motility    +   - 
Tween 20/80 degradation  +   - 
VP reaction    -   +  
 
 
 
Despite the research on EX5 Y. ruckeri isolates a number of unanswered questions 
remain. One essential question surrounding EX5 is why it is able to cause disease in 
the vaccinated host, since the strain used in the vaccine preparation is essentially the 
same bacterial species. Similarly, serological testing by Austin et al. (2003) showed 
that antibodies raised in rabbits against inactivated serotype O1 cells weakly 
agglutinated EX5, yet reacted strongly with a serotype O1 strain. Again, it is 
perplexing why the EX5 isolate did not agglutinate with polyclonal antibodies since 
both strains used in the agglutination assay are essentially the same bacterial species 
and serotype. Thus the majority of antigens presented by the serotype O1 cell should 
be very similar, if not identical, to that of the EX5. As noted by Tobback et al. 
(2007), the lack of information regarding the immunological response of fish to 
vaccination and what Y. ruckeri antigens/molecules are involved in conferring 
protection complicates the matter further.  
 
Unlike serotype O1 isolates, EX5 strains are non-motile and apparently unable to 
produce flagellin (Evenhuis et al., 2009). It has been suggested on numerous 
occasions that vaccinating fish against serotype O1 strains might have exerted a 
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selection pressure on flagellin. In this respect, hosts vaccinated with a flagellin-
producing strain would be susceptible to infection by a strain which is not producing 
this molecule. Again, even if flagellin is not produced by EX5 strains, it is 
conceivable that other differences exist between them. Therefore, it would be 
interesting to determine if any proteins are differentially expressed between the 
serotype O1 and EX5 isolates.  
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1.20 Aims of the project 
 
1. Evaluate the protective role of Y. ruckeri flagellin as a component of a 
 whole- cell-vaccine and as a purified (= sub-unit) vaccine.  
 
2. Identify potential virulence factors which are contributing to an increase in 
 EX5 pathogenicity using proteomic and transposon mutagenesis techniques.  
 
3. Investigate the role, if any, which overexpressed proteins produced by EX5 
isolates have towards virulence.  
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 General methods  
2.1.1 Materials 
Unless otherwise stated in the text, chemicals and reagents were purchased from 
Sigma-Aldrich
 
(UK) or Fisher Scientific (UK). All chemicals, enzymes and other 
materials were stored and handled in accordance with the manufacturers’ 
instructions.  
 
2.1.2 Centrifugation 
Small samples were centrifuged in a 1.5 ml Eppendorf tube using a Micro Centaur 
microfuge (MSE). The MSE centrifuges were run at room temperature or 4
º
C as 
appropriate and reached a maximum speed of 13,400 x g. Larger volumes, however, 
were centrifuged in a Beckman Avanti J26 XP centrifuge.  
 
2.1.3 Bacterial strains, antibiotics and storage conditions 
Compositions of all media used to cultivate bacteria are shown in the appendix 
(Table 5.1). All bacterial strains and vectors used in this study are outlined in Table 
2.1. A diagram of the pET28-b plasmid used in this research is available in the 
appendix (Fig 5.1), as is a map of the pRL27 vector (Fig 5.2). Y. ruckeri isolates 
were originally sourced from dead or moribund rainbow trout (Oncorhynchus 
mykiss, Walbaum) by Professor B. Austin and for this work were obtained from the 
fish pathogen collection of the School of Life Sciences, Heriot-Watt University. Y. 
ruckeri cultures were routinely grown on tryptone soya agar (TSA) plates or in 
tryptone soya broth (TSB) with incubation at 28
º
C or 16
º
C for 18-72 h. E. coli 
isolates, however, were grown on nutrient agar (NA) or Luria-Bertani agar (LA) 
plates at 37
º
C for 18-72 h. For liquid cultures, single colonies of E. coli were grown 
in nutrient broth (NB) or Luria-Bertani (LB) broth at 28
º
C or 37
º
C for 18 to 72 h. 
Heat labile chemicals (i.e. antibiotics) were sterilised by filtration using 0.22 µm 
porosity filters (Millipore). When required, antibiotics were added to media after 
autoclaving (121
º
C, 15 min) and cooling (~50
º
C) in the following concentrations; 
kanamycin (50 µg/ml), nitrofurantoin (5 µg/ml) and streptomycin (20 µg/ml). Iron-
deficient medium was prepared by the addition of 2’2’-bipyridyl (100 µM/ml) after 
washing glassware once with 1 M HCl and then several times in dH2O prior to 
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autoclaving. Stock cultures of bacteria were stored at −70 ºC in TSB, NB or LB broth 
supplemented with 30% (v/v) sterile glycerol. 
 
 
Table 2.1: Bacterial strains and plasmids used in this study 
Name Characteristics/Uses Reference/Source 
   
Y. ruckeri   
BA19           Serotype O1, biotype 1 (motile) This study 
YR1 - Austin et al.  (2003) 
EX5 Serotype O1, biotype 2 (non-motile) - 
R1 - - 
O2BA2 Serotype O2, biotype 1 (motile) This study 
O3BA3 Serotype O3, biotype 1 (motile) - 
O4BA4 Serotype O4, biotype 1 (motile) - 
 
E. coli   
 
BL21-DE3 Overexpressing recombinant proteins Stratagene, UK 
XL1-Blue Maintaining recombinant plasmids - 
DH5α/λpir 
Cloning transposon inserts as pir-
dependent plasmids  
Miller and Mekalanos 
(1988) 
BW20767 Donor strain for conjugation experiments Metcalf et al. (1996) 
 
Plasmids  
 
pRL27 Suicide vector possessing transposon, Km
R
 Larsen et al. (2002) 
pET28-b Gene cloning for overexpression  Invitrogen, UK 
   
 
 
2.1.4 Morphological, biochemical and phenotypic characterization of Y. 
ruckeri isolates 
Strains considered to be Y. ruckeri were verified following procedures outlined by 
Austin and Austin (2007).  
 
2.1.4.1 Micro-morphology  
Overnight cultures on TSA plates were used to study micro-morphology. Thus, a 
cell suspension in 0.9% (w/v) saline was spread over a sterile glass microscope slide 
and stained by Hucker’s modification of the Gram-stain (Hucker and Conn, 1923) 
before examining under a Kyowa light microscope (magnification = x1000). In 
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addition to the Gram-stain, colonies on plates were examined visually to determine 
cell morphology, arrangement, shape and colour. 
 
2.1.4.2 API-20E rapid identification system 
Isolates were examined using the substrate utilization API 20E (Bio-Mérieux, UK) 
rapid identification system following the manufacturer’s instructions, albeit with an 
incubation period for 48 h (as opposed to 24 h) and at a temp of 25
º
C instead of 37
º
C 
(Austin et al., 2003). Species were identified by entering the API-20E data into the 
manufacturers’ computer-based identification system. 
 
2.1.4.3 Oxidase and catalase production 
A piece of Whatman filter paper (No. 1) was moistened with 1% (w/v) N,N,N’,N’-
tetramethyl-p-phenylenediamine dihydrochloride before streaking the surface with a 
single colony grown overnight on TSA at 28
º
C. A positive reaction for oxidase was 
recorded visually by the development of a purple pigment within 30 seconds. The 
ability to produce catalase was examined by adding a drop of 5% (v/v) H2O2 
solution to a bacterial colony on a glass slide. If rapid evolution of bubbles entailed 
within a few seconds, due to oxygen being released from the breakdown of H2O2, 
then strains were considered positive. 
 
2.1.4.4 Motility assays 
Motility was determined by stab inoculating a single bacterial colony into the 
bottom of motility plates (Columbia broth supplemented with 0.3% [w/v] 
Bacteriological agar No 3, average depth = 3 mm) before incubating at 28
º
C for 24 h 
(Coquet et al., 2002, Evenhuis et al., 2009). Strains were considered to be motile if 
migration (= swimming) zones were visible from the point of inoculation after 
incubation. In addition to using semi-solid agar, swimming ability was observed 
using light microscopy (magnification of x400) while taking water movement and 
Brownian motion into consideration. 
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2.2 Protein methods 
2.2.1 Determination of protein concentrations  
Protein concentrations were measured using the protein assay based on the Bradford 
dye binding procedure (Bradford, 1976) using a standard curve based on bovine 
serum albumin (BSA).  
 
2.2.2 Protein purification buffers and storage conditions 
Autoclaved Millipore
®
 dH2O was used to make buffers for protein analysis. All 
buffers used for protein purifications were sterilized by filtration and stored 
throughout on ice to prevent protein proteolysis.  
 
2.2.3 Preparation of whole cell proteins (WCPs) for 1D and 2D SDS-PAGE 
WCPs were purified following a modified French press lysis method recommended 
by Cull and McHenry (1990). After growing bacterial cultures (Section 2.1.3), cells 
were harvested by centrifugation (4
º
C, 9,605 x g, 30 min) and resuspended in 10 ml 
of cell lysis buffer A (50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 5 mM 
ethylenediaminetetraacetic acid [EDTA], 1% (w/v) dithiothreitol [DTT], 2 mM 
phenylmethanesulphonylfluoride [PMSF]). After storing on ice for 20 min, the 
suspension was passed through a pre-chilled French pressure cell press (3 repeats at 
14,000 psi) to lyse cells. Samples were again stored on ice (20 min) before removing 
cellular debris and unbroken cells by centrifugation (4
º
C, 20,442  x g, 30 min). The 
supernatant was then precipitated using 10% (w/v) TCA in acetone (Section 2.2.9). 
 
2.2.4 Isolation of outer membrane proteins (OMPs) for 1D SDS-PAGE 
Outer membrane fractions were prepared using a method previously described by 
Chart and Trust (1983). After culturing bacteria, cells were harvested by 
centrifugation (4
º
C, 9,605 x g, 30 min) and gently washed in 20 ml of 200 mM Tris-
HCl (pH 7.5). Cells were again harvested (4
º
C, 7,741 x g, 20 min) before re-
suspending in 10 ml of ice-cold OMP lysis buffer (200 mM Tris-HCl [pH 7.5], 50 
mM NaCl, 10 mM EDTA, 2 mM PMSF). The suspension was disrupted on ice by 
sonication using 4 x 60 s bursts with 30 s cooling periods. Unbroken cells were 
removed by centrifugation (4
º
C, 20,442  x g, 30 min), whereas the cell envelope 
fraction was pelleted by high-speed centrifugation (10
º
C, 75,600 x g, 2 h). To 
selectively solubilise the cell membrane, the pellet was re-suspended in 5 ml of 
0.5% (w/v) N- laurylsarcosine sodium salt for 30 min at room temp prior to 
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centrifugation (10
º
C, 75,600 x g, 2 h). The pellet or outer membrane fraction (OM) 
was washed in 20 mM Tris-HCl (pH 7.5) to remove excess salts and was once again 
pelleted by centrifugation (10
º
C, 75,600 x g, 2 h). Finally, the OM pellet was 
solubilised in 1.5 ml of 1 x loading buffer (50 mM Tris-HCl [pH 6.8],  2% [w/v] 
SDS, 10% [v/v] glycerol, 1% [v/v] β-mercaptoethanol, 12.5 mM EDTA, 0.02% 
[w/v] bromophenol blue). Undissolved OM material was removed by centrifugation 
(13,400 x g, 20 min) before decanting supernatants into clean Eppendorf tubes and 
storing at -70
º
C. It was important to store OMPs at lower temps (e.g. -70
º
C) as high 
molecular weight proteins have been found to degrade when stored at -20
º
C (Davies, 
1991a).    
 
2.2.5 Purification of native Y. ruckeri flagellin 
Native flagellin was purified from a motile Y. ruckeri serotype O1 (BA19) strain 
following an acid disassociation and re-association method outlined by Ibrahim et 
al. (1985). A starter culture, which was grown from a single colony overnight in 10 
ml of TSB (23
º
C, 5 x g), was used to inoculate 6 x 1 L volumes (1:1000 dilution) of 
TSB and grown for a further 18 h (23
º
C, 5 x g). Cells were harvested (4
º
C, 9,605 x g, 
40 min) and gently mixed with ice cold saline (0.9% [w/v] NaCl) supplemented with 
2 mM PMSF to form a moderately thick suspension. The pH of the suspension was 
then reduced to pH 2 using 1M HCl and maintained at room temp under constant 
stirring for 40 min to disassociate flagella. Bacterial cells, now stripped of flagellin, 
were removed by centrifugation (4
º
C, 9,605 x g, 40 min). The supernatant, 
containing flagellin as soluble monomers, was centrifuged (10
º
C, 75,600 x g, 2 h) to 
remove insoluble contaminants before adjusting the pH to 7.5 with 1 M NaOH to 
reinitiate flagellin polymerization. To precipitate the protein, ammonium sulphate 
was slowly added to the solution with vigorous stirring to achieve two-thirds 
saturation (2.67 M) before holding overnight at 4
º
C. The resulting precipitate (= 
flagellin protein) was centrifuged (4
º
C, 48,384 x g, 30 min) and dissolved in sterile 
buffer (50 mM Tris-HCl [pH 8.0], 50 mM NaCl) prior to dialysing in pre-treated 
dialysis tubing (Section 2.2.8). Dialysis was initially performed under running tap 
water for 2 h and then for 18 h at 4
º
C with constant stirring in 6 L of dH2O. Purity 
and identity of native flagellin was confirmed via SDS-PAGE (Section 2.2.10) and 
Western blotting/immunodetection (Section 2.2.16). Prior to administering to fish 
(Section 2.4.4), the sample was diluted to the required concentration with sterile 
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phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 
mM KH2PO4 [pH 7.4]). 
 
2.2.6 Solubilisation and purification of recombinant Y. ruckeri flagellin 
Pellets of induced cells (Section 2.3.13.3) were re-suspended in 10 ml of buffer A 
(50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 5 mM EDTA, 0.1% [w/v] sodium azide, 2 
mM PMSF, 1 mg/ml lysozyme) and stored on ice for 30 min. Cells were lysed by 
passing through a French pressure cell press (3 repeats at 14,000 psi) with 5 min 
intervals on ice. Recombinant flagellin (r-flagellin), expressed in inclusion bodies 
(IBs), was pelleted by centrifugation (10
º
C, 75,600 x g, 1 h) before the supernatant 
(= soluble fraction) was removed. IBs were washed three times in 10 ml buffer A 
supplemented with 1% (v/v) Triton X-100 to remove any contaminating material. 
Excess Triton was removed by washing the pellet twice with buffer A without 
Triton-X100. IBs were denatured and solubilised in buffer B (50 mM NaCl, 2 mM 
PMSF, 0.1% [w/v] sodium azide, 8 M urea [pH 7.4]) by freeze-thawing, vortexing 
and sonication. Any insoluble material was removed by centrifugation (4
º
C, 75,600 
x g, 30 min) before dialysing in pre-treated dialysis tubing (below). Dialysis was 
initially carried out under running tap water for 2 h and then for 18 h at 4
º
C with 
constant stirring in 6 L of dH2O. Any precipitate (= insoluble r-flagellin) which 
formed was dissolved by changing the pH of the solution to 2 with 1 M HCl while 
stirring at room temp for 30 min. Insoluble material was removed by centrifugation 
(4
º
C, 75,600 x g, 1 h) before slowly changing the pH to 7.5 using 1 M NaOH. Purity 
of r-flagellin was confirmed via SDS-PAGE (Section 2.2.10) and Western blotting 
(Section 2.2.16). Finally, the solution was diluted with sterile PBS to give the 
required concentration of r-flagellin before administering to fish (Section 2.4.5). 
 
2.2.7 Purification of soluble r-flagellin using HisTrap™ FF Columns 
Y. ruckeri r-flagellin, expressed as soluble protein, was purified by passing through a 
HisTrap™ FF (IMAC) Column (GE Healthcare, UK) following the manufacturer’s 
instructions. Purity of protein elutes was confirmed by running 10 µg of protein on a 
10% (w/v) SDS-PAGE (Section 2.2.10). 
 
2.2.8 Preparation of dialysis tubing  
Dialysis tubing (Medicell International ltd, molecular weight cut-off = 14 kDa) was 
cut into strips of 10 to 15 cm and boiled (10 min) in 2% (w/v) sodium bicarbonate/1 
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mM EDTA (pH 8.0). Tubing was boiled for a further 10 min in 1 mM EDTA (pH 
8.0) before storing in 1 mM EDTA at 4
º
C for up to 1 week. Prior to use, tubing was 
washed in dH2O.  
 
2.2.9 Precipitation of proteins using trichloroacetic acid (TCA) in acetone  
Protein samples were precipitated by mixing with 4 x sample volumes of ice cold 
10% (w/v) TCA dissolved in acetone. Solutions were stored at -20
º
C overnight, 
followed by centrifugation (4
º
C, 48,384 x g, 30 min) to pellet protein. The 
supernatant was discarded before washing the pellet three times with ice-cold 
acetone to remove residual TCA. Protein pellets were allowed to air dry in a fume 
cupboard before re-suspending in the appropriate buffer.  
 
2.2.10 1-Dimensional (1-D) sodium dodecyl sulphate polyacrylamide gel 
electrophoresis of proteins (SDS-PAGE) 
2.2.10.1 Casting SDS-PAGE gels  
SDS-PAGE was carried out using a discontinuous buffer system described by 
Laemmli (1970). After assembling the gel casting apparatus (Mighty Small II, 
Hoefer), the polyacrylamide resolving gel (10-12% [w/v] polyacrylamide [19:1 
acrylamide: bisacrylamide, Melford], 375 mM Tris-HCl [pH 8.8], 0.1% [w/v] SDS, 
0.1% [w/v] ammonium persulphate (APS), 0.05% [v/v] N,N,N’,N’-tetramethyl-
ethylenediamine [TEMED]) was poured between the glass plates. The gel solution 
was overlaid with water saturated n-butanol to ensure a flat surface and allowed to 
polymerise at room temperature for 30 min. After removing the n-butanol, the 
stacking gel (4% [w/v] polyacrylamide, 125 mM Tris-HCl [pH 6.8], 0.1% [w/v] 
SDS, 0.05% [w/v] APS, 0.1% [v/v] TEMED) was cast directly over the resolving gel 
with an appropriate comb in place to create loading wells. Gels were stored 
overnight at 4
º
C.  
 
Once set, combs were removed, and the gel (still within the glass plates) was gently 
placed within the electrophoresis apparatus. Buffer tanks were then filled with 1 x 
SDS-PAGE running buffer (25 mM Tris-HCl [pH 8.3], 192 mM glycine, 0.1% [w/v] 
SDS) before loading the sample and running the gel (below).   
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2.2.10.2  Sample  loading and electrophoresis 
Protein samples were mixed (1:1) with 2 x sample loading buffer (100 mM Tris-HCl 
[pH 6.8], 4% [w/v] SDS, 20% [v/v] glycerol, 2% [v/v] β-mercaptoethanol, 25 mM 
EDTA, 0.04% [w/v] bromophenol blue). For SDS-PAGE analysis of crude whole 
cell proteins, 1 ml of bacterial culture was centrifuged (13,400 x g, 10 min) before 
resuspending the bacterial pellet in 200 µl of 1 x sample loading buffer. All protein 
samples were vigorously vortexed for 5 min before heating to 95
º
C for 15 min. Any 
insoluble material was removed by centrifugation (13,400 x g, 10 min) before 
loading 10-20µl (1–20 µg protein) into each well. Electrophoresis was carried out at 
150 V with water cooling the system for 1.5 h, or until the loading dye had reached 
the end of the gel. Molecular weight markers (Table 2.2) were run alongside protein 
samples as standard. Following electrophoresis, gels were carefully removed from 
the apparatus/glass plates and stained with Coomassie brilliant blue-R250 (Section 
2.2.12) or silver nitrate (Section 2.2.14) to visualize proteins. All gels were scanned 
with an ImageScanner™ II (GE Healthcare) after staining. If the gel was to be used 
in a Western blot, staining was omitted and proteins were electrophoretically 
transferred to a nitrocellulose membrane (Section 2.2.16).  
 
 
Table 2.2: Proteins used as molecular weight markers and their corresponding 
molecular weights in kiloDaltons (kDa). 
Protein       Molecular weight (kDa) 
 
Myosin, porcine 200 
β-Galactosidase, from E. coli 116 
Phosphorylase b, from rabbit muscle 97 
Bovine serum albumin 66 
Ovalbumin, from chicken egg white 45 
Carbonic Anhydrase, from bovine erythrocytes 29 
 
 
 
2.2.11 2-Dimensional (2D) SDS-PAGE separation of proteins 
2.2.11.1 Preparation of glass plates and gel casting for 2D SDS-PAGE  
Glass plates used to cast large (25.5 × 19.6 cm, 1.5 mm thick) SDS-PAGE resolving 
gels (GE Healthcare, UK) were soaked overnight in light detergent (1% [v/v] 
Decon
®
) before soaking (2-3 h) in 1 M NaOH to remove any remnants of previous 
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gels. Glass plates were then thoroughly rinsing in dH2O before wiping wth 70% 
(v/v) ethanol and air-dried. If gels were to be attached to gels, 4 ml of Bind-Silane 
solution (GE Healthcare, UK) was applied over each plate surface and allowed to air 
dry for 2 h. Gels were wiped with a small amount of 70% (v/v) ethanol before 
casting the gel. Large 10% (w/v) SDS-PAGE resolving gels were cast in the Ettan 
DaltSix apparatus system (GE Healthcare, UK) following the manufacturers’ 
recommendations. The composition of 10% (w/v) SDS-PAGE resolving gels 
remained unchanged (Section 2.2.10.1), although solutions were filtered through 
0.22 µm porosity filters (Whatman) prior to the addition of TEMED and APS. 
Again, water saturated n-butanol was applied over the surface of the gel to ensure a 
flat surface. Gels were allowed to polymerize overnight at room temperature before 
removing n-butanol and storing at 4
º
C with 1 x SDS-PAGE running buffer (Section 
2.2.10.1) covering the surface.  
 
2.2.11.2 First dimension - isoelectric focusing (IEF) of proteins 
After precipitating and pelleting protein (Section 2.2.9), the sample was resuspended 
in solubilisation buffer (7 M urea, 2 M thiourea, 4% [w/v] 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulphonate [CHAPS]) before centrifugation (13,400 x 
g, 20 min) to remove insoluble material. For a 24 cm IEF Immobiline DryStrip (pH 
3-11 NL), 300 µg of protein (not exceeding 100 µl volumes) was mixed with 
rehydration buffer (7 M urea, 2 M thiourea, 2% [w/v] CHAPS, 2% [v/v] pharmalyte 
[pH 3-11 NL], 40 mM DTT, 0.002% [w/v] bromophenol blue) to a final volume of 
450µl. The sample was then evenly distributed over a clean 24 cm ceramic strip 
holder before lowering a 24 cm Immobiline DryStrip (pH 3-11 NL) over the sample 
with the cathodic (+) region facing the pointed end of the holder. Care was taken to 
ensure no air bubbles formed under the plastic strip. To prevent evaporation, 
DryStrip cover fluid (GE Healthcare) was applied over the strip before covering 
with the lid. IEF was performed using an IPGphor II manifold following settings 
suggested by the manufacturers (Table 2.3). Strips were stored at -70
º
C overnight or 
reduced and alkylated (Section 2.2.11.3) before running the second dimension 
(Section 2.2.11.4).  
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Table 2.3: IEF conditions and settings for 24 cm strips (pH 3-11 NL) 
Voltage (V) IPGphor 
™ 
II setting Time (hours) 
   
30  Step and hold 12 (active rehydration) 
300 Step and hold 2 
1000 Gradient 1 
1000 Gradient 2 
8000 Step and hold 8 
   
 
 
2.2.11.3 Reduction and alkylation of proteins 
Following IEF, the Immobiline strip was carefully removed and placed in a plastic 
cylinder containing 10 ml of equilibration buffer (75 mM Tris-HCl [pH 8.8], 6 M 
urea, 29.3% [v/v] glycerol, 2% [w/v] SDS, 0.002% [w/v] bromophenol blue) 
supplemented with DTT (10 mg/ml). Reduction was performed for 15 min at room 
temperature with gentle shaking before alkylating the strip for 15 min in a new 
cylinder containing 10 ml of equilibration buffer with iodoacetamide (25 mg/ml). 
Equilibrated strips were then used immediately to run the second dimension (below).    
 
2.2.11.4 Second dimension – SDS-PAGE separation of proteins  
Following IEF and equilibration, gel strips were placed on top of a pre-cast (Section 
2.2.11.1) 10% (w/v) polyacrylamide resolving gel with the anodic (+) end of the 
strip facing the left hand side and the plastic backing touching the larger glass plate. 
After ensuring the strip was in contact with the gel, the strip was sealed in place by 
applying an agarose sealing solution (0.5% [w/v] agarose and 0.01% [w/v] 
bromophenol blue dissolved in 1 x SDS-PAGE running buffer [Section 2.2.10.1]) 
which had been heated to 100
º
C in a heating block. Once the sealing solution had 
set, gels were carefully lowered into the Ettan™ DALTSix (GE Healthcare) 
electrophoresis apparatus unit containing 4.3 L of 1 x SDS-PAGE running buffer in 
the lower (anodic) chamber. Furthermore, the electrophoresis unit had been 
equilibrated to 10
ºC using a MultiTemp™ III temperature controller unit (GE 
Healthcare) while ensuring the main pump cooling system was turned on. Any 
remaining gel holder slots were filled with blanks before filling the anodic chamber 
with running buffer up to the required volume. The cathodic chamber was then filled 
with 3 x SDS-PAGE running buffer before sealing the system with the lid. 
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Electrophoresis was initially carried out at 25
º
C at 5 W/gel for 45 min and then 17 
W/gel (maximum 100 W) for approximately 5 hours or until the dye front had 
reached the end of the gel. After completion, gels were removed from the 
electrophoresis unit and stained with colloidal Coomassie brilliant blue-G250 
(Section 2.2.13). All gels were scanned with an ImageScanner™ II (GE Healthcare) 
after staining. 
 
2.2.12 Coomassie brilliant blue-R250 staining  
Polyacrylamide gels were stained in Coomassie brilliant blue solution (50% [v/v] 
methanol, 10% [v/v] acetic acid, 0.1% [w/v] Coomassie brilliant blue-R250) 
overnight. The stain was discarded, and gels were repeatedly washed in destain 
solution (10% [v/v] methanol, 10% [v/v] acetic acid) until the background became 
clear and protein bands were distinct. Finally, the destain solution was discarded and 
gels were stored in dH2O.  
 
2.2.13 Colloidal Coomassie blue-G250 staining 
2D SDS-PAGE gels (Section 2.2.10.4) were fixed (30 min) in colloidal fixer (10% 
[v/v] acetic acid, 40% [v/v] ethanol) while gently shaking. Once fixed, gels were 
stained (4 days) in colloidal Coomassie blue-G250 stain (8% [w/v] ammonium 
sulphate, 1% [w/w] phosphoric acid, 0.08% [w/v] Coomassie blue-G250, 20% [v/v] 
methanol). Gels were then rinsed repeatedly in dH2O until the background became 
clear and proteins were distinct. Finally, gels were stored in dH2O.  
 
2.2.14 Silver staining of protein gels 
Following SDS-PAGE (Section 2.2.10.2), the gel was carefully removed from the 
apparatus and fixed (30 min) in fixer A (50% [v/v] methanol, 10% [v/v] acetic acid), 
followed by fixing (30 min) in fixer B (5% [v/v] methanol, 7.5% [v/v] acetic acid). 
The gel was then washed in dH2O (4 x 10 min) prior to sensitizing (30 min) in DTT 
(5 µg/ml). Next, proteins were stained (30 min) with 0.1% (w/v) silver nitrate before 
rinsing in dH2O (4 x 10 min). The gel was developed in 100 ml of ice-cold 3% (w/v) 
sodium carbonate (+ 0.05% [v/v] formaldehyde) until protein bands became clear 
and distinct. The reaction was terminated by the addition of 5 ml 2.3 M citric acid 
(10 min) prior to washing the gel in dH2O (4 x 5 min). Finally, the gel was stored in 
1% (v/v) acetic acid.  
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2.2.15 Peptide mass fingerprinting (PMF) 
Protein spots were excised from Coomassie stained 2D or 1D SDS-PAGE gels using 
a manual spot picker and digested with trypsin Gold (Promega, UK) following the 
“In-Gel” protein digestion protocol. Gel plugs were picked with a spot picker (head 
diameter = 1.5 mm) before placing in a sterile Eppendorf tube. Plugs were destained 
with 200 µl of PMF destain buffer (100 mM ammonium bicarbonate, 10% [v/v] 
acetonitrile) twice at 37
o
C for 45 min. The wash buffer was removed and gels were 
de-hydrated in 100% (v/v) acetonitrile for 5 min at room temp. At this stage, gel 
pieces were reduced in size and had become opaque in colour. Acetonitrile was 
removed before fully drying the gel pellet in a Speed Vac
®
 for 10-15 min. Dried 
pellets were then re-hydrated in 10 µl of trypsin digestion buffer (40 mM ammonium 
bicarbonate, 10% [v/v] acetonitrile) supplemented with trypsin Gold (20 µg/ml) and 
incubated at room temperature for 1 h. Ensuring the gel pellet  had fully re-hydrated 
(going from opaque to clear), the gel was fully covered in trypsin digestion buffer 
and digested overnight at 37
o
C.  
 
Once digested, 150 µl of Millipore water was added to the digest before vortexing 
the sample at room temperature for 10 min. The liquid fraction was retained in a 
fresh Eppendorf tube before washing the gel twice in extraction buffer (50% [v/v] 
acetonitrile, 5% [v/v] trifluoroacetic acid) with vigorous vortexing. Liquid fractions 
were pulled before concentrating peptides using ZipTips
® 
pipette tips as per the 
manufacturers’ instructions. Finally, 1-2 µl was spotted directly onto a MALDI-TOF 
target plate and run on an Ettan™ MALDI-TOF (GE Healthcare, UK). Peptide 
masses were then compared to those in the NCBI sequence database.  
 
2.2.16 Western blotting and immunodetection of Y. ruckeri flagellin 
2.2.16.1 Western blotting  
Proteins separated by SDS-PAGE (Section 2.2.10.2) were transferred to a 
nitrocellulose membrane (0.2 µm pore size, BioRad) using an electrophoretic 
method previously described by Towbin et al. (1979). Following SDS-PAGE, 
unstained gels were carefully removed from the glass plates and equilibrated in 1 x 
Towbin running buffer (25 mM Tris-HCl [pH8.3], 192 mM glycine, 20% [v/v] 
methanol) for 10 min at room temperature. Two Scotch-brite pads, four pieces of 
Whatman 3 MM paper and a nitrocellulose membrane (all cut slightly larger than the 
SDS-PAGE gel) were also pre-wetted in 1 x Towbin buffer. Using the EC140 mini 
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blot module (Thermo), the gel holder cassette was then set up as follows: one pre-
soaked Scotch-brite pad was placed on the back (cathode [+]) followed by two 
pieces of 3 MM Whatman paper. The SDS-PAGE gel was then placed on to the 
paper and flooded with running buffer before placing the membrane on top. 
Ensuring no air bubbles were trapped between the membrane and the gel, another 2 
pieces of 3 MM paper and pre-soaked Scotch-brite was placed on top to complete 
the sandwich. The gel holder was then closed and placed in the blotting chamber so 
that the cathode side was facing the cathode electrode. The chamber was filled with 
1 x Towbin buffer and blotted at a constant voltage of 14 V for 2 h. To ensure 
proteins had efficiently transferred, membranes were stained with Ponceau S 
solution (0.5% [w/v] Ponceau S, 5% [v/v] acetic acid) for 5 min and gently rinsed 
with dH2O. If protein transfer was successful (indicated by visible protein bands on 
the membrane), then proteins were hybridized with the appropriate antibody 
(below). 
 
2.2.16.2 Hybridization and detection of flagellin with a monoclonal antibody (MCA) 
#15D8 
Blotted membranes (above) were briefly washed in 1 x TBST (50 mM Tris-HCl [pH 
7.5], 150 mM NaCl, 0.05% [v/v] Tween 20) before blocking (2 h) in Western 
blocking buffer (1% [w/v] non-fat skimmed milk powder [Marvel] in 1 x TBST). 
The membrane was then hybridized (2 h or overnight at 4
 º
C) with the anti-flagellin 
MCA antibody #15D8 (Feng et al., 1990) diluted 1:2000 in Western blocking buffer. 
Unbound antibody was removed by washing (5 x 5 min) in 1 x TBST prior to 
hybridizing (45 min) with a secondary antibody (1:10,000 dilution of goat anti-
mouse horse radish peroxidase-linked IgG in Western blocking buffer). Any 
unbound antibody was again removed by washing (5 x 5 min) in 1 x TBST before 
covering the surface of the membrane in Lumi-Light
®
 substrate (Roche). After 
placing the membrane between two acetate sheets, the X-ray was exposed (1 to 10 
min depending on signal intensity) to an X-ray film and developed (below).  
 
2.2.17 Chemiluminescent development of X-ray films 
In accordance with the manufacturer’s instructions, developer and fixer solutions 
(Kodak) were diluted 1:5 in dH2O before use. The exposed X-ray film was 
developed (1 to 2 min) in developing solution until a signal was observed, washed 
briefly in dH2O, and then fixed (3 to 4 min) in fixer solution. Finally, films were 
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rinsed in dH2O and air dried at room temperature. All developing stages were 
carried out in a dark room under a red safety light. 
 
2.3 DNA methods 
2.3.1 Genomic DNA purifications 
Genomic DNA was purified from fresh bacterial cultures grown overnight using the 
QIAGEN DNeasy
®
 blood and tissue kit as per the manufacturers’ instructions. 
Genomic DNA was stored at -20
º
C until required. 
 
2.3.2 Plasmid DNA purifications 
Plasmids from E. coli cells were purified via the alkaline lysis method following 
Birnboim (1983). After growing single colonies in 5 ml LB (+ antibiotic) overnight 
at 37
º
C, 1.5 ml of this culture was transferred to a sterile Eppendorf tube and 
centrifuged (13,400 x g, 2 min). Supernatant was removed and the bacterial pellet 
was thoroughly re-suspended in 100 µl GTE buffer (50 mM Tris-HCl [pH 8.0], 10 
mM EDTA) supplemented with 1 µl RNase (100 µg/ml, Fermentas) before 
incubating at room temperature for 5 min. 200 µl of cell lysis buffer (1% [w/v] SDS, 
200 mM NaOH) was then added, mixed by inversion, and stored on ice for 5 min.  
After incubating, 150µl of 3 M potassium acetate solution (pH 5.5) was added, 
mixed, and stored on ice for a further 5 min. The solution was centrifuged (13,400 x 
g, 1 min) to harvest unbroken cells and cellular debris, whereas the supernatant (~ 
400 µl) was transferred to a fresh Eppendorf tube before adding an equal volume 
(1:1) of 95% (v/v) ethanol to precipitate plasmid DNA. After incubating at room 
temp for 5 min, plasmid DNA was pelleted by centrifugation (13,400 x g, 2 min) and 
washed with 1 ml 70% (v/v) ethanol. DNA was again pelleted by centrifugation 
(13,400 x g, 2 min) before removing the supernatant and drying (5-10 min) at 75
º
C. 
Finally, the DNA was re-suspended in sterile dH2O and stored at -20
º
C. 
 
2.3.3 Restriction enzyme digests 
Cleavage of plasmid (1-2 µg) or genomic DNA (up to 10 µg) with restriction 
endonucleases was routinely carried out in a reaction (total volume of 20 or 50 µl) 
containing restriction enzyme(s) (1 unit of enzyme per 1 µg of DNA) and enzyme- 
specific buffer (1 x from 10 x stock). Reactions were brought to the final volume 
using sterile dH2O. All restriction enzymes and buffers used in this study are 
illustrated in Table 2.4. Digests were incubated for 3 h (plasmid digests) or 
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overnight (genomic DNA digests) and deactivated by heating (as described by the 
manufacturers) or by gel purifying DNA fragments (Section 2.3.7) after 
electrophoresis (Section 2.3.6). The efficiency of the DNA digest was confirmed by 
running a small amount (5 µl) on a 1% (w/v) agarose gel before excising the band of 
interest and purifying DNA.  
 
 
Table 2.4: Restriction enzymes and digestion buffers used in this study. All 
restriction digests were performed at 37
º
C. 
Enzyme Buffers 
  
BamHI 
10 mM Tris-HCl (pH 8.0 at 37°C), 5 mM MgCl2, 100 mM KCl, 
0.02% (v/v) Triton X-100 and 0.1 mg/ml BSA. 
   
EcoRI 
50 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2, 100 mM NaCl, 
0.02% (v/v) Triton X-100 and 0.1 mg/ml BSA. 
  
HindIII 
10 mM Tris-HCl (pH 8.5 at 37°C), 10 mM MgCl2, 100 mM KCl 
and 0.1 mg/ml BSA. 
  
NdeI 
50 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2, 100 mM NaCl 
and 0.1 mg/ml BSA. 
  
XhoI 
50 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2, 100 mM NaCl 
and 0.1 mg/ml BSA 
  
 
 
2.3.4 DNA ligations  
Up to 10 µg of digested DNA (Section 2.3.3) was ligated in a total reaction volume 
of 20µl. A vector to insert molar ratio of 1:3 was used as routine. A typical reaction 
mix (20 µl) contained 2µl of 10 x ligation buffer (400 mM Tris-HCl [pH 7.8], 100 
mM MgCl2, 100 mM DTT, 5 mM ATP), 1 µl of T4 DNA ligase (5 units/µl, 
Fermentas), DNA and dH2O up to the final volume. Digested DNA was allowed to 
ligate overnight at 16
º
C before terminating the reaction by heat inactivation (70
º
C, 
10 min). The efficiency of ligation reactions was confirmed by running a small 
sample (~5 µl) alongside a digested, non-ligated sample on a 1% (w/v) agarose gel 
(Section 2.3.6).  
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2.3.5 Polymerase chain reaction (PCR) 
2.3.5.1 Primer design 
Primers were designed to be ~20 bp long in order to give an annealing temperature 
between 50
º
C and 60
ºC. The 3’-terminal nucleotides of the primers were designed to 
contain G or C when possible to enhance primer binding to template DNA. Primers 
were produced by MWG and upon receipt were re-suspended in sterile dH2O (final 
concentration of 100 pm/µl) before storing at -20
º
C. All primers used in this study 
are illustrated in Table 2.5. 
 
 
Table 2.5: Names, sequences and melting temperatures (Tm) of primers used in this 
study. The NdeI restriction site for the FLA-F primer is underlined, as is the XhoI 
restriction site for the FLA-R primer.   
Primer Sequence (5'   3') Tm (
º
C) Reference 
    
AGPT-F ATTCAACGGGAAACGTCTTG 
 
54 
This 
study 
    
AGPT-R ACTGAATCCGGTGAGAATGG 54 - 
    
FLA-F CGCCATATGGCGGTCATTAACACTAAC 61 - 
    
FLA-R TACTCGAGACGCAGCAGAGACAACACA 64 - 
    
FLG-L CCGTTGATGTTAGAGGTGAA 50 - 
    
FLG-R GGCGGCGCAACGGGTACAGC 62 - 
    
OMPA-F ATGAAAAAGACAGCTATCGCATT 54 - 
    
OMPA-R TTAAGCCTGTGGCTGAGTCA 56 - 
    
OMPA-F1 CAAGCGCTGGATCAACTGTA 55 - 
    
OMPA-R1 AACTGAACGCCTTGTGCTTT 56 - 
TPNRL17–1 AACAAGCCAGGGATGTAACG 
 
55 
Larsen et 
al. (2002) 
    
TPNRL13–2 CAGCAACACCTTCTTCACGA 56 - 
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2.3.5.2 PCR reactions 
A standard PCR reaction contained 5 µl 10 x DreamTaq™ PCR buffer (Fermentas), 
1 µl of each primer (100 pmol/µl), template DNA (up to 100 ng of genomic DNA or 
10 ng of plasmid DNA), and 0.2 µl (1.5 units) of Taq polymerase (DreamTaq™, 
Fermentas) brought to a final volume of 50 µl with (sterile) Millipure dH2O. For 
reactions where the PCR product was used for cloning, conditions were as described 
except 5 µl of 10 x High Fidelity Taq buffer (Fermentas) and 0.2 µl (1.5 units) of 
Pfu Taq polymerase (Fermentas) was added instead of DreamTaq™ buffer and Taq 
polymerase. The reaction mixture was pipetted into a 0.2 ml thin walled PCR tube 
(AxyGen, Inc) and placed in a thermal cycler (Gen Amp
®
 PCR system 2700, 
Applied Biosystems). A standard PCR cycle consisted of an initial denaturation step 
of 5 min at 94
º
C followed by variable cycles of denaturation (30 s at 94
º
C), 
annealing (30 s at primer specific temperatures) and extension (1 min at 74
º
C). A 
final step at 74
º
C for 7 min completed primer extension before holding at 10
º
C. 
Annealing temperatures were considered to be the Tm – 5
º
C. Negative controls 
contained dH2O in place of template DNA. PCR products were analysed by agarose 
gel electrophoresis (below) and stored at -20
º
C until required.  
 
2.3.6 Agarose gel electrophoresis of DNA  
DNA was analysed by electrophoretically separating fragments using the RunOne™ 
Electrophoresis Cell (EmbiTec). A 1% (w/v) agarose solution (effective resolution 
0.5 to 10 kb) in 0.5 x TBE (44.5 mM Tris-HCl [pH 8.0], 44.5 mM boric acid, 1 mM 
EDTA) was prepared by melting the agarose in a microwave oven. After cooling the 
gel below 60
º
C, ethidium bromide was added to give a concentration of 0.5 µg/ml. 
The gel was poured into the gel casting platform and allowed to cool with a comb in 
place. Care was taken to ensure no trapped air bubbles formed underneath the comb 
itself or on the surface of the agarose gel. Once solidified, combs were slowly 
removed before placing the gel within the electrophoresis tank and immersing with 
0.5 x TBE. DNA samples were mixed with 6 x loading buffer (60% [v/v] glycerol, 
60 mM EDTA, 0.09% [w/v] bromophenol blue, 0.09% [w/v] xylene cyanol; 
Fermentas) and loaded into the wells of the gel. Electrophoresis was carried out at 
100 V for 30 min, or until the loading dye reached the end of the gel front, before 
visualizing DNA with a UV transilluminator (UVItec ltd). A standard molecular 
weight marker (λ/HindIII, Fermentas) was run alongside DNA samples to give 
detectable fragments of 23130, 9416, 6557, 4361, 2322, 2027 and 564 bp on a 1% 
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(w/v) agarose gel. DNA gels were photographed under UV light using a UVP gel 
documentation system.  
 
When separating digested genomic DNA for Southern blotting (Section 2.3.12) a 
0.7% (w/v) agarose gel was prepared (as above) using the Gibco BRL Horizontal 
Gel Electrophoresis Apparatus (Life Technologies) system following the 
manufacturers’ instructions. Electrophoresis was carried out at 25 V for 16 h, or 
again until the dye front had reached the end of the gel. 
 
2.3.7 Gel purification of DNA 
After separating on a 1% (w/v) agarose gel (above), DNA (including plasmids and 
PCR products) was purified using a GeneJET™ gel extraction kit (Fermentas) 
following the manufacturer’s instructions.  
 
2.3.8 Preparation and transformation of chemically competent E. coli cells 
2.3.8.1 Preparation of chemically competent E. coli cells 
Highly competent E. coli cells were prepared following a calcium chloride method 
outlined by Inoue et al. (1990). Single colonies were inoculated into 5 ml of LB (+ 
20 mM MgSO4) and grown overnight at room temp (approx. 23
º
C) before using this 
initial culture to inoculate (1:50 dilution) a 250 ml LB (+ 20 mM MgSO4) culture. 
Bacteria was again grown at room temperature to mid exponential phase (OD600 > 
0.4 < 0.6). Next, cultures were stored on ice for 10 min prior to centrifugation (4
º
C, 
5,403 x g, 10 min). Bacterial pellets were then re-suspended in 80 ml of ice-cold 
transformation buffer (PIPES-HCl [pH 6.7], 15 mM CaCl2, 250 mM KCl, 55 mM 
MnCl2) and stored on ice (10 min) prior to centrifugation (4
º
C, 5,403 x g, 10 min). 
Finally, cells were resuspended in 20 ml ice-cold transformation buffer (+ 1.5 ml 
dimethyl sulphoxide) and again stored on ice (10 min) before dispensing into pre-
chilled Eppendorf tubes (200 µl volumes). Aliquots were frozen in liquid nitrogen 
and stored at -70
º
C until required for transforming (below). 
 
2.3.8.2  Transformation of competent E. coli cells 
Competent E. coli cells (above) were transformed using the heat shock method 
outlined by Sambrook et al. (1989). Briefly, aliquots were removed from the -70
º
C 
freezer and thawed on ice. Up to 100 ng of plasmid DNA (1-20 µl) was added to the 
thawed culture and briefly mixed by inversion before again storing on ice for a 
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further 20 min. Cells were then heat shocked for 45 s at 42
º
C before immediately 
placing back on ice for 5 min. Transformed cells were allowed to recover by adding 
up to 1 ml of pre-warmed LB (without antibiotic) to the mixture and incubating at 
37
º
C (5 x g, 30 min). After harvesting cells (2,855 x g, 2 min), bacterial pellets were 
re-suspended in ~200 µl of LB before plating onto pre-warmed (37
º
C) LA plates (+ 
antibiotic). Plates were allowed to incubate overnight at 37
º
C. 
 
2.3.9 Bacterial mutagenesis 
2.3.9.1 Minimum inhibitory concentration (MIC) determination for counteractive 
selection  
Antibiotic susceptibility for the E. coli strain BW2020767/pRL27 (Table 2.1) and Y. 
ruckeri strains (BA19 and EX5, Table 2.1) were initially tested using the Mast 
Diagnostics Mastring (M13 and M26) following the manufacturers’ instructions. 
The MIC for antibiotics of potential interest was subject to additional testing using 
serial dilutions. Briefly, overnight cultures (OD600 ≥ 1.0) were diluted (1:100) in 
fresh media containing the appropriate antibiotic at various concentrations (0, 2, 5, 
10, 15, 20, 25, 30, 35 and 40 µg/ml) before growing for a further 24 h. The MIC was 
considered to be the antibiotic concentration which inhibited or significantly reduced 
bacterial growth (OD600 ≤ 0.05).  
 
2.3.9.2 Transposon mutagenesis 
The pRL27 plasmid encoding kanamycin resistance (Km
R
) was transferred from the 
E. coli donor strain (BW2020767) to Y. ruckeri recipients following a conjugation 
method previously described by Larsen et al. (2002). Briefly, cultures were grown to 
mid exponential phase (OD550 ≥ 0.7 ≤ 0.9) before mixing E. coli with Y. ruckeri 
strains in a ratio of 1:10 (50:500 μl) or 1:1 (200:200 μl). Cells were then collected 
by filtration using a 0.45-μm porosity membrane (Whatman) and allowed to 
conjugate overnight on a TSA plate at 28
º
C or room temperature. After conjugation, 
cells were re-suspended in TSB and plated, with or without serial dilutions, onto 
selective TSA plates (+ 50 µg/ml kanamycin, + 5 µg/ml nitrofurantoin) to isolate Y. 
ruckeri transconjugants.  
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2.3.9.3 Cataloguing mutants  
Following mutagenesis (above), single colonies were picked aseptically using a 
sterile toothpick or pipette tip and inoculated into one of the 96 wells of a microtitre 
plate (Greiner) containing 100 μl of TSB (+ 50 µg/ml kanamycin, + 5µg/ml 
nitrofurantoin). Mutants were grown overnight at 28
º
C and stored at -70
º
C following 
the addition of 100 μl (1:1) glycerol stock solution (65% [v/v] glycerol, 100 mM 
MgSO4 [pH 8.0]) to each well. 
 
2.3.9.4 Plasmid recovery and sequencing  
Genomic DNA was purified (Section 2.3.1) from transconjugants of interest before 
digesting (Section 2.3.3) with BamHI, a restriction enzyme which does not cut 
within the Tn-Km
R
 transposon (Larsen et al., 2002). Next, genomic DNA was 
ligated (Section 2.3.4) and used to transform chemically competent E. coli 
DH5α/λpir strains (Table 2.1) via the heat shock method (Section 2.3.8.1) before 
plating onto pre-warmed NA plates (+ 50 µg/ml kanamycin) and incubating 
overnight at 37
º
C. Resulting colonies were picked and grown in 10 ml of NB 
overnight (+ 50 µg/ml kanamycin) before purifying the recombinant plasmid 
(Section 2.3.2) and sequencing with transposon flanking primers TPNRL17–1 and 
TPNRL13–2.  
 
2.3.10 Screening for non-motile Y. ruckeri serotype O1 (BA19) mutants 
A diagram outlining the screening and plasmid rescue process for isolating the non-
motile serotype O1 (BA19) transconjugant (termed BA19/RL27) is shown in Fig 
2.1. Transconjugants were picked and grown in 96 well microtitre plates (Section 
2.3.9.3) before screening on motility agar (Section 2.1.4.4) using a 96 well replicator 
(Greiner). Strains which did not exhibit motility were confirmed by microscopy and 
by stab inoculating fresh motility plates with a single colony. If a lack of motility 
was confirmed, then plasmids were recovered for sequencing (Section 2.3.2).   
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Figure 2.1: Diagram outlining the screening of Y. ruckeri serotype O1 (BA19) 
tranconjugates for a non-motile phenotype and the recovery of plasmid DNA from 
the genome for sequencing. 
5. 
2. Purification of genomic DNA and restriction digest 
with the restriction enzyme HindIII 
3. Ligation of DNA fragments with T4 Ligase 
4. Transformation of E. coli DH5α/λpir with ligated plasmid 
5. Plasmid purification and sequencing of transposon flanking 
regions with transposon primers TPNRL17–1 and TPNRL13–2 
 
mutagenesis and motility screening 
BLAST (Basic Local Alignment Search Tool) of 
DNA sequences 
1.  Conjugation and otility scree i g 
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2.3.11 Screening for Y. ruckeri ompA (ompA::Tn-RL27) mutants 
EX5 transconjugants grown in 96 well microtitre plates (Section 2.3.9.3) were 
pooled in groups of 200 before purifying genomic DNA (Section 2.3.1). 
Transconjugants were screened for a transposon insert within the ompA gene 
(ompA::Tn-RL27) using PCR (Fig 2.2). Primer OMPA-F was used in a PCR 
reaction with primer TPNRL17–1 or TPNRL13–2, whereas reactions with primer 
OMPA-R were carried out in conjunction with primer TPNRL17–1 or primer 
TPNRL13–2. Multiple PCRs in this case had to be performed with different primer 
sets as the Tn-RL27 transposon could have potentially inserted within the ompA 
gene in different orientations. Any resulting PCR products were hybridized with an 
ompA DIG-labelled PCR product using southern blotting (below). PCR products 
which gave a positive reaction were investigated further by reducing the number of 
strains in each test group (i.e. 200 to 4 x 50) in an attempt to isolate the 
transconjugants of interest.  
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Figure 2.2: Outline of PCR reactions performed to identify a Y. ruckeri EX5 (R1) 
transconjugants which carries a transposon within the ompA gene (ompA::Tn-RL27). 
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2.3.12  Southern blotting, hybridization and detection of DNA  
2.3.12.1 Preparation of a Digoxigenin (DIG) labeled DNA probes 
A 50µl standard PCR reaction was carried out as stated above (Section 2.3.5.2) with 
the addition of 1 µl 25 mM d UTP-DIG (Roche) to the reaction mixture. The cycle 
parameters remained the same, albeit with a doubling of the extension time at 72
º
C 
to allow the incorporation of DIG-d UTP into the PCR product. To ensure that the 
incorporation of DIG was successful, original PCR products (without DIG) were run 
alongside the DIG labeled products. If the incorporation of DIG was successful, the 
PCR product with DIG-dUTP ran higher in the gel compared to the original PCR 
products.  
 
2.3.12.2  Southern blotting  
Southern blotting was carried out using downward capillary blotting previously 
performed by Chomczynski and Mackey (1994). Genomic DNA (~10 ug) was 
digested with BamHI (Section 2.3.3) and separated on a 0.7% (w/v) agarose gel 
(Section 2.3.6) before being photographed under a UV light. The digested DNA was 
then depurinated by soaking the gel in 250 mM HCl for 30 min, followed with a 
brief wash in dH2O before submerging the gel in denaturation buffer (1.5 M NaCl, 
0.5 M NaOH) for 2 x 20 min. Following another brief wash in water, the gel was 
placed in neutralization solution (1.5 M NaCl, 0.5 M Tris-HCl [pH 7.0]) for 2 x 20 
min prior to assembling the blotting stack.  
 
Stacks consisted of ~7 cm of thick paper towels upon which 2 pieces of Whatman 
3MM paper, which was pre-soaked in 20 x SSC (1.5 M NaCl, 150 mM sodium 
citrate [pH 7.0]) and cut to the same size as the gel, was placed on top. A positively 
charged membrane, which had been rinsed in dH2O before wetting in 20 x SSC, was 
placed on top of the Whatman paper. The gel, after removing the loading wells, was 
then placed upon the membrane before removing any air bubbles by rolling a glass 
pipette gently over the assembly. To complete the stack, 2 long pieces of 3 MM 
paper the same width of the gel was placed on top to build a bridge between a buffer 
tank filled with 20 x SSC. In order to prevent the stack from drying, the assembly 
was covered in cling film. Blotting took place for at least 8 h or overnight before 
disassembling the stack and covalently fixing the DNA onto the membrane using a 
UV crosslinker (UVC-508, Anachem) emitting 120,000 µJ of short-wavelength UV 
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light. Excess salt was removed by washing the membrane in dH2O and air-dried at 
room temperature before hybridization and detection of DNA fragments (bleow).  
 
2.3.12.3 Hybridisation and detection of DNA  
DNA blots were firstly pre-hybridised for 1 h in DIG Easy Hyb Buffer (Roche) at 
65
º
C in a rotating roller bottle within a hybridization oven (Hybaid). The DIG-
labelled DNA probe was then denatured (100
º
C, 10 min) before adding up to 25 
ng/ml of probe and hybridizing overnight at 65
º
C. Following hybridization, the 
membrane was washed once in pre-warmed (65
º
C) low stringency wash buffer (2 x 
SSC, 0.1% [w/v] SDS) and then twice in pre-warmed (65
º
C) high stringency wash 
buffer (0.2 x SSC, 0.1% [w/v] SDS). Next, the membrane was briefly washed in 
DIG 1 buffer (100 mM Tris-HCl [pH 8.5], 1 M NaCl, 0.2% [v/v] Tween 20) and 
then incubated in blocking solution (0.5% [w/v] blocking reagent in DIG 1 buffer) 
for 1 h at room temperature with gentle shaking. Anti-DIG conjugated alkaline 
phosphatase (Roche) was diluted (1:20,000) in blocking buffer and incubated with 
the membrane for 30 min at room temperature. After washing 5 x in DIG 1 buffer, 
the membrane was equilibrated in detection buffer (100 mM Tris-HCl [pH 9.5], 100 
mM NaCl) for 5 min before evenly spreading 2 ml of the chemiluminescent 
substrate CDP-Star (Roche) over the surface of the membrane. Finally, the 
membrane was gently pressed between two sheets of acetate and exposed to an X-
ray film for 1 to 20 min (depending on signal intensity) and developed (Section 
2.2.17).  
 
2.3.13 Cloning and overexpression of the Y. ruckeri flagellin (fliC) gene 
2.3.13.1 PCR amplification of the Y. ruckeri fliC gene 
Specific forward (FLA-F) and reverse (FLA-R) flagellin primers  (Table 2.6)  were 
designed using conserved N- and C- terminals of fliC from Y. enterocolitica 
(GenBank accession No: ADB96220.1) as a sequence template. This Y. 
enterocolitica strain was chosen due to a protein-protein BLAST (Basic Local 
Alignment Search Tool) showing 100% identity to 185 amino acid flagellin 
fragment of Y. ruckeri ATCC 29473 (GenBank accession No: ZP_04618012.1). Y. 
ruckeri genomes were shown to possess these primer-specific sequences by 
performing a DNA BLAST on the sequenced genome of Y. ruckeri ATCC 29473. In 
addition, FLA-F and FLA-R primers included 5’ sequences which would allow PCR 
fragments to contain XhoI and NdeI restriction sites (underlined in Table 2.6). 
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Amplification of Y. ruckeri flagellin was performed using genomic DNA isolated 
from the motile Serovar O1 BA19 strain. PCR conditions were as above (Section 
2.3.5.2) albeit with an annealing temp at 55
º
C for the first 5 cycles followed with an 
annealing temp at 64
º
C for 25 cycles. The initial reduction in annealing temperature 
(55
º
C) allowed the incorporation of XhoI and NdeI restriction sites within the PCR 
product.  
 
2.3.13.2 Cloning of the Y. ruckeri fliC gene  
After running a small amount (5 µl) of the PCR mix on a 1% (w/v) agarose gel 
(Section 2.3.6) to ensure that the fliC gene was successfully amplified, DNA 
products were digested with XhoI and NdeI (Section 2.3.3). The pET28-b plasmid 
was also digested overnight with XhoI and NdeI. After digesting, PCR products and 
plasmid DNA were gel purified (Section 2.3.7) and ligated together (Section 2.3.4) 
to create YRF1 (pET28-b + fliC). Chemically competent E. coli XL1-Blue cells 
(Table 2.1), prepared using the calcium chloride method (Section 2.3.8), were 
transformed with 10 µl of this ligation mixture before plating onto pre-warmed LA 
(+ 50 µg/ml kanamycin) plates. After incubating at 37
º
C overnight, any resulting 
colonies were grown in LB (+ 50 µg/ml kanamycin) before purifying plasmids 
(Section 2.3.2) and digesting with XhoI and NdeI to confirm the presence of insert. 
A positive E. coli XL1-Blue transformant which contained the YRF1 construct 
(termed E. coli XL1-Blue/YRF1) was stored at -70
º
C with glycerol (Section 2.1.3) 
or used to purify the recombinant plasmid. 
 
2.3.13.3 Induction and overexpression of Y. ruckeri flagellin  
Purified plasmid YRF1 (Section 2.3.2) was used to transform chemically competent 
E. coli BL21-DE3 strains (Table 2.1) using the heat shock method (Section 2.3.8). 
Transformants were selected by plating out on LA plates (+ 50 µg/ml kanamycin) 
and grown overnight at 37
º
C. Resulting colonies (termed E. coli BL21-DE3/YRF1) 
were inoculated into 10 ml of LB (+ 50 µg/ml kanamycin) and grown for a further 
18 h (37
º
C, 5 x g). This starter culture was used to inoculate fresh LB (+ 50 µg/ml 
kanamycin, 1:100 dilution) and grown (37
º
C, 5 x g) until reaching mid to late log 
phase (OD600> 0.6). Gene expression was induced by the addition of isopropyl β-D-
1-thiogalactopyranoside (IPTG) to a final concentration of 1 mM and grown for a 
further 4 h. Induced cells were harvested (4
º
C, 9,605 x g, 30 min) before purifying 
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the recombinant protein as IBs (Section 2.2.6) or by passing soluble protein through 
an IMAC column (Section 2.2.7). 
 
2.4 Fish trials 
2.4.1 Ethics statement 
All vaccinations and bacterial challenges were carried out in compliance with the 
Animals (Scientific Procedures) Act 1986 by a UK Home Office license holder (Ref: 
PIL60/00107) under instruction. Rainbow trout were sedated by immersion in 
anaesthetic (0.1% [w/v] Ethyl 3-aminobenzoate methane sulphonate salt [MS222]) 
prior to intraperitoneal (i.p.) injection and monitored for 15 min post-injection to 
ensure recovery from anaesthesia. Handling and movement of livestock was limited 
to prevent overstressing. When required, fish were killed by immersion in 
concentrated MS222. Remaining carcasses were disposed of following university 
regulations.  
 
2.4.2 Maintenance of fish stocks 
Non-vaccinated rainbow trout (average weight = 4 to 5g) were purchased from a 
commercial fish farm in Scotland. The health status of fish was checked at 48 h after 
arrival to the aquarium and then every two weeks according to Austin and Austin 
(1989). Livestock were maintained in continuously aerated, dechlorinated and free 
flowing freshwater at approx. 12
º
C in polypropylene tanks. Fish were fed daily to 
satiation with a commercial pellet diet (Trouw Nutrition, UK). 
 
2.4.3 Preparation of whole cell vaccines 
Bacterial whole cell vaccines for fish vaccinations were prepared following Austin 
et al. (2003). Bacterial cells were grown overnight (28
º
C, 5 x g) in 1 L of TSB (+ 
antibiotic when required) before the addition of formaldehyde to a final 
concentration of 0.5% (v/v). Cultures were maintained at room temperature for 72 h 
to allow the inactivation of cells before confirming sterility by spreading 100 µl 
volumes of culture over 10 TSA plates and incubating for 7 days at 28
º
C. Bacteria 
were considered inactive if colonies failed to form following the incubation period.  
Once sterility was confirmed, 40 ml of culture was centrifuged (4
º
C, 4,355 x g, 20 
min) before gently re-suspending the bacterial pellet in 40 ml of sterile PBS. Cell 
density was determined using a haemocytometer slide (Improved Neubauer Type, 
CHAPTER 2: MATERIALS AND METHODS 
66 
 
Merck) at a magnification of x1000. Cultures were adjusted, if necessary, with 
sterile PBS to a final concentration of 5 x 10
8
 cells/ml before storing at 4
º
C. 
 
2.4.4 Dose determination of native Y. ruckeri flagellin  
Native flagellin purified via the acid disassociation and re-association method was 
administered to fish (average weight = 5-6 g) by i.p. injection over a range of 
concentrations (0, 10, 20, 30, 40, 50, 100, 150, 200 and 250 µg/fish) in sterile PBS 
to a final volume of 100 µl/fish. For each concentration, 5 rainbow trout were 
vaccinated (N = 5). Fish were monitored over 14 days to determine the highest 
concentration of native flagellin which did not cause mortality. 
 
2.4.5 Dose determination of recombinant Y. ruckeri flagellin 
Recombinant flagellin (r-flagellin) purified from inclusion bodies was administered 
to rainbow trout (average weight = 5 to 6 g) by i.p. injection over a range of 
concentrations (0, 10, 20, 30, 40, 50, 100, 150 and 200 µg/fish) in sterile PBS to a 
final volume of 100 µl/fish. For each concentration, 5 fish were vaccinated (N = 5). 
Fish were monitored for a period of 14 days post-vaccination. 
 
2.4.6 LD60 dose determination of Y. ruckeri challenge strains YR1 and R1 
A lethal dose for 60% of the population (LD60) was calculated by the Probit method 
of Wardlaw (1985) for strains BA19, YR1, EX5 and R1 (Table 2.1). Thus, groups of 
rainbow trout (N = 5) were i.p. injected with 100 µl/fish
 
of pathogen suspended in 
saline ranging from 10
5
 to 10
9 
cells/ml before recording mortalities over 14 days.  
 
2.4.7 Fish immunizations and bacterial challenges 
Rainbow trout (average weight = 5 to 6 g) were randomly chosen from fish stocks 
and vaccinated via i.p. injection with 100 µl volumes of inactivated whole cell 
vaccines (5 x 10
7
 cells/fish, Section 2.4.3), native flagellin (50 µg/fish, Section 
2.2.5) or recombinant flagellin (12, 25 or 50 µg/fish, Section 2.2.6). Controls were 
i.p. injected with 100 µl volumes of sterile PBS. During the 28 day period between 
vaccination and challenge, all experimental fish remained within the one tank, but 
differentiated by various clippings of the caudal fin. Livestock were then separated 
into different tanks 48 h prior to i.p. challenge with YR1 (9 x 10
6
 live cells/fish) or 
R1 (4.5 x 10
6
 live cells/fish) in a total volume of 100 µl saline.  The number of cells 
administered to fish was estimated to be the LD60 values for non-vaccinated rainbow 
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with an average weight of 5 to 6 g (above). Control fish were challenged either with 
YR1 or R1 (as above) or i.p. injected with sterile PBS. Test subjects were monitored 
daily after challenge and then more frequently following mortality. After 14 days 
post-challenge, any remaining fish were killed in concentrated anaesthetic. The 
layout of initial vaccinations and bacterial challenges undertaken are represented in 
Table 2.6, whereas the second set of fish trials associated with r-flagellin as a 
vaccine at various concentrations is illustrated in Table 2.7 and Table 2.8. Data from 
fish experiments was statistically analysed using methods outlined in Section 2.4.9. 
Bacteria from dead or moribund fish were reisolated and identified (Section 2.4.8).  
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Table 2.6: Experimental design of initial vaccinations and bacterial challenges for 
rainbow trout. 
Tank   No of fish (N) Vaccine type   Challenge strain 
 
A  25   Saline (Control)  Serotype O1
b 
  
25   Serotype O1
a   
Serotype O1
b
 
 
B  25   Saline (Control)  EX5
b 
  
25   Serotype O1
a   
EX5
b 
 
C   25   Serotype O1
c   
Serotype O1
b
 
      (Non-motile mutant) 
 
D  25   Serotype O1
c   
EX5
b  
     (Non-motile mutant)
 
 
E   25   EX5
a    
Serotype O1
b 
 
F   25   EX5
a    
EX5
a 
 
G   38   Native flagellin   Serotype O1
b 
      (50 μg per fish) 
 
H   37   Native flagellin   EX5
a 
      (50 μg per fish) 
 
Abbreviations: Serotype O1
a
 = BA19 (WT), Serotype O1
b
 = YR1 (WT), EX5
a 
= 
EX5 (WT), EX5
b 
= R1 (WT) 
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Table 2.7: Second phase of fish vaccinations with r-flagellin as a vaccine at 
different dosages. Bacterial challenge was performed 28 days post-vaccination. 
Tank  No of fish (N) Concentration of  Challenge strain 
     r-flagellin (μg per fish) 
 
A  75   50 (N = 25)   Serotype O1
a
 
     25 (N = 25)   - 
     12 (N = 25)   - 
 
B  75   50 (N = 25)   EX5
a
 
     25 (N = 25)   - 
     12 (N = 25)   - 
 
C  25   0 (PBS control)  Serotype O1
a
 
 
D  25   0 (PBS control)  EX5
a 
  
Abbreviations: Serotype O1
a 
=YR1 (WT), EX5
a 
= R1 (WT) 
 
 
Table 2.8: Third phase of fish vaccinations using r-flagellin as a vaccine at different 
dosages. All fish were maintained within the same tank and were challenged with 
the Y. ruckeri R1 (EX5) strain 14 days post-vaccination. 
 
 
2.4.8 Bacteriological examination of infected fish 
Bacteria were recovered from dead or moribund fish following challenge. From each 
test group (including the controls), five fish were examined. Firstly, fish surfaces 
were washed with 70% (v/v) ethanol before dissecting with a sterile blade. Internal 
organs (e.g. liver, kidney and spleen) were swabbed before streaking onto a TSA 
plate and incubating overnight at 28ºC. Once grown, bacteria were streaked out onto 
No of fish (n) Concentration of r-flagellin (µg per fish) 
  
20 0 (PBS control) 
20 10 
20 25 
20 50 
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RPS
a fresh TSA plate and incubated (28ºC) until single colonies formed. Isolates were 
identified using bacteriological methods previously outlined in Section 2.1.3.    
 
2.4.9 Statistical analysis  
Experimental analysis was calculated as the absolute percentage (%) of fish 
surviving two weeks post-challenge. In addition, relative percentages (RPS
*
) of trout 
survival was calculated after Amend (1981).  
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3.1 Bacteriological examination of Y. ruckeri isolates 
Using bacteriological methods described earlier (Section 2.1.4), all presumptive Y. 
ruckeri isolates were confirmed as belonging to this bacterial species. Furthermore, 
strains were biotyped depending on their ability to exhibit motility and degrade 
Tween 20/80 (Table 3.1). Biochemical and morphological phenotypes for all Y. 
ruckeri cultures used in this study were in agreement with Austin et al. (2003).  
 
 
Table 3.1: Selected phenotypes of Y. ruckeri strains used in this study. 
Strain   Sorbitol Motility Tween 20/80  Biotype 
 
Serotype O1  
BA19   -  +  +   1  
YR1   -  +  +   1 
EX5  
EX5   -  -  -   2 
R1   -  -  -   2 
Serotype O2 
O2BA2  +  +  +   2 
Serotype O3 
O3BA3  +  +  +   2 
Serotype O4  
O4BA4  +  +  +   2 
 
 
 
3.2 Pathogenicity of Y. ruckeri strains towards naïve rainbow trout 
It was possible to estimate the LD60 values of certain Y. ruckeri strains by i.p. 
challenging naïve (= non-vaccinated) rainbow trout with increasing amounts of 
bacteria (Section 2.4.6). It was estimated that LD60 values for the two Y. ruckeri 
EX5 strains used in this study (termed EX5 and EX5 [R1]) was approx. 4 x 10
5
 
cells/fish, although this value was higher for a serotype O1 (termed YR1) isolate (8 
x 10
5
 cells/fish). The higher LD60 value of the serotype O1 (YR1) strain, when 
compared to the EX5 isolates (EX5 or EX5 [R1]), suggests that this serotype O1 
strain is not as virulent.  
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The second serotype O1 Y. ruckeri strain, termed BA19, was the strain used in this 
study to create the non-motile mutant (BA19/Tn-RL27). Indeed, this BA19 strain is 
considered to be the isolate used to manufacture the original (= monovalent) ERM 
vaccine (Prof. B. Ausin, University of Stirling, personal communication). However, 
the BA19 strain was considered to be avirulent since injecting naïve fish with this 
isolate over a range of concentrations (i.e. 1 x 10
5
, 10
6
, 10
7
, 10
8
, 10
9
 cells/ml;  N = 5 
x 5) did not result in any mortalities 14 days post-challenge (100% survival).  
 
3.3 Constructing a non-motile Y. ruckeri strain for vaccinations 
3.3.1 Optimizing  mutagenesis 
Random genomic transposon mutagenesis was employed in this study to convert a 
motile (= serotype O1) Y. ruckeri isolate to a non-motile (= EX5) phenotype. Two 
types of transposon delivery vectors were available for use in this work. The first, 
termed pRL27, carries a mini Tn5 (Tn-RL27) transposon and a hyperactive Tn5 
transposase (Larsen et al., 2002). The role of the transposase enzyme is to bind to 
the ends of a transposon, excise it, then randomly integrate the transposon into the 
host genome in a “cut-and-paste” manner. Transposase encoded within the pRL27 
construct is expressed from the tetA promoter and is considered to be 1000 times 
more active than the wild-type transposase (Larsen et al., 2002). This Tn-RL27 
transposon also carries a gene which confers resistance towards kanamycin. In 
addition, the transposon contains the origin of replication from the plasmid R6K, 
thereby allowing the insertion site to be cloned via plasmid rescue. Flanking regions 
can then be sequenced to determine which gene(s) the transposon has potentially 
disrupted. This process is generally outlined in Fig 2.1. The second transposon 
delivery vector (termed pLM1) described by Fox et al. (2008) is essentially identical 
to pRL27, albeit carrying the gene required for gentamicin resistance (Gm
R
) as 
opposed to the gene encoding kanamycin resistance (Km
R
).   
 
Although both transposon vectors (pRL27 or pLM1) could be administered to 
bacteria via electrotransformation, bacterial conjugation is generally preferred 
(Larsen et al., 2002, Fox et al., 2008, Evenhuis et al., 2009). This involves mixing 
the E. coli donor strain (carrying the pRL27 or pLM1 vectors) with the host strain 
(e.g. Y. ruckeri) before filtering bacteria onto a membrane and allowing membrane-
bound bacteria to conjugate overnight on  media plates (e.g. TSA). Transconjugants 
(i.e. host strains which carry the Tn-R27 [Km
R
] construct) can then be recovered by 
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plating the conjugation mix out onto medium containing antibiotics which select 
against the donor and untransformed host strains.   
 
For conjugation to be applied in this study, Y. ruckeri isolates would have to be 
sensitive to kanamycin or gentamicin to allow for mutant selection. Whereas both 
the serotype O1 isolate (BA19) and EX5 (R1) isolates failed to grow on TSA plates 
containing either kanamycin (50 μg/ml) or gentamicin (10 μg/ml) after 48 h at 28°C. 
Therefore, either one of the transposon vectors could be used for mutagenesis. 
However, the pRL27 plasmid was eventually chosen for use in this study because it 
has been previously applied by Evenhuis et al. (2009) to screen for non-motile Y. 
ruckeri isolates.  
 
While kanamycin could be used to select for transformed Y. ruckeri strains, it could 
not be used to remove the E. coli donor strain (in this case E. coli BW20767/pRL27) 
because it is resistant to this antibiotic. The antibiotic employed by Evenhuis et al. 
(2009) to remove the E. coli donor strain after mating was not stated.  
 
A second antibiotic was therefore required to counteract the growth of the E. coli 
donor strain (BW20767/pRL27). Hence, the Y. ruckeri serotype O1 (BA19) and EX5 
(R1) strain, along with the E. coli BW20767/pRL27 isolate, were tested against a 
range of antibiotics. Although this part of the study initially focused on creating a 
non-motile mutant from a motile parent strain, the EX5 (R1) isolate was included in 
testing antibiotic susceptibility as this strain was required for transposon 
mutagenesis at a later stage. Antibiotic susceptibility test patterns for each of the 
three strains tested are shown in the appendix (Table 5.2). From these results it was 
clear that the Y. ruckeri and E. coli donor strain shared a great deal of similarity in 
antibiotic resistance patterns. It is worth noting that the Y. ruckeri serotype O1 
(BA19) strain, obtained from a lyophilised culture since 1983, exhibited broad levels 
of antibiotic resistance (appendix; Table 5.2). This indicates that Y. ruckeri strains in 
1983 had already developed a strong resistance to most of the conventional 
antibiotics (e.g. erythromycin) which were used to treat ERM. 
 
Y. ruckeri strains (BA19 and R1) exhibited higher levels of resistance towards 
nitrofurantoin compared to the E. coli donor strain (BW20767/pRL27). The MIC of 
this antibiotic for the Y. ruckeri isolates was 10 μg/ml, but significantly lower (2 
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μg/ml) for the E. coli donor strain (appendix; Fig 5.3). Transconjugants could 
therefore be obtained after mating by plating out onto TSA or NA plates 
supplemented with 50μg/ml kanamycin and 5μg/ml nitrofurantoin. In addition, 
culturing at 28°C, as opposed to 36°C, also significantly hindered E. coli growth. 
Hence, kanamycin, nitrofurantoin and lower incubation temperatures (e.g. 28°C) 
could be used to select for Y. ruckeri Tn-RL27 Km
R
 transconjugants (Fig 3.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Use of temperature and antibiotics to select for Y. ruckeri Tn-RL27 
(Km
R
)
 
transconjugants after mating Y. ruckeri cells with the E. coli donor strain 
(BW20767/pRL27). Single colonies were streaked out onto nutrient agar (NA) 
supplemented with kanamycin (50 µg/ml) and nitrofurantoin (5 µg/ml). Plates were 
incubated for 48 h at 28ºC. A: Wild-type (WT) serotype O1 (BA19) Y. ruckeri 
strain. B: WT EX5 Y. ruckeri (R1) isolate. C: E. coli BW20767/pRL27 donor strain. 
D: Y. ruckeri/Tn-RL27 (Km
R
) transconjugant (BA19/Tn-RL27). 
 
 
The conjugation efficiency between the E. coli donor strain with that of the Y. 
ruckeri BA19 or EX5 (R1) isolate was investigated. A standardized conjugation 
(Section 2.3.9.2) resulted in a transformation efficiency of 1.2 + 0.5 x 10
7
 cells/ml, 
approx. equating to 1.2 + 0.5 x 10
8
 transconjugants from one mating experiment. 
The number of transconjugants was not significantly different between the E. coli 
BW20767/pRL27 and Y. ruckeri BA19 or R1 strain. This rate of mutagenesis was 
D 
A 
B 
C 
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considered to be adequate for the purposes of this study. Moreover, contamination 
with other bacteria (e.g. E. coli) was minimal since 20 randomly picked colonies 
from both transformations were all confirmed to be Y. ruckeri using conventional 
bacteriological techniques (Section 2.1.4).    
 
In addition to ensuring that the transformation efficiency was adequate, the presence 
of the kanamycin resistance gene (Km
R
) and the random integration of the 
transposon within the genome had to be confirmed. Firstly, a PCR reaction using the 
kanamycin forward (AGPT-F) and reverse (AGPT-R) primers was performed to 
amplify the region of DNA containing the kanamycin resistance gene using genomic 
DNA from 7 randomly chosen transconjugants as templates (Fig 3.2; A). Four of 
these tranconjugants were from a mating experiment using the E. coli donor and Y. 
ruckeri BA19 strain (generically termed BA19/Tn-RL27 1 to 4). The last 3 
transconjugants were sourced from a mating experiment using the E. coli donor and 
Y. ruckeri EX5 (R1) isolate (termed R1/Tn-RL27 1 to 3). It was clear from this 
experiment that Y. ruckeri transconjugants obtained the Km
R
 gene via conjugation 
since all 7 PCR reactions generated a detectable PCR product, whereas reactions 
using genomic DNA from the WT parent strains did not (Fig 3.2; A). 
 
To determine if the transposon insertions within the genome of these mutants were 
random, genomic DNA was digested with BamHI and separated on a 0.7% (w/v) 
agarose gel (Fig 3.2; B). BamHI was chosen as this restriction enzyme does not cut 
within the kanamycin gene or indeed the transposon itself (Larsen et al., 2002). 
Digested genomic DNA was then blotted to a membrane before hybridizing with a 
DIG-labelled Km
R
 probe (Fig 3.2; C). Should transposons all integrate within the 
same region of host genomic DNA then hybridized bands between different 
transconjugants would have all been the same size. This is clearly not the case for 
hybridized bands visible in Fig 3.2 (C), thus indicative of random transposon 
insertions (more specifically the Km
R
 gene) within the genome.  
 
At this stage it was clear that the conjugation system described by Larsen et al. 
(2002) could be successfully used to create Y. ruckeri transconjugants.  
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Figure 3.2: Detection of the Tn-RL27 Km
R
 (aph) gene within the genomes of Y. 
ruckeri transconjugants. A: PCR amplification of the Tn-RL27 Km
R
 gene from 
bacterial genomes using the primers AGPT-F and AGPT-R. B: BamHI digestion of 
genomic DNA separated on a 0.7% (w/v) agarose gel; C: Detection of Tn-RL27 
Km
R
 genes using a DIG-labeled Tn-RL27 Km
R
 PCR product. M: Molecular weight 
marker (λ HindIII; Fermentas). Lane 1: WT serotype O1 (BA19). Lane 2: WT EX5 
(R1). Lanes 3-6: Serotype O1 (BA19) transconjugants (BA19/Tn-RL27 1 to 4). 
Lanes 7-9: EX5 (R1) transconjugants (R1/Tn-RL27 1 to 3). 
 
 
 
 
 
 
 
A 
B 
C 
         1     2     3      4     5     6     7     8      9 
 M     1    2    3     4    5     6    7    8     9 
     1     2     3      4      5      6      7      8     9 
         1     2     3     4     5     6     7    8     9 
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3.4 Screening for a non-motile BA19 mutant 
Matings were performed between the WT Y. ruckeri serotype O1 (BA19) and the E. 
coli donor strain (BW20767/pRL27). In total, 4000 Y. ruckeri serotype O1 (BA19) 
transconjugants were randomly picked and grown overnight at 28ºC in individual 
wells of 96-well microtitre plates containing 200 µl of TSB (+ 50 µg/ml kanamycin, 
+ 5 µg/ml nitrofurantoin). Using a 96-pin microtitre replicator, Y. ruckeri 
transconjugants were stab inoculated onto semi-solid motility media (an example is 
shown in the appendix; Fig 5.4) and incubated overnight at 28ºC. Each microtitre 
plate had glycerol added to each well and was stored at -70ºC. 
 
After screening 4000 mutants on motility media, 3 mutants (B2A12, C4C12, and 
C4F11) were seen to be potentially non-motile. Fresh cultures of all 3 strains were 
purified from glycerol stocks and again stab inoculated onto motility media. Two 
strains (B2A12 and C4C12) showed some signs of motility, whereas the third 
(C4F11) did not. The non-motile phenotype of the C4F11 transconjugant, which was 
termed BA19/Tn-RL27 for simplicity, can be observed in Fig 3.3.  
 
 
 
 
 
 
 
 
 
Figure 3.3: Flagellin-mediated motility of Y. ruckeri isolates. Single bacterial 
colonies were stab inoculated onto motility plates (Columbia broth + 0.3% [w/v] 
agar) and incubated overnight at 28
o
C. Strains were considered motile if an 
outgrowth or halo formed from the point of inoculation after incubation. Whereas the 
WT serotype O1 (BA19) strain is motile (A), the WT EX5 (R1) (B) and serotype O1 
transconjugant (BA19/Tn-RL27) (C) are non-motile.   
 
 
 
A B C 
5 mm 5 mm 5 mm 
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Although the serotype O1 (BA19/Tn-RL27) transconjugant is clearly non-motile, it 
does not necessarily imply that the flagellin monomer is not produced by this strain. 
To determine if this protein is expressed by this transposon mutant, whole-cell 
proteins (WCPs) from both the serotype O1 (BA19) and BA19/Tn-RL27 
transconjugant were separated electrophoretically on a 10 % (w/v) SDS-PAGE gel 
(Fig 3.4; A) before blotting proteins to a nitrocellulose membrane and hybridizing 
with a monoclonal anti-flagellin (#15D8) antibody (Fig 3.4; B). In addition, WCPs 
from the non-motile EX5 isolate were run alongside these samples. Proteins in lanes 
4, 5 and 6 of Fig 3.4 will be the topic of discussion at a later stage. It is clear from 
this result that the serotype O1 (BA19) strain is producing a flagellin monomer 
(approx. 45 kDa) as it is recognised by the anti-flagellin antibody. On the other 
hand, both the EX5 and non-motile BA19/Tn-RL27 transconjugant are not 
producing detectable flagellin. Thus, it was clear that the BA19/RL27 mutant was 
non motile and unable to produce flagellin under growth conditions used to cultivate 
this strain (i.e. 28ºC in TSB for 48 h at 250 rpm). Like the EX5 strain and the non-
motile mutant isolated by Evenhuis et al. (2009), the BA19/RL27 transconjugant 
was unable to produce and/or excrete an extracellular lipase (appendix; Fig 5.5).  
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Fig 3.4: Immunodetection of flagellin within vaccines and challenge strains. A: 
Proteins fractionated on a 10% (w/v) SDS-PAGE gel. B: Immunodetection of 
flagellin after blotting proteins to a membrane and hybridizing with the anti-flagellin 
monoclonal antibody #15D8. M: Molecular weight marker (29 to 200 kDa; Sigma). 
Lanes 1: Vaccines used to immunize naïve rainbow trout. Lanes 5-6: Whole cell 
proteins (WCPs) of bacterial strains used for challenges. Lane 1: WCPs of a 
serotype O1 strain (BA19). Lane 2: WCPs of the EX5 strain. Lane 3: WCPs of the 
non-motile serotype O1 transconjugant mutant (BA19/RL27). Lane 4: Native 
flagellin (5 µg) purified from the serotype O1 (BA19) isolate via the acid 
disassociation and re-association method described by Ibrahim et al. (1985). Lane 5: 
WCPs of a serotype O1 strain (YR1). Lane 6: WCPs of an EX5 (R1) strain. See text 
for details. 
   M   1        2         3        4                   5        6 kDa 
                Vaccine          Challenge 
      1        2         3         4                   5        6 
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The next stage was to determine the location of the inserted transposon within the 
bacterial chromosome. For this to be achievable, the transposon and flanking DNA 
was recovered from the BA19/Tn-RL27 genome in the form of a plasmid for 
replication and sequencing. A diagrammatic representation of plasmid recovery can 
be seen in the Materials & Methods (Fig 2.2). Briefly, genomic DNA was purified 
from the BA19/Tn-RL27 mutant and digested with BamHI. DNA fragments were 
then ligated with T4 ligase to create synthetic plasmids before using this ligation 
mixture to transform chemically competent E. coli DH5α/λpir bacteria. The 
transformation mixture was then plated out onto LA (+ 50 µg/ml kanamycin) and 
incubated at 37˚C for 48 h. Resulting colonies were grown in LB (+ 50 µg/ml 
kanamycin) before purifying the recovered plasmid. Flanking regions (e.g. genomic 
DNA sequences to the left and right hand side of the transposon) were sequenced at 
least twice using the TPNRL17–1 or TPNRL13–2 primer.  
 
BLAST analysis of genomic DNA sequences flanking the transposon showed that 
the transposon had inserted within the flhA gene of Y. ruckeri (Fig 3.5), a region of 
DNA which is believed to encode a protein involved in the flagellar secretion 
apparatus (Chevance and Hughes, 2008). Annotated DNA sequences regarding this 
transposon insert are included in the appendix (Fig 5.6). The flhA gene of Y. ruckeri 
was also disrupted by Evenhuis et al. (2009) using the same transposon mutagenesis 
method. This would suggest that this particular region is a so-called “hot-spot” for 
transposon integration. Although the gene encoding flagellin has not been disrupted, 
the BA19/Tn-RL27 transconjugant is not producing detectable flagellin (Fig 3.4; 
Lane 3) and can therefore be used in fish vaccination studies.  
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Fig 3.5: Diagrammatic representation of the Tn-RL27 transposon insertion within 
the flhA gene of the serotype O1 (BA19/Tn-RL27) Y. ruckeri transconjugant. The 
WT serotype O1 (BA19) flhA site is shown (A), whereas the insertion of the Tn-
RL27 transposon in the BA19/Tn-RL27 site is also depicted (B).  
 
 
3.5 Flagellin as a component of a whole-cell Y. ruckeri vaccine 
The protective role of flagellin as a component of a whole-cell vaccine was 
investigated. Both the presence and absence of flagellin within the formalin-
inactivated whole-cell vaccine preparations was confirmed by Western blotting and 
immunodetection using an anti-flagellin antibody (Fig 3.4) before carrying out 
immunizations. Similarly, the presence or absence of flagellin in each of the 
challenge strains was also confirmed prior to challenging fish (Fig 3.4).  
 
All naïve rainbow trout (average weight = 5 to 6 g) mock-vaccinated and/or mock-
challenged by intraperitoneal (i.p.) injection with sterile PBS survived (Relative 
flhA::Tn-RL27 
flhA 
Kan
R
 (Km
R
) 
IR IR 
OriVR6K aph 
A 
B 
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Percent Survival [RPS] = 100%). This shows that any subsequent mortality in this 
study was not due to the stress of i.p. injection, handling or submersion in 
anaesthetic. However, only 32 and 48% of all mock-vaccinated fish survived after 
challenging with a serotype O1 (YR1) (8 x 10
5
 cells/ fish) and EX5 (R1) Y. ruckeri 
strain (4 x 10
5
 cells/ fish) respectively. This confirms the pathogenicity of bacterial 
isolates towards non-vaccinated rainbow trout.  
 
Survival rates 14 days post-challenge for trout i.p. vaccinated with a motile, 
flagellin-producing Y. ruckeri serotype O1 (BA19) strain (1 x 10
8
 inactivated 
cells/fish) is shown in Fig 3.6. Whereas serotype O1 (BA19) vaccinated fish were 
moderately protected against challenge with a serotype O1 (YR1) isolate (total 
survival = 76%; RPS = 65%), vaccinates were less protected against the EX5 (R1) 
strain (total survival = 60%; RPS = 23%). On the other hand, vaccinating fish with 
the non-motile flagellin-devoid serotype O1 transconjugant (BA19/Tn-RL27) 
resulted in a reduction in the level of protection against challenge with the serotype 
O1 (YR1) strain (total survival = 60%; RPS = 41%). This suggests  that flagellin is 
not the only immunostimulatory molecule in the vaccine preparation. However, this 
reduction in protection was not specific for challenge against a flagellin-producing 
strain as survival rates for fish vaccinated with the serotype O1 BA19/Tn-RL27 
transconjugant was also reduced when challenged with the EX5 (R1) strain (total 
survival = 46%; RPS = 0%).  
 
It should be noted that, for ethical reasons, numbers of fish were kept to a minimum 
in each group (N = 25). As a result, the standard error rates are high. When taking 
this into consideration, total survival values are not statistically significant between 
survival rates of fish vaccinated with a flagellin producing (e.g. serotype O1 
[BA19]) or flagellin-devoid (e.g. serotype O1 [BA19/Tn-RL27]) mutant strain (P < 
0.05). This indicates that the presence or absence of flagellin does not have a 
profound effect on the levels of protection towards bacterial challenge, suggesting 
that Y. ruckeri flagellin is not the main immunogenic/immunostimulatory molecule 
involved in eliciting an immunoprotective response.  
 
Vaccinating with inactivated whole cells of the non-motile, flagellin-devoid Y. 
ruckeri EX5 strain was also included in these fish trials (Fig 3.6). Vaccinating with 
this strain (1 x 10
8
 inactivated cells/fish) gave excellent levels of protection (total 
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survival = 96%; RPS = 95%) against challenge with the serotype O1 (YR1) strain. 
This level of protection is significantly higher than that obtainable using the 
serotype O1 (BA19) or non-motile BA19/Tn-RL27 mutant as a vaccine. Thus, 
flagellin is clearly not required for conferring a protective immune response against 
ERM in rainbow trout. Furthermore, EX5 must harbour molecules or epitopes that 
enhance the protective reaction against serotype O1 (YR1) challenge.  
 
Interestingly, fish vaccinated with the EX5 strain, although strongly protected 
against challenge with the serotype O1 (YR1) strain, were not protected to the same 
extent after challenging with the EX5 (R1) strain (72% survival; RPS = 42%). This 
is difficult to explain, particularly since both the EX5 strains are very similar in 
terms of biochemistry and physiology. One explanation is that the EX5 isolate is 
more capable of resisting clearing by the immune system, a feature which is 
associated with Y. ruckeri pathogenicity (see discussion). However, this would 
require further investigation.  
  
Overall, this study shows that flagellin, or at least flagellin within the whole cell 
vaccine preparations, is not required to protect against a motile Y. ruckeri isolate 
(e.g. YR1). Although it is possible that flagellin may have a non-specific role in 
protection in a serotype O1 vaccine, it is not an essential component in developing 
protection. Results therefore suggest that other molecules, possibly those presented 
on the surface of EX5 cells, can sufficiently protect against challenge with a 
serotype O1 (YR1) and, to some extent, the non-motile (e.g. EX5 [R1]) Y. ruckeri 
strain.   
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Fig 3.6: Use of formalin-inactivated whole-cell vaccines to protect rainbow trout 
against challenge with a serotype O1 (YR1) ( ) or EX5 (R1) ( ) Y. ruckeri strain. 
Control fish were mock-vaccinated/challenged with PBS ( ). Survival rates 14 days 
post-challenge are given. Standard error values, where applicable, are shown for 
each group (N = 25).  
 
 
 
3.6 Purity of native Y. ruckeri flagellin  
In addition to investigating the role of flagellin in protecting against ERM as part of 
a whole-cell vaccine, the use of flagellin as a purified, sub-unit vaccine was also 
explored. Native flagellin was obtained from live serotype O1 (BA19) Y. ruckeri 
cells following the acid disassociation and re-association method outlined by 
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Ibrahim et al. (1985). Initial attempts were made to acquire flagellin from cultures 
grown in M9 minimal as this was originally thought to prevent contamination from 
protein-rich broth (Ibrahim et al., 1985). However, bacterial growth was poor (OD600 
< 0.4), resulting in a low yield of flagellin (< 166 µg/L). On the other hand, when 
grown overnight in 6 x 1 L of TSB, 5 mg of flagellin (approx. 833 µg/L) could be 
recovered without any apparent contamination with media proteins. No flagellin 
could be obtained when using the Y. ruckeri EX5 (R1) culture as a source of the 
protein.  
 
After purifying protein using a method described by Ibrahim et al. (1985), 5 µg was 
fractionated on a 10% (w/v) SDS-PAGE gel (Fig 3.4; A: Lane 4). A protein band 
approximately 45 kDa in weight was clearly visible after staining with Coomassie 
brilliant blue-R250. No other protein bands were observed. Western blotting and 
immunodetection with the anti-flagellin antibody (#15D8) confirmed that this 45 
kDa protein was flagellin (Fig 3.4; B: Lane 4). Given that only one protein band was 
observable, this flagellin preparation was considered to be of a sufficient purity for 
testing protein toxicity for fish (below) and for use as a sub-unit vaccine (Section 
3.8).  
 
3.7 Toxicity of native Y. ruckeri flagellin to rainbow trout 
Native flagellin was intraperitoneally (i.p.) administered to naïve rainbow trout 
(average weight = 5 to 6 g) at various amounts (0, 10, 20, 30, 40, 50, 100, 150, 200 
and 250 µg/ fish) to determine what effect this may have for health. Groups of five 
fish were used to test each concentration of native flagellin. Antigen was 
administered in a total volume of 100 µl PBS. Prior to injection, fish were 
anesthetised. Livestock was then observed for 3 days post-injection, after which any 
remaining fish were killed by overdosing with anaesthetic as described in Section 
2.4.1. 
 
Results from this experiment are shown in Fig 3.7. It was evident that concentrations 
up to 50 µg of native flagellin/fish did not have a detrimental effect on health. Post-
mortem examination of trout showed no signs of disease, nor did they show any 
physiological changes either externally (e.g. skin, eyes, mouth) or internally (e.g. 
liver, intestine or spleen). Conversely, fish administered with higher concentrations 
of the native preparation died. In fact, fish did not fully recover from the anaesthesia 
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administered for vaccination and died shortly afterwards. There was no observable 
inflammation and/or reactions at the site of injection in fish which died or lived 
following injection. 
 
Since i.p. injection of 50 µg flagellin/fish did not cause death, nor was it apparently 
detrimental to fish health, this concentration was considered to be safe for use on 
larger scale vaccinations (below). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.7: Toxicity of native Y. ruckeri flagellin to naïve rainbow trout over a range of 
concentrations. 
 
 
3.8 Protection conferred by native Y. ruckeri flagellin 
The protective properties of native Y. ruckeri flagellin protein for rainbow trout 
against challenge with a serotype O1 (YR1) or EX5 (R1) Y. ruckeri strain were 
determined. It should be noted that experiments regarding flagellin as a sub-unit 
vaccine were carried out alongside vaccination/challenge studies regarding flagellin 
as part of a whole-cell vaccine (Section 3.5). Rainbow trout (average weight = 5 to 6 
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g; N = 80) were sedated in anaesthetic and i.p. vaccinated with native flagellin 
(50µg/fish). As previously stated, controls were mock-vaccinated with sterile PBS 
(N = 60). All fish recovered from anaesthesia within a matter of minutes and showed 
no signs of disease or distress. After 28 days post-vaccination, half of the flagellin-
vaccinates (N = 40) were i.p. challenged with the serotype O1 (YR1) strain (8 x 10
5
 
cells/ml), whereas the other half (N = 40) were i.p. challenged with the EX5 (R1) 
isolate (4.5 x 10
5
 cells/fish). Fish mock-vaccinated with PBS were either challenged 
with the serotype O1 (YR1) (8 x 10
5
 cells/ml; N = 25) or EX5 (R1) (4.5 x 10
5
 
cells/fish; N = 25) strain. A further control group of trout mock-vaccinated with PBS 
(N = 10) were mock-challenged with PBS. Prior to i.p. injection, all fish were again 
sedated in anaesthetic and fully recovered from anaesthesia. Survival rates for all 
groups 14 days post-challenge are outlined in Fig 3.8. 
 
All fish administered with native flagellin (N = 80) after 14 days post-challenge 
survived (RPS = 100%) (Fig 3.8). Furthermore, fish injected with flagellin showed 
excellent signs of health and behaviour compared to control fish surviving 
challenge. Protection was strain-independent as half (N = 40) were challenged with 
the serotype O1 (YR1) isolate, whereas the second half (N = 40) were challenged 
with the EX5 (R1) strain. These results are significant insofar as native flagellin can 
protect against both a flagellin-producing (i.e. serotype O1) (Fig 3.4; Lane 6) and 
flagellin-devoid (i.e. EX5) (Fig 3.4; Lane 7) Y. ruckeri strain.  
 
Post-mortem examination of fish which succumbed to disease following bacterial 
challenge all showed signs of haemorrhaging and liquefaction of internal tissues. 
Bacterial cells were recovered from internal tissues (e.g. kidney, spleen and ascetic 
fluid) as pure cultures and were confirmed to be Y. ruckeri serotype O1 (YR1) or 
EX5 (R1) depending on the strain used for challenge.  
 
Overall, these results demonstrate that native flagellin can be an efficacious vaccine 
in preventing ERM in rainbow trout. The ability to protect against a strain which 
does not produce this protein (i.e. EX5) also suggests that it may be a potent non-
specific vaccine. Thus, the next rational step in this study was to investigate the 
possibility of cloning/overexpressing the protein encoding Y. ruckeri flagellin for 
use as a recombinant vaccine. 
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Fig 3.8: Use of native flagellin as a vaccine (50 µg/fish) to protect rainbow trout 
against challenge with a serotype O1 (YR1) and EX5 (R1) Y. ruckeri strain. Fish 
were mock-vaccinated with PBS ( ) or immunized with PBS + native Y. ruckeri 
flagellin ( ) 28 days before challenging. Vaccinates were then mock-challenged 
with PBS only (control) or challenged with PBS + live serotype O1 (YR1) or EX5 
(R1) bacteria. Survival rates were recorded 14 days post-challenge. Standard errors, 
where applicable, are included. 
  
 
3.9 Cloning of the Y. ruckeri fliC gene 
The Y. ruckeri genome has been sequenced, although it is currently lacking 
annotation and is available only as short sequence reads (NCBI Accession: 
PRJNA55249; ID: 55249). Consequently, the gene encoding the Y ruckeri flagellin 
monomer (termed fliC) could not be readily located. Moreover, the Y. ruckeri fliC 
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gene has not been described within the literature. Still, the sequence of a 185 amino 
acid (aa) peptide from Y. ruckeri, which was considered to be a “flagellin-like” 
protein, was available within the NCBI protein database (GenBank accession No: 
ZP_04618012.1). Protein BLAST analysis of the peptide sequence showed that it 
shared a high level of protein identity (90%) to that of Y. enterocolitica flagellin. 
BLAST analysis of the gene encoding Y. enterocolitica flagellin (fliC) (GenBank 
accession No: ADB96220.1) found it to be similar to other Yersinia spp., particularly 
at both the N- and C- terminals. Similar sequences were also found within the 
genomic library of the Y. ruckeri strain ATCC 29473, suggesting that the gene of 
interest was not dissimilar to that of other Yersinia. Therefore, primers containing 
restriction sites for XhoI and NdeI could be designed based upon conserved N- and 
C- terminal sequences to amplify the fliC gene of Y. ruckeri.  
 
A PCR reaction using Pfu enzyme and genomic DNA from the serotype O1 (BA19) 
strain as a template, with the primers FLA-F/FLA-R, resulted in a single product 
~1200 bp in size (Fig 3.9). This PCR product (termed fliC) was purified, digested 
with the restriction enzymes XhoI and NdeI, and cloned into vector pET28-b to 
create the plasmid YRF1 (pET28-b + fliC). The ligation mixture was then used to 
transform chemically-competent E. coli XL1-Blue bacteria. Six colonies were 
picked and grown overnight before purifying plasmid DNA from each culture. 
Purified plasmids were digested with the restriction enzymes NdeI and XhoI (Fig 
3.10). Of the six plasmids digested, two (Fig 3.10; Lanes 3 and 4) gave a detectable 
band of ~1000 bp, indicating that the fliC PCR product was correctly inserted within 
the pET28-b vector. The E. coli XL1-Blue transformant, containing the YRF1 
plasmid shown in Fig 3.10 (Lane 3), was termed E. coli XL1-Blue/YRF1. This strain 
was stored as glycerol stocks at -70ºC and used in all subsequent experiments as a 
source of YRF1. 
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Fig 3.9: PCR amplification of the serotype O1 (BA19) Y. ruckeri flagellin (fliC) 
gene using primers (FLA-F and FLA-R). Primers were based on conserved N- and C- 
terminal sequences of the Y. enterocolitica flagellin gene. M: Molecular weight 
marker (λ HindIII; Fermentas). Lane 1: PCR product using Y. ruckeri genomic DNA 
as a template. Lane 2: Negative PCR control. A detectable PCR product of ~1200 
bp, the estimated size of fliC, is visible in lane 1.  
 
 
 
 
 
 
 
 
Fig 3.10: Screening of six E. coli XL1-Blue transformants for pET28-b plasmid with 
a Y. ruckeri flagellin gene (fliC) insert (YRF1). Plasmids were purified via the 
alkaline lysis method before digesting overnight with XhoI and NdeI at 37
o
C. M: 
Molecular weight marker (λ HindIII). Lanes 1-6: Digested plasmids isolated from 
XL1-Blue E. coli transformants. DNA fragments in lanes 3 and 4 gave a detectable 
fragment of approx.1000 bp (indicated), indicating that the Y. ruckeri fliC gene was 
incorporated into the plasmid in the correct orientation.  
 M      1        2       3        4        5       6 
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3.10 Sequencing the YRF1 plasmid insert 
The YRF1 plasmid from the E. coli XL1-Blue/YRF1 transformant was sequenced 
using the FLA-F and FLA-R primers. Additional sequences adjacent to original 
primers were obtained by sequencing with the internal primers FLG-L and FLG-R. 
Each sequencing reaction was repeated to ensure that the DNA sequence was 
correct. The final DNA sequence, along with the predicted amino acids encoded by 
the open reading frame (ORF), is available in the appendix (Fig 5.7). The ORF also 
includes 5’ and 3’ sequences from the pET-28b vector. 
 
Analysis of the fliC DNA sequence showed that the gene has an overall G+C content 
of 52.6%, a number which is not dissimilar to that predicted for the Y. ruckeri 
genome (Ewing et al., 1978). The deduced protein sequence (Fig 5.7; B) consists of 
452 amino acids and has an estimated molecular weight of 46.77 kDa. The protein 
also has histidine (His) tags successfully incorporated at both the N- and C- 
terminal. BLAST analysis of this sequence showed that it is similar (69% identity) 
to that of the Y. enterocolitica 39.6 kDa flagellin protein (Fig 3.11). A tree of the 
flagellin monomer amino acid sequence (Fig 3.12) could be constructed using the 
online phylogeny program (http://www.phylogeny.fr/). What is apparent from this 
tree is that the amino acid sequence of Y. ruckeri flagellin is most similar to flagellin 
of other Yersinia spp. Some degree of amino-acid relatedness was also shown 
between Y. ruckeri flagellin and that of Serratia, Salmonella and E. coli flagellins 
(Fig 3.12). However, the 39.6 kDa flagellin monomer from Y. enterocolitica is the 
most closely related flagellin species. In particular, amino-acid sequences were 
highly conserved at the N- and C-terminals between both proteins (Fig 3.11). Using 
the web based Sequence Annotated by Structure program (SAS) 
(http://www.ebi.ac.uk/thornton-srv/databases/sas), the secondary structure of both Y. 
ruckeri and Y. enterocolitica flagellin proteins were predicted to be helical at each 
terminal, with some variability in the central sequences (Fig 3.13). At this stage 
therefore it was established that the gene (fliC) encoding the Y. ruckeri flagellin 
monomer (FliC), or at least a gene encoding a protein with significant identity to 
flagellin, was successfully cloned within the pET28-b vector. Therefore, the YRF1 
construct could be used to overexpress recombinant Y. ruckeri flagellin (r-flagellin). 
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3.11 Presence of the flagellin (fliC) gene within the Y. ruckeri EX5 genome 
Interestingly, a fliC PCR reaction which was performed using genomic DNA from 
the Y. ruckeri EX5 (R1) isolate also generated a PCR product (Fig 3.14) of the same 
size as that produced when using serotype O1 (BA19) DNA. This shows that the 
EX5 group, or at least an EX5 strain described by Austin et al. (2003), still carries 
the fliC gene within the genome despite it being unable to express this protein (Fig 
3.4; Lane 2 and 6). 
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21   MAVINTNSLSLLTRHLNKSQGSLGTAIERLSSGLRINSAKDDAAGQAIANRFTSNINGLT80 
1    MAVINTNSLSLLTQNLNKSQSSLGTAIERLSSGLRINSAKDDAAGQAIANRFTSNING-T59 
 
81   QAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQRMEE140 
60   VAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQRMEE119 
 
141  INRVTKQTDFNGIKVLDNRTAANAEYAFQVGSQDAQKINIEIGSSAGWNLATAGAGGTSS200 
120  INRVTKQTDFNGIKVLDNRTATDSSYDFQVGSKDNEQISIAIGASSGWNLAAAGAGGISG179 
 
201  DVVNDSTQISKAKETVVQTLSGKTEAQINTALTKFTTDVKAATDAAGVV-TAKGALTTAL259 
180  DTIN------TYKFTTT------------TALKTAQDNVKTATDDVPVKQKAYEDAVAAD221 
 
260  GLKADADLGTAVSSAAFGTDLSVDQIAGVKSGVYSAAINGANYATAKTEAEVSAAQAGAK319 
222  PADAERALKTAWDTAK--------TLVTTNTGLYNTALK---TATATGEA----------260 
 
320  TAGAMVNGNFRSVEAKGFDVLKGNVTGGATGTATGTTPLADIDAALKAVDSQRSSLGASQ379 
261  -----VNGNARTVAAEGFDVLKGQV--AADGTAAGTTPLADIDKALKAVDTQRTGLGASQ313 
 
380  NRFESTITNLNNTVNNLTSARSRIQDADYSTEVSNMSRAQILQQAGTSVMAQANQVPQTV439 
314  NRFESTITNLNTTGNNLTSARSRIQDADYSIEVSNMSRAQILQQAGISVLAQANQVPQIV373 
 
440  LSLLR  444           
374  LSLLR  378 
 
 
Fig 3.11: Alignment of the predicted amino-acid sequence of Y. ruckeri flagellin 
(FliC) with that of the 39.6 kDa flagellin protein from Y. enterocolitica (PIR: 
S69767). The amino acid sequence of Y. ruckeri flagellin is shown in bold. 
Conserved areas shared by the two proteins are highlighted in grey.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.12: Tree showing the relatedness of peptide sequences of proteins similar to 
the Y. ruckeri flagellin (FliC) protein based on amino acid sequence similarity. 
 
 
0.1 
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Y. ruckeri flagellin 
 
 
 
 
 
 
 
 
 
 
Y. enterocolitica flagellin 
 
 
 
 
 
 
 
Fig 3.13: Predicted secondary structure of Y. ruckeri and Y. enterocolitica flagellin 
proteins. Note that both proteins are helical at the N- and C- terminals. 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.14: PCR amplification of the flagellin (fliC) gene using genomic DNA from a 
Y. ruckeri EX5 (R1) isolate. M: Molecular weight marker (λ HindIII). Lane 1: 
Negative control (dH2O only). Lane 2: Positive control using genomic DNA from a 
serotype O1 (YR1) Y. ruckeri strain. Lane 3: PCR reaction using EX5 (R1) genomic 
DNA as template. A PCR product, in addition to the positive control (lane 2), was 
generated for the reaction using genomic DNA from the EX5 (R1) strain (lane 3).   
         M       1        2        3 
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3.12 Overexpression and purification of recombinant Y. ruckeri flagellin 
 (r- flagellin) 
All results regarding the induction and purification of recombinant flagellin (r-
flagellin) are shown in Fig 3.15. After confirming that the Y. ruckeri flagellin gene 
was cloned (above), the YRF1 construct was used to transform the E. coli BL21 
DE3 expression strain. Prior to induction with IPTG, the E. coli BL21 DE3 
transformant (E. coli BL21 DE3/YRF1) is either expressing low levels of r-flagellin 
or perhaps endogenous E. coli flagellin (Fig 3.15; B: Lane 2). However, the addition 
of 1 mM IPTG significantly induced expression of r-flagellin (Fig 3.15; B: Lane 3), 
predominately as insoluble inclusion bodies (IBs) (Fig 3.15; B: Lane 5). A moderate 
amount of soluble r-flagellin was also present (Fig 3.15; B: Lane 4), although 
preliminary attempts to purify the His-tagged protein by binding to an IMAC 
column were initially unsuccessful. Nonetheless, the recombinant protein could be 
cleaned and purified by exploiting the insoluble nature of inclusion bodies.  
 
It is estimated that the production of r-flagellin, under the current conditions of 
induction (see Materials and Methods), was in the range of 40 mg of protein/L. This 
is approximately 8 times more than what could be obtained from 6 L of bacterial 
culture using the acid disassociation and re-association (Section 3.6). By varying 
culture and induction conditions it was later shown that growing the E. coli BL21 
DE3/YRF1 transformant at 28ºC (OD600 > 1.5), before inducing with 0.1 mM IPTG 
for 4 h, can significantly increase the amount of soluble flagellin without adversely 
affecting overall flagellin yield. Preliminary tests have also shown that this soluble 
r-flagellin could be purified using an IMAC column (Fig 3.16; B).    
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Fig 3.15: Induction, overexpression and purification of recombinant Y. ruckeri 
flagellin (r-flagellin). A: Proteins fractionated on a 10% (w/v) SDS-PAGE gel. B: 
Immunodetection of flagellin with the monoclonal antibody #15D8. Lane 1: Whole-
cell proteins (WCPs) of a motile serotype O1 Y. ruckeri strain (BA19) used to source 
the flagellin (fliC) gene. Lane 2: WCPs of the E. coli BL21/YRF1 transformant 
before induction. Lane 3: WCPs of BL21/YRF1 4 h after induction with 1 mM 
IPTG. Lane 4: Soluble fraction of induced cells. Lane 5: Insoluble fraction of 
induced cells; Lane 6: Final r-flagellin product (1 µg) after further purification steps 
(see Materials & Methods) used to vaccinate fish. 
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To ensure that the final r-flagellin product (Fig 3.15) was relatively pure and without 
major contaminants (e.g. other proteins or LPS), the sample was again separated on 
a 10% SDS-PAGE gel and visualised by staining with Coomassie brilliant blue 
R250 or silver nitrate (Fig 3.16; A). Aside from the recombinant protein, no other 
protein or carbohydrate bands were observed within the gels. Although this does not 
rule out the potential presence of very low level contaminants which may not be 
visible on the SDS-PAGE gels, it does suggest that it is of sufficient purity for use in 
fish trials.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.16: SDS-PAGE analysis of r-flagellin preparations. After running samples on 
a 10% (w/v) SDS-PAGE gel, protein were stained with Coomassie brilliant blue-
R250 (A; Lane 1 and B) or silver nitrate (A; Lane 2) following electrophoresis. R-
flagellin was purified from IBs (A) or by passing r-flagellin (expressed as soluble 
protein) through an IMAC column (B). Lane A; 1: r-flagellin (5 µg). A; Lane 2: r-
flagellin (20 ng). B; Lane 1: Soluble fraction of induced E. coli BL21-DE3/YRF1. 
B; Lane 2-4: IMAC elutes 1 (5 µg), 2 (5 µg) and 3 (2 µg). M: Molecular weight 
marker. See text for details.  
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3.13 Toxicity of r-flagellin to rainbow trout 
Since native Y. ruckeri flagellin (Section 3.7) caused fish mortality at higher levels, 
it was considered vital that r-flagellin was also administered to fish (average weight 
= 5 to 6 g) over a range of amounts (0, 10, 25, 50, 100, 150, 200 µg/fish) before 
commencing large-scale vaccinations in order to test for toxicity. For each test 
group, at least 5 fish were injected with each amount. After anaesthesia, each 
preparation was administered in volumes of 100 µl. All fish had recovered from 
anaesthetic within 15 min and showed no signs of distress. After 48 h, all fish 
remained alive (100% survival), again showing excellent signs of health. Moreover, 
there was no sign of inflammation or discolouration on any fish at the point of 
injection, nor were there any observable changes between the internal organs of test 
or control fish (i.e. those which did not receive injections). In this respect, it is likely 
that Y. ruckeri flagellin was not the cause of death in fish previously administered 
with the native preparation since all fish administered with the recombinant protein 
survived.  
 
One explanation as to why the native preparation killed fish at high doses is the 
presence of additional molecules and/or compounds which are toxic for fish at 
higher concentrations (e.g. LPS). Silver staining of both native and recombinant 
protein was performed to detect any contaminating material (Fig 3.17). Whereas the 
r-flagellin preparation was again shown to be pure, a low molecular weight band was 
present within the native preparation. This may be low molecular weight proteins or 
the lipid A region of LPS. However, the characteristic “smear” of carbohydrate from 
LPS was not detectable, suggesting that LPS is not a major contaminant. 
Contamination with other proteins was considered to be minimal.  
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Fig 3.17: Silver staining of native and recombinant Y. ruckeri flagellin (r-flagellin). 
Proteins were fractionated on a 12% (w/v) SDS-PAGE gel before staining proteins 
with silver nitrate. M: Molecular weight marker. Lanes 1 to 3: Native flagellin (20 
ng). Lanes 4 to 6: r-flagellin (20 ng).  
 
 
A notable difference between fish administered with r-flagellin or native flagellin 
was the rate by which fish recovered from anaesthetic. Whereas trout administered 
with r-flagellin recovered within a matter of minutes, fish injected with higher 
concentrations of native flagellin failed to fully recover before dying. Thus, r-
flagellin could be safely administered to fish at relatively high concentrations 
without any detrimental effects to health.  
 
3.14  Protection conferred by r-flagellin 
The protective effect of r-flagellin against Y. ruckeri infections for rainbow trout 
(average weight = 5 to 6 g) was investigated. Groups of 25 fish were i.p. injected 
with 0, 10, 25 and 50 µg of r-flagellin in PBS (100 µl/fish). Fish fully recovered 
from anaesthesia and showed excellent signs of health. After 28 days post-
vaccination, trout were again anaesthetised before challenging with the serotype O1 
(YR1) (8 x 10
5
 cells) or EX5 (R1) (4.5 x 10
5
 cells/ml)
 
strains. All fish recovered 
from anaesthesia.  
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Results from this challenge are shown in Fig 3.18. After 48 hours, 92 and 94% of all 
control fish had died after challenging with the serotype O1 (YR1) and EX5 (R1) 
strain, a number which was much higher than that was expected to occur over a 
period of 2 weeks (50-70% mortality). The challenge dose (supposedly 8 x 10
5
 cells 
and 4.5 x 10
5 
cells) was probably higher than expected, thus an explanation is that 
the bacterial counts were incorrect. Nonetheless, the levels of survival were 
proportionate to the amount of antigen administered insofar as trout injected with 
10, 25 or 50 μg of r-flagellin showed a survival rate of 38, 63 and 73% after 
challenging with the EX5 (R1) strain. This equates to RPS values of 33, 60 and 72%, 
respectively. Similarly, r-flagellin vaccinated trout challenged with the YR1 isolate 
displayed survival rates of 60, 52 and 68%. This corresponds to RPS values of 59, 
50 and 67%, respectively.   
          
It is evident from these results that protection conferred by this protein is dose-
dependent. However, given the severity of challenge against control groups, the 
experiment was terminated after 48 h.   
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Fig 3.18: Survival rates of rainbow trout 48 h after challenge with a Y. ruckeri 
serotype O1 (YR1) ( ) or EX5 (R1) ( ) isolate. Bacterial challenge was performed 
28 days post-vaccination. Standard error values are included (N = 25).  
 
 
3.15 Onset of protection and estimation of the minimal protective dose 
 with r-flagellin 
As the challenge dose was considered to be too high, the experiment was repeated. 
Furthermore, since protection could be obtained after 28 days post-vaccination, 
challenge was performed after 14 days to determine if protection was conferred after 
a shortened period of time. In this case, only the Y. ruckeri EX5 (R1) strain was used 
for challenging fish. 
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Groups of non-vaccinated rainbow trout (average weight = 5 to 6 g) were 
administered with a low range of r-flagellin (0, 10, 25 and 50 µg/ fish in 200 µl 
PBS). The highest concentration of r-flagellin tested was again 50 µg/fish as this 
concentration sufficiently protected against bacterial challenge when using the 
native protein as a vaccine (Section 3.6). Each group consisted of 20 fish (N = 20) 
and were anaesthetised prior to administering the vaccine by i.p. injection. All fish 
fully recovered from anaesthesia and resumed feeding. No observable discoloration 
and/or inflammation occurred at the site of injection. Livestock were maintained in 
the aquarium, without disturbing, for 14 days as opposed to 28 days. Fish were then 
sedated in anaesthetic before injecting freshly grown Y. ruckeri EX5 [R1] cells (1 x 
10
5
 bacterial cells/fish). All fish fully recovered from anaesthesia and were closely 
observed for 7 days post-challenge.  
 
Results from this challenge are shown in Fig 3.19. In this case, all fish administered 
with r-flagellin survived (RPS = 100%), whereas those mock-vaccinated with PBS 
showed mortalities of 30%. Many of those which died showed characteristic signs of 
ERM (Fig 3.20) including haemorrhaging around/within the oral cavity and 
exophthalmia. Other symptoms included the darkening of skin and internal 
scaring/liquefaction of tissues. Although not shown in Fig 3.20 other signs of 
disease included the formation of petechial haemorrhaging around the fins, gills and 
anus. Infected fish also produced excessive amounts of mucus. When taking any of 
these symptoms into consideration, in combination with the number of fish which 
died, 75% of all fish showed disease-related symptoms (Fig 3.21). On the other hand 
the majority of r-flagellin vaccinated fish (59/60) showed excellent signs of health.  
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Fig 3.19: Use of Y. ruckeri r-flagellin to protect fish against intraperitoneal (i.p.) 
challenge with the EX5 (R1) isolate. Control fish were i.p. injected with 200µl PBS 
( ), whereas other groups were vaccinated with various concentrations (10, 25 and 
50 µg per fish) of r-flagellin in 200µl PBS ( ). After 14-days, fish were i.p. 
challenged with 4.5 x 10
5
 cells of the EX5 (R1) strain. Survival after 7 days post-
challenge is shown above. The standard errors of controls are included (N = 20).  
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Fig 3.21: Using Y. ruckeri r-flagellin to prevent mortalities and/or the development 
of symptoms associated with ERM after challenging with the EX5 (R1) isolate. 
Controls were administered with PBS ( ) or vaccinated with various concentrations 
(10, 25 and 50 µg per fish) of r-flagellin ( ). The total number of mortalities, in 
combination with the number of fish showing signs of ERM, is presented above as 
an absolute percentage.  Standard error is shown where appropriate (N = 20). 
 
 
Interestingly, all r-flagellin vaccinated fish showed heightened levels of hunger 
compared to the controls. To investigate what effect this may have on fish 
physiology, all fish were weighed (Fig 3.22; A) and measured (Fig 3.22; B) 7 days 
post-challenge. Although the mean values of weights and lengths of fish between 
control and vaccinated groups were not significantly different (P < 0.05), it 
nonetheless shows that the vaccine does not have a detrimental effect to health.  
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Fig 3.22: Average weight (A) and length/width (B) of fish surviving 7 days post-
challenge with the EX5 (R1) isolate. Data for fish mock-vaccinated (N = 14) with 
PBS is shown ( ), as is that of fish vaccinated with recombinant Y. ruckeri flagellin 
( ) (N = 60). Standard deviation values are included.  
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Overall, these data demonstrates that the r-flagellin protein, even at low 
concentrations (e.g. 10 µg/fish), can be an efficacious vaccine for preventing the 
development of ERM associated symptoms and mortalities. Protection can also be 
conferred after a relatively short period of time (e.g. 14 days). In addition, the mode 
of protection appears to be non-specific insofar as the Y. ruckeri EX5 (R1) strain 
used to challenge vaccinates is not producing the flagellin molecule used as a 
vaccine (Fig 3.4; Lane 6). 
 
3.16 Investigating the EX5 (R1) strain for motility and flagellin 
 production 
Although the Y. ruckeri EX5 (R1) strain does not produce detectable flagellin under 
standard culturing conditions (Fig 3.4; Lanes 2 and 6), this does not rule out its 
production under conditions which are known to induce virulence, especially since 
the fliC gene is present within the genome (Fig 3.14). Furthermore, these conditions 
are known to be somewhat similar to the conditions encountered by the pathogen 
inside the host. Thus experiments were carried out to investigate if motility and 
flagellin expression could be induced in EX5 by varying culture conditions. 
 
The Y. ruckeri EX5 (R1) strains grown at 28˚C in TSB were non-motile. Culturing 
over a range of temperatures (e.g. 17, 20, 25, 30˚C) in TSB, with or without the iron 
chelator 2, 2’-dipyridyl (100 µM), did not influence the non-motile phenotype. This 
shows that motility is not induced under conditions which are known to influence 
virulence-gene expression. In addition, EX5 (R1) isolates remained non-motile 
irrespective of culturing conditions even when recovered from dead or moribund 
fish.   
 
Western blots using WCPs from the EX5 (R1) isolate, which was again grown under 
iron-limiting and/or temperature limiting conditions (17ºC as opposed to 28ºC), are 
shown in Fig 3.23. Hybridizing with the anti-flagellin antibody (#15D8) similarly 
demonstrated that flagellin was not produced by the EX5 (R1) strain under any of 
the conditions known to induce virulence. Taking these results into consideration, it 
is unlikely that flagellin would be expressed within the host. 
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Fig 3.23: Confirmation that the Y. ruckeri EX5 (R1) strain does not produce 
detectable flagellin under iron-limiting and/or temperature limiting conditions. 
Crude WCP of the Y. ruckeri EX5 (R1) strain was separated on a 10% SDS-PAGE 
(A) after growing overnight in TSB at 28˚C (Lanes 2 and 3) or 17˚C (Lane 4). Cells 
were grown in the absence (Lane 2) or presence (Lanes 3 and 4) of the iron chelator 
2, 2’-bipyridyl (100 µM). Proteins were blotted onto a nitrocellulose membrane 
before hybridizing with the anti-flagellin antibody (B). Only the recombinant 
flagellin is detectable (= positive control), whereas no flagellin is detected in any of 
the EX5 (R1) WCP preparations. Lane 1: Recombinant flagellin (2 µg) acting as a 
positive control. M: Molecular weight marker. 
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3. 17 WCP protein profiles of serotype O1 and EX5 Y. ruckeri isolates 
From work associated with the characterisation of flagellin, it was evidently clear 
that both EX5 strains (EX5 and R1) used in this study, compared to the serotype O1 
Y. ruckeri isolates (BA19 and YR1), are overexpressing a protein with an apparent 
molecular weight between 30 to 40 kDa (Fig 3.4). Indeed, comparing crude WCPs 
of all available EX5 isolates with that of other serotypes (i.e. serotype O2, O3 and 
O4) showed that the overexpressed protein of 30 to 40 kDa was only observed in the 
EX5 isolates. Whereas a limited number of isolates have been included in Fig 3.24 
for simplicity, it should be noted that all EX5 strains described by Austin et al. 
(2003) exhibited an overexpressed protein in the range of 30 to 40 kDa as compared 
to 6 additional serotype O1 strains.. Furthermore, growing strains under virulence 
inducing conditions (i.e. iron and temperature limiting) had no effect on the 
expression of this protein by EX5. 2D SDS-PAGE analysis of WCPs from EX5 (R1) 
and serotype O1 (YR1) cultures grown under iron and temperature limiting 
condition (Fig 3.25) demonstrated that four major protein spots (30 to 40 kDa) were 
more abundant in EX5 relative to O1 (Fig 3.25). It should be noted that although 
only a single gel from each sample is shown in Fig 3.25, the experiment was 
repeated four times with new samples to ensure that these proteins were indeed 
overexpressed by EX5 (R1). 
 
Maldi-ToF mass spectroscopy performed on tryptic digests of all four of these spots 
showed that they were similar to the outer membrane protein A (OmpA) of Y. 
enterocolitica. Specifically purifying outer membrane proteins (OMPs) from serotype 
O1 and EX5 isolates via the sodium sarkosyl method demonstrated that the 
overexpressed protein was in fact an outer membrane protein (Fig 3.26). Thus, it is 
clear from these results that the EX5 Y. ruckeri strain is overexpressing the outer 
membrane porin protein OmpA. 
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Fig 3. 24: Crude Y. ruckeri whole-cell proteins (WCP) representing different serotypes 
fractionated on a 10% (w/v) SDS-PAGE gel. Proteins were visualised by staining with 
Coomassie brilliant blue-R250. A: Lanes 1 and 2: O2BA2; Lane 3: O3BA3; Lane 4: 
O4BA4; Lane 6: EX5; Lane 7: EX5 (R1). B: Lanes 1 to 3: YR1; Lanes 4 to 6: 
EX5 (R1). 
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Fig 3. 25: Separation of Y. ruckeri serotype O1 (YR1) (A) and EX5 (R1) (B) WCPs on 
a large (24 cm) 2D (pH 3-11 NL) 10% (w/v) SDS-PAGE. Proteins were stained with 
colloidal Coomassie blue-G250. Differentially expressed proteins 30 to 40 kDa in 
weight are shown both for the serotype O1 (C) and EX5 (D) strain, which represent the 
enlarged insert boxes in A and B, respectively. These proteins are predominately more 
abundant within EX5 (D) compared to the serotype O1 strain (C). 
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Fig 3.26: Sarkosyl purified outer membrane proteins (OMPs) from a Y. ruckeri serotype 
O1 (YR1) and EX5 (R1) isolate fractionated on a 10% (w/v) SDS-PAGE. 
 
 
3. 18 Identification of the Y. ruckeri ompA gene  
Given that EX5 isolates are overexpressing OmpA, attempts were made to identify 
the Y. ruckeri gene (ompA) encoding this protein. Again this initially posed a 
problem as the Y. ruckeri genome has not yet been sequenced. However, 
approaching this problem in a similar manner used to isolate the Y. ruckeri flagellin 
gene, it was found that both the N- and C- terminals of the Y. enterocolitica ompA 
gene were conserved among Yersinia spp. Hence the gene of interest was 
successfully amplified (Fig 3.27) using forward (OMPA-F) and reverse (OMPA-R) 
primers based on the Y. enterocolitica ompA gene sequence.  
 
 
 
 
 
 
 
 
 
Fig 3.27: PCR amplification of the Y. ruckeri ompA gene using conserved forward 
(OMPA-F) and reverse (OMPA-R) primers. M: Molecular weight marker (λHindIII). 
Lane 1: Negative control (H2O as template). Lane 2: Serotype O1 (YR1) genomic 
DNA used as template. Lane 3: EX5 (R1) genomic DNA used as template.  
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The full Y. ruckeri ompA gene was sequenced and is available in the appendix (Fig 5.8) 
along with the predicted amino-acid sequence of the OmpA protein. Both the serotype 
O1 (YR1) and EX5 (R1) ompA ORFS were sequenced and found to be identical (100% 
identity). The Y. ruckeri ompA gene (1148 bp; 50.3% G+C) is predicted to encode a 
34.08 kDa protein comprised of 321 amino acids. BLAST analysis of the predicted 
protein sequence showed that it shared a great deal of identity (84%) to the OmpA 
protein of Y. pseudotuberculosis strain IP 32953 (NCBI Reference Sequence: 
YP_069984.1) (Fig 3.28). 
 
 
1    MKKTAITHSSALAGFATVAQAAPKDNTWYTGGKLGWSQFHDVGTGSDISNDGPTHKSQLG  60 
1    MKKTAIALAVALVGFATVAQAAPKDNTWYTGGKLGWSQYQD--TGSIINNDGPTHKDQLG  58 
 
61   AGAFVGYQANQYLGFEMGYDWLGRMPYKGDTVNGAFKAQGVQLAAKLSYPIAQDLDLYTR  120 
59   AGAFFGYQANQYLGFEMGYDWLGRMPYKGDINNGAFKAQGVQLAAKLSYPVAQDLDVYTR  118 
 
121  LGGMVWRADASVNEPSTNSHASAHDTGVSPLAAVGLEYAVTKNWATRLDYQWVNNIGDRG  180 
119  LGGLVWRADAKGSFDGGLDRASGHDTGVSPLVALGAEYAWTKNWATRMEYQWVNNIGDRE  178 
 
181  TVGARPDNGMLSVGVSYRFGQDDAIVPVVAPAPAPAPVVDTKRFTLKSDVLFAFNKATLK  240 
179  TVGARPDNGLLSVGVSYRFGQEDAAAPIVAPTPAPAPIVDTKRFTLKSDVLFGFNKANLK  238 
 
241  PEGQQALDQLYSQLSSIDPKDGSVVVLGFADRIGQAAPNLKLSENRARSVVEYLVAKGIP  300 
239  PEGQQALDQLYAQLSSIDPKDGSVVVLGFADRIGQPAPNLALSQRRADSVRDYLVSKGIP  298 
 
301  ADKISARGMGQADPVTGNTC  320 
299  ADKITARGEGQANPVTGNTC  318 
 
 
Fig 3.28: Alignment of the predicted amino-acid sequence of the Y. ruckeri OmpA 
protein with that of the OmpA protein from Y. pseudotuberculosis (IP 32953). The 
amino acid sequence of the Y. ruckeri OmpA protein is shown in bold. Conserved 
areas shared by the two proteins are highlighted in grey.  
 
 
3.19 OmpA overexpression and gene copy number  
As the ompA genes of Y. ruckeri EX5 (R1) and serotype O1 (YR1) are identical, this 
cannot account for why it is overexpressed in the EX5 (R1) strain. However, should 
the EX5 isolate have more than one copy of the gene, then this may explain as to 
why it is overexpressed. To determine copy number, a Southern blot was performed 
with Y. ruckeri genomic DNA before hybridizing with a DIG-labelled ompA probe. 
Briefly, genomic DNA from the serotype O1 (YR1) and EX5 (R1) strain was 
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purified and digested overnight with either EcoRI, HindIII or BamHI before 
separating on a 0.7% (w/v) agarose gel (Fig 3.29). It is worth noting that these 
restriction enzymes used to digest DNA do not cut within the ompA gene itself. 
Digested genomic DNA was blotted to a membrane before hybridizing with the 
DIG-labelled ompA probe (Fig 3.29; B). 
 
From these results it is clear that both the Y. ruckeri EX5 (R1) and serotype O1 
(YR1) carry one single copy of this gene within the genome as only a single 
hybridization band is observable for each digest. It also shows that there are no gross 
alterations (for example a transposon insertion) to the genome at this locus, since the 
fragment size was identical in both genotypes. This would suggest that expression is 
regulated at the transcriptional level as opposed to an increasing in the number of 
ompA gene copies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.29: Detection of the ompA gene within the genomes of a serotype O1 (YR1) or 
EX5 (R1) Y. ruckeri strain by Southern blotting and hybridization/detection using a 
DIG-labelled ompA probe. A: Digested genomic DNA separated on a 1% (w/v) 
agarose gel. B: Hybridization/detection of ompA genes carried within the Y. ruckeri 
genome. M: Molecular weight marker (λ HindIII). Lanes 1 to 3: Genomic DNA 
from the serotype O1 (YR1) strain. Lanes 4 to 6: DNA from the EX5 (R1) isolate. 
DNA was digested with either BamH1 (1 and 4), EcoR1 (2 and 5) or HindIII (3 and 
6).  
M    1     2      3      4      5      6          1     2      3     4      5      6 
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3.20 Screening for an ompA::Tn-RL27 Y. ruckeri EX5 (R1) transconjugant 
Since large amounts of OmpA was seen to be produced by the Y. ruckeri EX5 (R1) 
strain, it is possible that this protein may contribute to virulence. Attempts were 
therefore made to disrupt the ompA gene encoding this protein (OmpA) with an aim 
of determining what role this molecule may have in virulence towards rainbow trout. 
Although a number of options are available for introducing mutations within a given 
gene, the Tn-RL27 transposon mutagenesis system described in Section 3.3 was 
chosen as it was shown to be efficient in generating large amounts of randomly 
integrated Tn-RL27 EX5 (R1) transconjugant mutants.  
 
A fresh Y. ruckeri EX5 (R1) isolate, which was passed through naïve rainbow trout 
numerous times by Dr D. Austin (Heriot-Watt University) to confirm virulence, was 
conjugated with the E. coli BW20767/pRL27 strain. In total, 5 conjugations were 
performed using the Y. ruckeri EX5 (R1) and E. coli BW20767/pRL27 strains before 
plating bacteria out onto TSA (+ 50 μg/ml kanamycin, + 5 μg/ml  nitrofurantoin) and 
incubating overnight at 28˚C. The conjugation was considered to be successful 
insofar as 20 randomly chosen colonies were all confirmed to be Y. ruckeri EX5 
(R1). Moreover, a PCR reaction on all 20 colonies confirmed the presence of the 
gene encoding kanamycin resistance, thus showing that the Tn-RL27 transposon had 
successfully integrated within the genome. Successful transconjugation rates were 
not dissimilar to those obtained previously (Section 3.3).  
 
From 100 TSA selection plates, each carrying ~100 colonies, 4800 were picked and 
grown in individual wells of a 96-well microtitre plate containing 200 μl TSB (+ 50 
μg/ ml kanamycin, + 5 μg/ml nitrofurantoin). All mutants had grown after the 48 h 
incubation period.  
 
Unlike the previous experiment, which used phenotypes to isolate the mutant of 
interest (Section 3.3), screening for ompA mutants could not make use of this 
method. However, the ompA forward (OMPA-F) and reverse primers (OMPA-R) 
were available, as were the flanking transposon primers TPNRL17-1 and TPNRL13-
2. In principle, transconjugants with a Tn-RL27 transposon within the ompA gene 
(ompA::Tn-RL27) could be identified with PCR using a combination of these 
primers. A diagrammatic representation of this process can be seen in Fig 2.2. PCR 
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screening would also allow multiple samples to be tested at the same time by 
pooling data and using a high number of PCR cycles.  
 
In total, samples from 50 microtitre plates (= 4,800 mutants) were pooled (100 μl 
from each well) in groups of 2 microtitre plates (= 192 mutants per group). Plates 
were then stored at -70˚C after the addition of glycerol. Genomic DNA was purified 
from the pooled cultures to give 25 samples. Thus, all 4,800 mutants were 
represented by 25 DNA samples.   
 
Theoretically, the transposon could have inserted within the ompA gene in two 
orientations. This can be accommodated using different combinations of primers.  
Thus the ompA forward (OMPA-F) or reverse (OMPA-R) primer could be used in 
combination with the transposon flanking primers TPNRL17-1 or TPNRL13-2. This 
equates to a total of 4 PCR reactions for each pooled DNA sample, making 100 
reactions in total for all 25 reactions. 
 
Results from all initial PCR reactions are shown in Fig 3.30. The PCR products 
would have to be smaller (< 1000 bp) than the WT ompA gene for the transposon to 
be inserted within the ompA gene. Although PCR products were visible, none of 
these bands hybridized with the DIG-labelled ompA probe after Southern blotting. In 
this case, all PCR products were probably a result of non-specific primer binding. 
PCR conditions used here had an annealing temperature of 55ºC and 30 cycles. The 
experiment was repeated using an annealing temperature of 53ºC and 35 cycles. In 
total, six separate DIG probe hybridising bands were detected using the OMPA-F 
and TPNRL13-1 primer (not shown), each smaller than the WT ompA gene. This 
would suggest that the Tn-RL27 transposon had inserted within the gene of interest 
(ompA). Unfortunately, this was later found to be a result of non-specific primer 
binding as 50 colony PCR reactions on individual transconjugants all hybridized 
with the ompA probe. Moreover, decreasing the number of PCR cycles (34 to 28) 
and increasing the annealing temperature (53 to 55ºC) for a second round of colony 
PCR did not result in any PCR products or hybridized bands. At this point in the 
project it seemed unlikely that the transposon had inserted within the ompA gene of 
any Y. ruckeri transconjugant.  
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Fig 3.30: Example of PCR screening and Southern blotting to detect for a Y. ruckeri 
EX5 (R1) transconjugant with a transposon within the ompA gene (ompA::Tn-
RL27). PCR was performed at 55ºC for 30 cycles with different primer 
combinations before separating on a 1% (w/v) agarose gel (A and C) and 
blotting/hybridizing with the DIG-labelled ompA probe (B and D). PCR reactions 
were performed with the primer OMPA-F (A) with TPNRL17-1 (1) or TPNRL13-2 
(2). Reactions were also carried out with the OMPA-R (C) and TPNRL17-1 (3) or 
TPNRL13-3 (4) primer. Whereas all positive PCR ompA products (generated using 
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the OMPA-F and OMPA-R primers) hybridized with the ompA probe (indicated), no 
transconjugant strains were detected using the DIG-labelled primer.  
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CHAPTER 4: DISCUSSION 
 
4.1 General discussion 
Aquaculture is currently the fastest growing sector of agriculture in many countries, 
with the notable exception of Sub-Saharan Africa (Plant and Lapatra, 2011), and has 
increased its annual production of fish from 28 to 50 million tonnes between 1998 
and 2007 (National Oceanic and Atmospheric Administration, 2007). Unfortunately, 
as production of fish increases, so does the incidence of disease. Currently, disease 
is the major contributor to the loss of fish in aquaculture. In fact 90% of all the 
deaths associated with rainbow trout reared in captivity in 2009 were considered to 
be due to disease (National Agricultural Statistic Service, 2010). This can often have 
significant socio-economic consequences, particularly in rural areas and/or 
developing countries. Knowing the impact that disease can have for the industry, 
controlling and preventing disease is of paramount importance.  
 
ERM is an example of a problematic disease in aquaculture, with much effort 
recently being expended in an attempt to develop effective control strategies. 
Preventing ERM was initially a success story insofar as the early application of an 
inactivated whole-cell immersion vaccine successfully prevented major disease 
outbreaks (Austin, 2007). Actually, this was the first bacterial fish vaccine to be 
officially licensed by the USA in 1976 for use in aquaculture (Plant and LaPatra, 
2011). However the success of the original vaccine led to a decline in research 
aimed at other methods of disease control, or indeed the disease process itself. 
During the early 1980s, most of the research regarding ERM was based around the 
nature of the fish immune system and its response towards live or inactivated Y. 
ruckeri vaccines (Austin, 2007). It was not until the early 1990s that research started 
to focus on the molecular basis of pathogenicity (Romalde and Toranzo, 1993, 
Davies, 1991a, Davies, 1991b, Romalde et al., 1991, Furones et al., 1990). The last 
decade alone has seen a significant increase in the number of publications regarding 
this fish pathogen. This upturn in research is due to a number of reasons. Firstly, 
antimicrobial compounds are no longer as effective in preventing disease due to an 
increase in bacterial resistance. Moreover their use in a non-urgent or prophylactic 
situation is also not encouraged because of the perceived effect on antibiotic 
resistance of human pathogens. Antimicrobials can also be a costly commodity, 
particularly if they have little or no effect in preventing/treating disease. Secondly, 
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the recent failure of the monovalent whole-cell vaccine in protecting against Y. 
ruckeri has again stimulated interest in this fish pathogen (Austin et al., 2003). 
Finally, with the advent of sophisticated molecular biology techniques, gaining an 
insight into the molecular basis of Y. ruckeri pathogenicity is now becoming 
possible (Tobback et al., 2007, Fernandez et al., 2007).   
 
4.2 ERM and a new problem for aquaculture 
Y. ruckeri strains which are capable of causing disease in monovalent-vaccinated 
livestock shared a number of phenotypic and biochemical features. One notable 
phenotype observed by Austin et al. (2003) regarding these isolates was their 
apparent lack of motility and Tween 20/80 degradation; phenotypes which were not 
usually associated with Y. ruckeri. Other authors have since isolated similar non-
motile strains from dead and/or moribund fish (Arias et al., 2007, Davies and 
Frerichs, 1989, Strom-Bestor et al., 2010, Fouz et al., 2006, Wheeler et al., 2009, 
Evenhuis et al., 2009, Welch et al., 2011, Welch, 2011). It is probable that these Y. 
ruckeri strains belong to the serotype O1 (= serovar I) subgroup as they are unable 
to ferment sorbitol and have an increased virulence towards rainbow trout. 
Moreover, LPS from these non-motile strains hybridized with rabbit polyclonal 
antibodies against serotype O1 LPS (Fouz et al., 2006). Serotype O1 isolates are 
also associated with the presence of a 50 MDa plasmid (Garcia et al., 1998), the 
presence of which was also confirmed to be within non-motile isolates obtained by 
Austin et al. (2003) in this study (not shown). Thus it is likely that non-motile 
strains, termed EX5, were originally serotype O1 isolates which have naturally 
caused disease in rainbow trout previously vaccinated against ERM.  
 
4.3 EX5 and loss of flagellin expression 
Since the initial isolation of non-motile EX5 isolates, there has been considerable 
interest regarding the non-motile phenotype, particularly since the majority of ERM 
outbreaks were previously associated with serotype O1 (= motile) Y. ruckeri strains. 
In addition to being non-motile, Evenhuis et al. (2009) showed that the flagellin 
protein was not produced by EX5 isolates in vitro under standard culturing 
conditions, i.e. 72 h at 15°C in TSB. This was demonstrated using a monoclonal 
antibody described by Feng et al. (1990) which recognises a conserved epitope 
present on Enterobacteriaceae flagellin. It is noteworthy that while Feng et al. 
(1990) found that that this antibody reacted specifically with Enterobacteriaceae 
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flagellin, it is likely that the sequence recognised by this antibody is within the N- or 
C- terminal as these regions are conserved amongst this group of bacteria (Fig 3.13). 
Work presented in this thesis using the monoclonal antibody raised in mice against 
flagellin by Feng et al. (1990) confirms observations by Evenhuis et al. (2009) as to 
the lack of flagellin production in EX5 isolates (Fig 3.4). Culturing EX5 under 
conditions which are known to influence virulence (i.e. iron and temperature 
limiting) again had no effect upon the non-motile phenotype, nor was flagellin 
detectable using the anti-flagellin monoclonal antibody (Fig 3.23). Similarly, 
passing non-motile Y. ruckeri isolates through naïve fish again had no effect on 
motility or flagellin production.  
 
Using conserved primers for flagellin, it was shown by PCR that Y. ruckeri EX5 
strains do carry the gene encoding flagellin (fliC). Similarly, Evenhuis et al. (2009) 
found that the genes involved in flagellar secretion, organised as an operon (termed 
flhBAE-flgNMABC), are also carried within the genome of non-motile Y. ruckeri 
isolates. Interestingly, the fliC gene was not within the flhBAE-flgNMABC operon, 
suggesting that it is transcribed separately. The presence of flagellin (fliC) or 
flagellin-associated genes within the EX5 genome indicates that these isolates have 
previously arisen from a motile ancestor.  
 
One explanation for the lack of flagellin production is that the EX5 strain has 
acquired mutations in genes required for flagellin production. Evenhuis et al. (2009) 
showed that inactivating the putative flagellin transport operon (flhBAE-flgNMABC) 
via transposon mutagenesis completely repressed flagellin production for a motile Y. 
ruckeri serotype O1 isolate. Functional complementation with the wild-type flhBAE-
flgNMABC operon reversed the non-motile phenotype. Hence, introducing a 
mutation within a gene associated with flagellin and/or flagellar assembly can 
completely repress the production of the flagellin protein, even if the mutation is not 
within the fliC gene itself. Results from transposon mutagenesis experiments carried 
out in this study confirm this observation; transposon insertions within motility-
associated genes can completely repress flagellin production. However the 
mechanism by which flagellin production is repressed in Y. ruckeri is currently 
unknown. Evenhuis et al. (2009) suggested that it may not be dissimilar to 
Salmonella enterica serovar Typhimurium whereby the expression of flagellin is 
dependent on the successful completion of the flagellin basal-hook body (Rosu and 
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Hughes, 2006). In this bacterium the unnecessary expression of flagellin is 
prevented when other necessary components of the flagellar architecture (i.e. basal 
hook proteins) are not present or produced by the bacterial cell.  
 
Whereas Evenhuis et al. (2009) found that inactivating flagellin-associated genes 
results in the complete repression of flagellin production, they did not describe the 
specific genes which have been rendered non-functional in naturally occurring EX5 
isolates. However, Welch et al. (2011) discovered that the natural mutations 
responsible for causing loss of flagellin production in EX5 strains have all arisen 
within the fliPQR gene cluster; a group of genes thought to encode integral 
membrane components of the flagellar secretion pathway. All UK and US EX5 
strains employed by Welch et al. (2011) carried a fliRΔ1 mutant allele caused by the 
deletion of a single nucleotide within the fliR gene at codon 30 of 260. This links 
well with the view that non-motile strains in the USA and UK are clonal (Tinsley et 
al., 2011a, Wheeler et al., 2009). Using functional complementation, it was possible 
to convert a non-motile (= flagellin devoid) EX5 isolate back to a motile (= flagellin 
producing) phenotype by complementing with the WT fliR gene. This confirms the 
previous hypothesis by Evenhuis et al. (2009) which states that the expression of 
flagellin is dependent on the successful completion of underlying membrane 
proteins involved in the flagellar architecture (Rosu and Hughes, 2006). Also, it 
shows that the fliC gene in EX5 is not mutated as a functional flagellin can still be 
produced when complemented with the WT fliR gene. Taking results outlined in 
both this work and that of others (Evenhuis et al., 2009, Welch et al., 2011), EX5 
isolates are unlikely to be producing flagellin or even a truncated/undetectable form 
of the protein under any condition. 
 
4.4 EX5 and flagellin loss: Immune evasion? 
As EX5 strains cause disease in vaccinated fish, it seemed possible that some form 
of Darwinian selection pressure has driven the appearance of the non-motile 
phenotype. However, the nature of this pressure has not yet been identified. It is 
understood that the expression of flagellin within the mammalian host can be a 
potent initiator of the innate immune system, thus its repression and/or loss could 
confer a selective advantage for a pathogenic bacterium (Minnich and Rohde, 2007, 
Steiner, 2007). For example, Y. pestis was originally motile, although it was 
rendered non-motile due to the acquisition of mutations within the fliD gene 
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(Minnich and Rohde, 2007). This is thought to have resulted in an increase in 
virulence towards mammals as the loss of flagellin production presumably prevented 
the detection/stimulation of an innate immune response. Indeed, as was the case with 
Y. enterocolitica, the artificial expression of flagellin within the host can completely 
attenuate virulence (Minnich and Rohde, 2007).  
 
Since EX5 isolates do not produce detectable flagellin, it was reasonable to consider 
whether the loss of flagellin production aided in bacterial evasion of the fish 
immune system. However, Evenhuis et al. (2009) showed that the mutational loss of 
flagellin production in a motile serotype O1 Y. ruckeri background (discussed 
earlier) did not increase pathogenicity towards naïve rainbow trout. Similarly, Wiens 
and Vallejo (2010) demonstrated that challenge with an EX5 strain still resulted in a 
significant up-regulation of innate immunity (e.g. TNFα1, IL1-β1 and SAA). Hence 
the presence/absence of flagellin does not affect the robust pro-inflammatory and 
acute-phase gene transcription response towards EX5 infection. Moreover, this work 
has shown that inactivated EX5 cells can be used as an effective vaccine against 
challenge with a serotype O1 (YR1) strain; hence EX5 may still stimulate an 
immune response even in the absence of flagellin. Overall, taking data by Evenhuis 
et al. (2009) and Wiens and Vallejo (2010) into consideration, it would seem 
unlikely that EX5 strains can evade immune recognition/stimulation via the 
mutational loss of flagellin.  
 
4.5 Flagellin as a component of a vaccine  
Assuming that the loss of flagellin expression by EX5 isolates does not directly 
influence virulence for naïve rainbow trout, it remains perplexing why there was a 
sudden increase in the number of ERM outbreaks associated with the non-motile 
phenotype, particularly when the majority of previous cases were linked with mot ile 
strains. Furthermore, ERM outbreaks associated with the non-motile phenotype 
occurred in livestock which had previously undergone vaccination against this 
disease (Austin et al., 2003). As noted by Tobback et al. (2007), it is strange why 
vaccination with the monovalent vaccine (= inactivated serotype O1 Y. ruckeri cells) 
did not protect against the EX5 strain, particularly since Cipriano and Ruppenthal 
(1987) found that vaccinating fish with serotype O1 cells can broadly protect against 
other serotypes. However, understanding why the vaccine failed to protect may be 
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problematic, particularly since the main molecules involved in eliciting a protective 
immune response towards Y. ruckeri are poorly understood (Tobback et al., 2007).  
 
One possible theory, which has recently been proposed by numerous authors in the 
published literature (Tobback et al., 2007, Evenhuis et al., 2009, Welch et al., 2011, 
Wheeler et al., 2009), is that prolonged and extensive vaccination against a serotype 
O1 strain has exerted a selection pressure on the motile (= flagellin-producing) 
phenotype. Thus, should flagellin and/or flagellin associated molecules be an 
important component of the monovalent vaccine for conferring protection against a 
serotype O1 strain, then EX5 cells may be able to evade a vaccine-mediated 
response directed towards flagellin. This would explain the link between vaccine 
failure and the non-motile phenotype.   
 
To address sufficiently the immunoprotective/immunostimulatory role of flagellin as 
part of a whole-cell vaccine, all possible antigens and/or immunostimulatory 
molecules aside from flagellin (including flagellin-associated molecules) would 
have to be removed from the vaccine preparation. On the other hand, potentially 
immunogenic/immunostimulatory molecules not associated with flagellin (e.g. 
OMPs and LPS) would presumably have to remain. Like Evenhuis et al. (2009), a 
flagellin-devoid serotype O1 strain was obtained using the transposon mutagenesis 
system described by Larsen et al. (2002). Sequencing DNA flanking the transposon 
insert found that the transposon had inserted within the flhA gene of the flhBAE-
flgNMABC operon, a region of DNA which was also disrupted by transposon 
mutagenesis in the research carried out by Evenhuis et al. (2009). It seemed 
unfortunate that the transposon had inserted within the same region, particularly 
since it may have elucidated the roles of other genes involved in motility and/or 
flagellar biosynthesis. The fact that the transposon has inserted within this site on 
two different occasions suggests that this region of genomic DNA is a so-called 
“hot-spot” for transposon insertions. Nonetheless, a flagellin-devoid transconjugant 
was adequate for the purposes of this study.   
 
Assuming that extensive vaccination against a flagellin-producing serotype O1 Y. 
ruckeri strain resulted in a rise in the number of ERM cases associated with 
flagellin-devoid EX5 strains, fish vaccinated with serotype O1 would presumably be 
protected against challenge with a serotype O1 strain, yet susceptible to infection 
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with an EX5 Y. ruckeri isolate. This possibility was addressed here by vaccinating 
with the serotype O1 (BA19) parent (= flagellin-producing) and non-motile 
BA19/Tn-RL27 (= flagellin-devoid) mutant strain. Vaccinates were then challenged 
with the serotype O1 (YR1) (= flagellin-producing) or EX5 (R1) (= flagellin-devoid) 
strain. 
 
For the purposes of this study, vaccine efficiencies were evaluated by calculating the 
relevant per cent survival (RPS) after 2-weeks post challenge. Using these criteria, it 
was found that vaccinating fish with the serotype O1 (BA19) isolate conferred 
moderate levels of protection against challenge to a serotype O1 (YR1) strain (RPS 
= 65%), but not to an EX5 (R1) isolate (RPS = 23%). This result represents the 
inefficiency of the monovalent (= serotype O1) vaccine to effectively protect against 
the EX5 strain. However, when flagellin was essentially removed from the vaccine 
preparation using the BA19/Tn-RL27 mutant strain, levels of protection towards 
challenge with the serotype O1 (YR1) fell only slightly (total survival from 76% to 
60%). This decrease in the levels of survival following bacterial challenge is not 
statistically significant (P < 0.05; N = 25), suggesting that flagellin is not the main 
immunostimulatory molecule in eliciting a protective immune response towards 
infection. Furthermore, removing flagellin from the vaccine also resulted in a small 
reduction in the level of protection against the EX5 (R1) strain (total survival from 
60% to 46%). Although this is not statistically significant (P < 0.05, N = 25), it does 
indicate that flagellin may have a minor role in eliciting a non-specific immune 
response towards a flagellin-devoid strain in a serotype O1 background. Increasing 
the number of replicates in each group (i.e. 25 to 250) may show that flagellin, 
although not entirely required for protection, can nonetheless contribute towards a 
non-specific immune response. 
 
In addition to vaccinating fish with the serotype O1 (BA19) and BA19/Tn-RL27 
mutant, fish were also vaccinated with inactivated EX5 cells. When used as a 
vaccine, EX5 conferred excellent levels of protection (RPS = 95%) towards 
challenge with the serotype O1 (YR1) strain. This shows that flagellin is not the 
main molecule responsible for mounting a protective immune response since EX5, 
which does not produce flagellin, can effectively protect against a flagellin-
producing strain.   
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Thus from these experiments it would seem unlikely that flagellin is the main 
immunogenic/immunostimulatory molecule in the vaccine leading towards 
protection against a serotype O1 strain. It also seems unlikely that extensive 
vaccination has led to the development and spread of non-motile isolates. Nonetheless, 
Y. ruckeri must be producing other kinds of immunostimulatory/immunogenic 
molecules since the EX5 isolate can protect against challenge with the serotype O1 
(YR1) strain. Tinsley et al. (2011b) recently suggested that the O-antigen of LPS is the 
main immunogenic molecule in conferring protection against ERM. This is entirely 
possible since LPS, in itself a well-established PAMP, can be a powerful 
immunogen for fish (Austin, 2007). However, it is likely that a combination of 
molecules in addition to LPS is contributing to an effective immune response, 
although this would require further research.  
 
Due to time constraints and limited space in the aquarium, challenges were 
performed 28 days post-vaccination. Whilst this time period is generally sufficient 
for evaluating the effectiveness of a given vaccine, it does have some limitations 
insofar as a humoral response (i.e. antibody production) will not generally occur 
until after 8 or 12 weeks post-vaccination (Raida et al., 2011). Although the role of 
antibody-mediated protection in salmonids towards Y. ruckeri is still a contentious 
area of debate, Welch et al. (2011) suggested that flagellin may be the main 
immunogenic molecule in the original vaccine. Thus long term vaccination against a 
serotype O1 Y. ruckeri strain has led to the production of antibodies which 
specifically target flagellin and/or flagellin molecules. In this respect, vaccinates 
would presumably be susceptible to infection with EX5 since they do not produce 
flagellar antigens. However, this would be unlikely for a number of reasons. On the 
one hand, IgM produced by fish towards inactivated bacteria would presumably be 
polyclonal and thus react against a whole range of antigenic determinants (e.g. LPS 
and OMPs). If flagellin was absent, then polyclonal antibodies would theoretically 
still agglutinate the bacterium. Secondly, a recent study by Deschmuch et al. (2012) 
showed that vaccinating fish with a serotype O1 strain did in fact offer some level of 
cross-protection against challenge with an EX5 isolate 8 or 12 weeks post-
vaccination. Therefore, long-term protection must not be entirely dependent on anti-
flagellin antibodies. Finally, the inadequacy of the serotype O1 vaccine to protect 
against challenge with the EX5 strain is observable after 1 month post-vaccination 
(Fig 3.6). As discussed, antibody production is unlikely to have occurred within this 
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limited time period (Raida et al., 2011). This shows that the serotype O1 vaccine 
still fails to protect sufficiently against the EX5 strain even in the absence of 
antibody production. Overall, it would seem unlikely that vaccination against a 
flagellin-producing serotype O1 isolate has resulted in the non-motile phenotype of 
EX5 strains.  
 
4.6 Reasons for the non-motile phenotype of EX5 
The majority of research to date regarding EX5 strains has focused on the non-
motile phenotype of EX5 isolates, principally in an attempt to link loss of motility 
with an increase in virulence. As previously discussed, it initially seemed likely that 
EX5 strains were evading the immune system via the loss of flagellin production in 
vivo. However, this theory has largely since been disproven since EX5 cells can still 
stimulate an immune response even in the absence of flagellin. Others have since 
suggested that excessive vaccination against a motile strain has resulted in the non-
motile phenotype; experiments outlined in this study suggest otherwise. 
 
Why then is there a sudden increase in ERM cases associated with non-motile EX5 
strains? It is reasonable to assume that flagellar production was previously required 
for spread and infection since serotype O1 isolates are motile. However, it is 
possible that the rapid expansion and intensification of aquaculture has led to a rise 
in the non-motile phenotype. For example, non-motile bacteria could presumably be 
spread in faecal material which would, in turn, come into contact and/or be ingested 
by neighbouring fish. Dead carcases infected with EX5 cells may also be a recurring 
source of infection, particularly as fish are known to be cannibalistic. As to bacterial 
survival in the natural environment, Y. ruckeri may remain viable in faecal material 
for a number of months (Hunter et al., 1980, Rodgers, 1992), perhaps even longer in 
a non-culturable state (Romalde et al., 1994a) or as biofilms (Coquet et al., 2002a, 
Coquet et al., 2002b). Of note, Coquet et al. (2002) found that outer membrane 
proteins contributing to motility were overexpressed by serotype O1 cells involved 
in biofilms. It would be interesting to fully determine what effect the lack of 
flagellin production by EX5 has on the establishment of these structures. However, 
even if the formation of biofilms is dependent on flagellin production, it is of little 
consequence since EX5 can effectively cause disease and persist within the natural 
environment. 
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Spread of EX5 over long distances may be facilitated via the movement of 
asymptomatic livestock (Busch and Lingg, 1975). Studies to date have shown that 
fish stocked in overpopulated and unsanitary waters become stressed, thereby 
leading to the immunocompromised state. This would presumably aid in both the 
spread and establishment of ERM by non-motile EX5 cells. In fact, EX5 isolates 
were originally obtained from dead fish sourced from a severely overstocked and 
poorly managed fish farm. Clearly, the motile phenotype is not required for the 
spread of bacteria between hosts, which might have been facilitated by the 
intensification of aquaculture i.e. overstocking and poor management.  
 
Questions have also been raised over how non-motile EX5 cells establish infection, 
primarily since flagella are known to play a major role in the attachment and 
invasion of bacteria for host tissues. A notable example is V. anguillarum, a 
bacterial fish pathogen which requires a functional flagellin protein to establish an 
infection (Milton et al., 1996). Nonetheless, other molecules such as LPS, pili and 
adhesins are known to contribute to attachment and adherence. Tobback et al. (2008) 
found that Y. ruckeri attachment to host cell tissues involves a number of 
macromolecules which are proteinaceous and/or carbohydrate in nature. 
Furthermore, researchers have shown that EX5 strains retain the ability to be 
adhesive and invasive for both gill and gut mucus (Tobback et al., 2010). The very 
fact that a flagellin-devoid serotype O1 mutant can cause disease in rainbow trout 
when challenged via submersion (fish are bathed in a bacterial suspension) 
demonstrates that flagellin is not an essential requirement for establishing an 
infection in vivo (Evenhuis et al., 2009). Thus while flagellin production might have 
a very minor role in attachment and/or invasion in a serotype O1 background, its 
loss is not detrimental for retaining infectivity or virulence by EX5 cells towards 
fish. 
 
As flagellin is evidently not required for infectivity and virulence, its loss is not 
detrimental for EX5 bacterial cells. Similarly Welch et al. (2011) suggested that 
mutations in flagellar genes may represent a form of genomic decay. It could be 
theorised that EX5 strains acquiring mutations in flagellin-associated genes might 
have a selective advantage over traditional serotype O1 strains. Should EX5 
conserve metabolic energy which would otherwise be expended constructing the 
complex flagellar architecture, then this free energy may be redirected towards other 
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aspects of virulence. It would be of interest to perform co-infection experiments 
with a motile and non-motile mutant to determine if non-motile strains have a 
selective advantage over flagellin producing isolates in vivo. If non-motile isolates 
do have a selective advantage over motile bacteria, then it may explain why there is 
an increase in the isolation of non-motile strains. However, it is also possible that 
the non-motile phenotype of EX5 strains has been a so-called “red herring” in that 
research to date has potentially ignored other aspects of EX5 pathogenicity.  
 
4.7 Native flagellin as a sub-unit vaccine 
In addition to investigating the protective role of flagellin as a component of a 
whole-cell vaccine, the use of native flagellin as a sub-unit vaccine was also 
investigated. This experiment was initially performed to investigate the protective 
properties of flagellin as part of a whole-cell vaccine. Results demonstrated that 
native flagellin purified using the acid disassociation and re-association method 
described by Ibrahim et al. (1990), when used as a vaccine for naïve rainbow trout 
by i.p. injection (50 µg/fish), can confer excellent protection (RPS = 100%) against 
challenge with a serotype O1 (YR1) or EX5 (R1) Y. ruckeri strain 28-days post-
vaccination. This was an unexpected, yet potentially significant result for a number 
of reasons.  
 
As previously discussed, it was proposed by some researchers that excessive 
vaccination towards a serotype O1 Y. ruckeri strain might have exerted a selection 
pressure on flagellin, particularly if it is the main immunogenic molecule in the 
monovalent vaccine. Theoretically, this would explain why EX5 strains can cause 
disease in the vaccinated host. Thus in addition to investigating the protective 
properties of flagellin as part of a whole-cell vaccine, experiments were carried out 
using flagellin as a sub-unit vaccine. In this respect, should flagellin be an essential 
component of the monovalent vaccine, then vaccinates administered with flagellin 
would be protected against the flagellin-producing serotype O1 isolate, yet 
susceptible to challenge with the flagellin-devoid EX5 strain. This was clearly not 
the case since flagellin protected against both. Results thereby show that flagellin 
could protect against a flagellin-producing and flagellin-devoid strain, implying that 
flagellin is a highly effective, non-specific sub-unit vaccine.  
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From experiments investigating flagellin as part of a whole-cell vaccine, it was 
concluded that flagellin is not a major component in conferring protect ion. On the 
other hand, the use of flagellin as a sub-unit vaccine sufficiently protected against 
bacterial challenge. These results might appear to be contradictory; however, this 
could simply be down to a matter of dosage. For example (assuming a recovery of 
100%), approximately 5 mg of native flagellin from 6 L of bacterial culture (1 x 10
9
 
cells/ml) could be obtained. Thus, each inactivated whole-cell preparation (1 x 10
8
 
cells/fish) contains approximately 0.08 µg (83 ng) of flagellin per fish. On the other 
hand, fish vaccinated with native flagellin were administered with 50 µg/fish; 
effectively 625 times more flagellin than that present within the whole-cell vaccine. 
It would seem likely that flagellin, while still not the main molecule responsible for  
eliciting a protective immune response in the whole-cell serotype O1 vaccine, can 
effectively protect when administered to fish in sufficient quantities. 
 
The non-specific nature of protection conferred by flagellin towards a strain which is 
not producing this molecule is significant for a number of reasons. Should a vaccine 
target a specific antigen and/or combination of antigens which are produced by a 
bacterium in vivo, then there is the risk that immunity generated by vaccination can 
break down through selection pressure on the bacterium. For example the 
extracellular protease Yrp1, when used as an inactivated toxoid, was shown to 
protect against a Yrp1-producing Y. ruckeri strain (termed Azo
+
) (Fernandez et al., 
2003). However, while production of this enzyme may have a role in establishing 
disease for Azo
+
 isolates, it is not an essential prerequisite for virulence since some 
highly pathogenic Y. ruckeri strains do not produce this protease (termed Azo
-
) 
(Secades and Guijarro 1999). Consequently, extensive vaccination with the Yrp1 
toxoid could result in a rise in ERM cases associated with Azo
-
 Y. ruckeri strains. 
Similarly, the theory that extensive vaccination against a flagellin-producing 
serotype O1 Y. ruckeri strain has resulted in the rise of flagellin-devoid EX5 
isolates, although probably not the case, would be an example of this break-down in 
immunity.  
 
Whereas other vaccines may exert a selective pressure on the pathogen, it is likely 
that the use of flagellin as a vaccine would not result in such a selection pressure 
since protection is not dependent upon the expression of flagellin by the invading 
pathogen e.g. EX5. This would make it difficult for the pathogen to adapt and/or 
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overcome such a potent, non-specific immune response. Since protection is non-
specific, there is also the real possibility that protection is not confined to this 
bacterial pathogen. Certainly the non-specific nature of protection potentially points 
towards the use of flagellin as a broad-spectrum vaccine candidate for conferring 
protection against a variety of pathogens problematic in aquaculture.   
 
Compared to inactivated whole-cell vaccines used in this study, RPS values for 
challenge against both a serotype O1 and EX5 strain was excellent (100%) when 
using flagellin as a sub-unit vaccine. This is particularly encouraging as even the 
most efficacious whole-cell or sub-unit Y. ruckeri vaccine does not give RPS values 
of ~100%. For example the current ERM vaccine described by Austin et al. (2003), 
which has been made commercially available to prevent serotype O1 and EX5 
outbreaks, was shown to confer excellent protection against a serotype O1 strain 
(RPS = 97%). On the other hand, only moderate levels of protection against a fresh 
EX5 isolate was obtainable (RPS = 56%). Thus the use of flagellin as a sub-unit 
vaccine can offer better levels of protection 28-days post-vaccination against ERM 
compared to the vaccine currently available.  
 
Overall, it would seem that flagellin is potentially an effective, non-specific sub-unit 
vaccine candidate against ERM. However, the acid disassociation and re-association 
method used to obtain native flagellin was labour intensive, costly and time 
consuming (e.g. 4 to 5 days) for comparatively low yields of protein (e.g. 5 mg). 
Hence while adequate for the purposes of small scale vaccination studies, this 
protein purification technique would not be economically viable on a large scale, nor 
for further experimentations.   
 
4.8 Use of recombinant Y. ruckeri flagellin (r-flagellin) as a sub-unit 
 vaccine 
In recent years, recombinant DNA technology has been used to create 
live/attenuated bacteria for administering to fish. A prominent example of such a 
vaccine is the aroA auxotrophic Y. ruckeri mutant discussed in Section 1.17.2. 
However, sub-unit vaccines have also been developed using recombinant methods; a 
prime example being the VP2 protein coat particle of infectious pancreatic necrosis 
virus (IPNV) (Fridholm et al., 2007). In this respect, large amount of antigen can be 
overexpressed in E. coli which can then be purified for administering to fish as a 
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vaccine. This technique also has the added benefit of being fast (recombinant protein 
is obtainable within 24 to 48 h) and is relatively cost/labour effective for 
manufacturing. As native Y. ruckeri flagellin was an effective sub-unit vaccine 
against ERM, yet limited the means of purification methods, it was deemed 
reasonable to investigate the possibility of flagellin as a recombinant vaccine.    
 
As shown in the results (Section 3.9), the gene encoding Y. ruckeri flagellin (fliC) 
was successfully cloned and overexpressed in E. coli. Yields of flagellin were in the 
region of 40 mg/L; approx. 8 times higher than that obtainable from 6 L of bacterial 
culture using the acid disassociation and re-association method. Furthermore, 
protein could be easily expressed by growing cultures overnight at 28°C (OD600 > 
1.0) and inducing with 0.1 mM IPTG for 4 h; thus simplifying production and 
reducing production costs. Proteins could also be purified from inclusion bodies or 
by passing through an IMAC column, thus removing and/or limiting contamination 
with other molecules (e.g. LPS). Overall, the recombinant method of producing 
flagellin is far more effective and thus makes it appealing for use in production on a 
commercial scale. 
 
Like native flagellin, administering r-flagellin to naïve fish protected against a 
virulent serotype O1 and EX5 Y. ruckeri strain. Challenging fish initially posed a 
problem in that the virulence of bacterial cultures varied significantly. For example, 
a dose held to be 1 x 10
5
 EX5 cells/fish killed the majority (> 90%) of control fish 
within 48 h. This was probably due to a miscalculation in bacterial numbers.  
Nonetheless, it does show that flagellin is effective against ERM as even the most 
efficacious vaccine and/or immune host would not be able to protect against such a 
high inoculum. Another interesting observation was that protection conferred by 
flagellin in this case was dose dependent. However, reducing the bacterial load used 
to challenge fish demonstrated that comparatively low amounts of this protein (e.g. 
10 µg/fish) can offer significant protection against disease.  
 
In addition to protecting against ERM-associated mortalities, administering flagellin 
also prevented the development of disease symptoms (e.g. exophthalmia). In some 
respects, preventing the development of disease symptoms is as important as 
preventing diseases-associated mortalities in that fish showing signs of disease 
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cannot be brought to market. In this respect severe financial losses may still entail 
even if livestock remain alive.   
 
An apparent effect on fish upon administering r-flagellin vaccinates was a rapid 
increase in appetite/growth. A similar phenomenon has been observed for fish after 
administered probiotics (Brunt et al., 2007). Although vaccinates in this study were 
not comparatively larger when compared to controls, it should be noted that all fish 
were only monitored for a period of three weeks post-vaccination. As is the case 
with probiotics, a longer period of time (e.g. 6 to 8 weeks) is usually required before 
any obvious differences in size can be detectable. It would be interesting to repeat 
this experiment over a longer period of time as an increase in appetite would 
presumably increase growth rate and, as a result, increase turnover of livestock. 
Still, this is only speculative and requires further investigation. 
 
4.9 Toxicity of native flagellin for rainbow trout 
Applying r-flagellin via i.p. injection over a wide range of concentrations to rainbow 
trout (0 to 200 µg/fish) had no detrimental effects on health or behaviour. This again 
makes it an appealing vaccine in that livestock which may become accidentally 
overdosed with flagellin on a large scale by the aquaculturist would not result in 
mortalities. This aspect is crucial for the development of a new vaccine.  
 
On the other hand, when native flagellin was administered to trout, relatively low 
protein concentrations (> 100 µg/fish) caused mortalities. This was clearly 
independent of flagellin since very high levels of r-flagellin (above) did not have 
any detrimental effects on health. It could be speculated that contaminants, such as 
LPS or non-flagellin protein, were responsible for mortalities. Low MW 
contaminants which were visible in the native protein preparation (Fig 3.17) may be 
detrimental to fish health.  
 
Nonetheless, another explanation may be put forward to explain why vaccination 
with native flagellin resulted in mortalities. As outlined in the results (Section 3.7), 
it was clear that fish did not recover from anaesthesia following sedation and i.p. 
injection. It should also be noted that all fish were sedated in anaesthetic at the same 
time before injecting groups with flagellin in an ascending order of concentrations. 
Thus it is likely that by the time higher concentrations (e.g. 100 µg/fish) were 
CHAPTER 4: DISCUSSION 
134 
 
administered, fish had already become overdosed in anaesthetic. This is a plausible 
explanation since all fish administered with r-flagellin at higher concentrations (e.g. 
200 µg/fish), which involved a shorter sedation time in anaesthetic directly before 
injection, did not result in any mortalities. It should be stated that sedation of fish 
was still ensured before injection. Still, whatever the cause of death, the r-flagellin 
preparation is non-toxic for rainbow trout and could be used as a vaccine without 
detrimental effects on livestock.  
 
4.10 Immunological aspect of protection associated with flagellin 
The use of flagellin to protect against a flagellin-devoid pathogen is a paradoxical 
result. If flagellin is a target of the immune system in fish that have undergone 
vaccination with this protein, why should it then protect against a pathogen which 
does not produce this epitope? It may be that this very question or line-of-thought 
has prevented others from performing and/or publishing these results in the past. 
Although no immunological assays were performed in this study, there are 
nonetheless a number of features both within this study and that within published 
literature, which offers a rational explanation as to why flagellin protects against a 
non-motile pathogen. 
 
Many vertebrates, including fish, possess both an innate and adaptive immune 
system. Unlike an adaptive immune response, the innate immune system is quick to 
react to an infection and is temperature independent (Ellis, 2001). Stimulation of an 
innate immune response is also not dependent on the recognition of specific 
molecules which are exclusively associated with any one pathogen. In this current 
study, protection against bacterial challenge was studied after 14 and 28 days post-
vaccination with r-flagellin. This time period is clearly insufficient for an adaptive 
immune response insofar as antibody production against Y. ruckeri in rainbow trout 
does not occur until after 8 to 12 weeks post-vaccination (Deshmukh et al., 2012). 
Furthermore, had flagellin induced an antibody response within this time period, it 
would not account for the levels of protection observed against a flagellin-devoid 
EX5 strain. Results therefore allude to an innate immune response, as protection is 
obtainable after a short period of time and is non-specific (i.e. not dependent upon 
flagellin expression by the invading pathogen). As noted by Ellis (2001), the innate 
immune system can be either constitutive (i.e. always present) or inducible 
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following vaccination/bacterial infection. Thus, flagellin is capable of inducing a 
protective immune response which can prevent the establishment of disease.  
 
Whereas results thus far have demonstrated that flagellin is capable of inducing a 
protective immune response, it does not provide any detail on what specific aspects 
of the innate immune system are involved in providing this level of protection. 
However, there has been an extensive amount of research exerted in an attempt to 
understand the fish immune system, particularly regarding the response of the innate 
immune system to flagellin. 
 
The innate immune system makes use of so-called pathogen recognition receptors 
(PRRs) or pathogen recognition proteins (PRPs) to detect the presence of conserved 
molecules generally associated with bacteria or viruses. Collectively these molecules 
are termed as pathogen-associated molecular patterns (PAMPs) or microbial-
associated molecular-patterns (MAMPs) (Palti, 2011). The recognition of PAMPs by 
PRRs ultimately results in the production of immune effector molecules (e.g. 
cytokines, chemokines and interferons) to inhibit and/or eliminate the invading 
pathogen. Flagellin is an example of such a PAMP and is widely recognised by 
PRRs in mammals, flies and plants as well as fish.  
 
In humans, flagellin is recognised by Toll-like receptor 5 (TLR5), a PRR which is a 
member of the Toll-like receptor (TLR) family. This receptor is comprised of an 
extracellular N-terminus with a leucine-rich repeat region (LRR), a transmembrane 
(TM) domain and an intracellular C-terminus with a Toll/IL-1 receptor domain 
(TIR) (Palti et al., 2011). Rainbow trout also carry TLR5 orthologues within the 
genome. However, unlike higher vertebrates (e.g. humans), rainbow trout genomes 
carry both a membrane-bound form of TLR5 (TLR5M) and a soluble form of the 
protein (TLR5S) (Tsujita et al., 2004). Whereas TLR5M has all the previously 
described domains (e.g. LRR, TM and TIR), TLR5S isoforms contain only a LRR 
domain (Fig 4.1). Nonetheless, both rainbow trout TLR5 isoforms bind to and 
recognise flagellin (Tsujita et al., 2004, Hwang et al., 2010, Basu et al., 2012, Moon 
et al., 2011). Additionally, recognition of flagellin by TLR5 can have a positive 
feedback effect on the expression of soluble TLR5 (TLR5S), but less of an effect on 
the membrane form of the receptor (TLR5M) (Moon et al., 2011, Tsujita et al., 
2004, Hwang et al., 2010). 
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The recognition of flagellin in fish (Fig 4.1) can also result in the activation of 
downstream components including MyD88 (myeloid differentiation primary 
response protein), IRAK (interleukin-1 receptorassociated kinase), TRAF6 and 
nucleation factor NF-κB (Tsujita et al., 2004, Hwang et al., 2010, Basu et al., 2012, 
Hynes et al., 2011). This, in turn, results in the expression of pro-inflammatory 
cyotokines such as tumour necrosis factor-α (TNFα) and interleukin 1-β (IL-1β). 
Hynes et al. (2011) also found that expression of TNFα was significantly increased 
at days 2 and 4 post-vaccination. As noted by the authors, the production of TNFα 
following flagellin recognition is significant in that it is an important macrophage-
activation factor which can stimulate nitric-oxide production, phagocytosis and 
respiratory burst activity in rainbow trout macrophages (Hardie et al., 1994). TNFα 
production can also increase chemotaxis of anterior kidney leucocytes and positively 
regulate the expression of IL-1β and COX2.  
 
Published literature to date clearly demonstrates that flagellin can initiate a robust 
immune response towards bacterial infection. This is reinforced by work in this 
study as flagellin can prevent the development of ERM when used as a vaccine. In 
this respect, it is likely that administering flagellin prior to bacterial challenge can 
stimulate a robust innate immune response which essentially “primes” the host 
against bacterial infection. It is also possible that Y. ruckeri cells (serotype O1 or 
EX5) grown in vitro are not fully expressing all genes required for virulence and/or 
growth in vivo. Thus, when cultures are used as in the challenge model, bacteria are 
quickly and efficiently cleared by the immune system without adequate time to 
mount bacterial defences and/or acclimatise to the new environment. This would 
explain why the majority of fish (98%) vaccinated with r-flagellin did not show any 
symptoms associated with disease after challenging with the EX5 (R1) strain. It is 
therefore possible that protection in a commercial setting, when the challenge comes 
from bacteria derived from fish, may be not as robust as that seen here. 
Nevertheless, it does show that the innate immune system is a powerful aspect of 
rainbow trout immunity which in itself can protect against ERM. 
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Figure 4.1: Recognition of flagellin by TLR5 in rainbow trout and potential down-
stream signalling pathways leading to protection against challenge with a virulent 
serotype O1 or EX5 Y. ruckeri strain. Flagellin is recognised by membrane 
(TLR5M) or soluble (TLR5S) TLR5 (A) which initiates the downstream activation 
of the MyD88 dependent pathway (B). This ultimately results in the activation of 
NFκB (C) and its localisation to the nucleus whereby it initiates the expression of 
T
L
R
5
 (
M
) 
TM 
TIR 
LR
R 
LRR 
TLR5 (S) 
 
MyD88 
NFκB 
NM 
TLR5 (S) 
O1 EX5 
IRAK 
TRAF6 
OM 
A 
B 
C 
D 
CHAPTER 4: DISCUSSION 
138 
 
pro-inflammatory cytokines (e.g. IL-1β and TNFα). This would result in a pro-
inflammatory response which would lead to the repression and/or clearing of Y. 
ruckeri (serotype O1 and EX5).  
 
4.11 Flagellin as a vaccine in other research 
Given the increasing amount of information regarding the immunological response 
to flagellin in fish, other researchers have endeavoured to investigate the potential 
role of this protein as a vaccine. However, unlike results outlined in this work, all 
published research to date has involved administering flagellin with an adjuvant 
(e.g. Freunds complete adjuvant) in an attempt to stimulate antibody production 
against challenge with a flagellin-producing strain. For example, recombinant 
flagellin from Piscirickettsia salmonis (Wilhelm et al., 2006), V. alginolyticus 
(Liang et al., 2010) and A. hydrophila (Yeh and Klesius, 2011) have been shown to 
induce antibody production when injected to fish with adjuvant. Any protection 
conferred against challenge to motile (= flagellin-producing) strains was again 
linked with an increase in antibody titres. In light of current research it is entirely 
possible that flagellin, in addition to initiating an adaptive immune response, is also 
eliciting a non-specific immune response in fish.  
 
As well using the flagellin protein in a vaccine formulation, workers have also used 
DNA vaccines harbouring genes encoding flagellin. This technique was used with 
some success by Liang et al. (2011) to specifically protect red snapper (Lutjanus 
sanguineus) against V. alginolyticus infection, again with the ultimate goal of 
stimulating antibody production. In contrast, Jiao et al. (2009) suggested that a DNA 
vaccine containing the flagellin gene (fliC), expressed within Japanese flounder, did 
not adequately protect against E. tarda. These researchers also found that 
administering recombinant flagellin protein did not sufficiently protect (70% 
mortality) against challenge. This is in contrast with results outlined in this thesis 
whereby recombinant flagellin protected fish against a motile bacterium. However, 
work by Jiao et al. (2009) involved a different flagellin, fish and bacterial species. It 
also made use of a Bacillus spp. B187 adjuvant in the flagellin preparation.  
 
Studies exploring the use of flagellin as a component of a vaccine have similarly 
been performed on terrestrial animals such as rats (Shi et al., 2012), mice (Hong et 
al., 2012), chickens (Chaung et al., 2011) and monkeys (Weimer et al., 2009). 
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However, these experiments have all involved the use of flagellin as an adjuvant in 
an attempt to stimulate a pro-inflammatory response which would precede antibody 
production against viral or bacterial antigens. In this respect, flagellin research 
regarding its use as a vaccine in mammals is not dissimilar to that in fish since 
researchers are ultimately trying to initiate a humoral response towards an infect ive 
agent. A notable study by Lee et al. (2006) showed that flagellin (FlaB) from the 
bacterial fish pathogen V. vulnificus has potent mucosal adjuvant activities when 
intranasally administered to mice. What is more, administering FlaB in conjunction 
with a tetanus toxoid (TT) resulted in the production of specific anti-TT 
immunoglobulin A (IgA). Lee et al. (2006) also demonstrated that flagellin was 
bound to TLR5 which resulted in the activation of TNF-κB and IL-8. Thus while 
flagellin, like in fish, has the potential to elicit a strong immune response, no 
research has been performed concerning flagellin as a standalone vaccine. 
 
4.12 Non-specific vaccines for fish 
In aquaculture, so-called non-specific immunostimulants or immunomodulators have 
gained an increasing amount of attention in recent years. While flagellin has 
consistently been referred to as a vaccine for the purposes of this work, it would also 
match the criteria of an immunostimulant. These can take a number of forms which 
broadly include probiotics and dietary supplements that apparently result in the 
stimulation of the innate immune system. How these compounds or bacteria result in 
a protective immune response is a matter open to some debate. Probiotics, which 
have been shown to be effective against ERM (Section 1.16.2), are broadly 
considered to be live bacteria that, when administered to fish, has a beneficial effect 
on health and in combatting against disease. This terminology may not strictly hold 
true, however, since Sharifuzzaman et al. (2011) showed that administering crude 
cell wall proteins (200 to 250 µg/fish) from probiotic bacteria could offer protection 
against challenge with V. anguillarum (RPS = 80 to 87%). It is possible that 
immunostimulatory molecules or MAMPs produced by these strains are stimulating 
an immune response which is not dissimilar to that induced by flagellin 
administration. More recently Li et al. (2012) showed that vaccinating zebrafish 
with glyceraldehyde-3-phosphate dehydrogenase conferred some level of cross-
protection against a range of fish pathogens including A. hydrophila, V. anguillarum 
and E. tarda. However, levels of cross protection was relatively low (RPS = ~60%). 
Taking RPS values obtained in this study using flagellin into consideration, it would 
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reinforce the need to test the ability of this protein to protect against the range of 
pathogens outlined by Li et al. (2012). It is noteworthy that while probiotics are 
known to stimulate an innate immune response, the role of food supplements in 
stimulating such a response is well understood. There is much debate over the role 
of improved nutrition in combatting disease rather than the compound directly 
stimulating an immune response.   
 
4.13 Flagellin as a commercial, non-specific vaccine 
Results outlined in this work are promising regarding the use of flagellin as a non-
specific vaccine for protecting against disease in fish. However, there are a number 
of areas not approached in this work which would have to be addressed before 
flagellin could be used as a vaccine on a commercial basis.  
 
4.13.1 Pathogen specificity and length of protection  
Work outlined here is limited in that only two specific types of Y. ruckeri strains 
were used in the challenge model after 14 and 28 days post-vaccination. As 
previously discussed, protection conferred by flagellin towards bacteria was non-
specific. It would be of interest to investigate the protective properties of this protein 
against a range of motile and non-motile bacterial pathogens of fish which are either 
Gram-negative (e.g. V. anguillarum and A. hydrophila) or Gram-positive (e.g. 
Edwardsiella tarda and Streptococcus iniae). Exploring the protective effects, if 
any, of this vaccine against viral infection should also be considered as the number 
of vaccines currently available against viral agents are limited (Austin et al., 2007). 
Actually, should a viral outbreak occur in livestock, there is little option but to cull 
infected livestock as many compounds used to treat bacterial infections (e.g. 
antibiotics) are completely ineffective towards curtailing viruses.  
 
Length of protection conferred by this vaccine should also be investigated as an 
innate immune response may subside after some time. For example, Deschmukh et 
al. (2012) has shown that levels of protection 8 or 12 weeks post-vaccination can 
result in a significant drop in the levels of protection towards challenge. Should 
vaccination induce an innate immune response, it is then possible that levels of 
protection against challenge 8 or 12 weeks would subside. A similar result might be 
observed when using flagellin as a vaccine, thereby necessitating long term 
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vaccination studies (e.g. challenge after 8 or 12 weeks post-vaccination with 
flagellin). 
  
In addition to preventing the development of disease, it would be interesting to 
investigate the immunostimulatory properties of flagellin on fish showing signs of 
disease. For example, it is widely known that ERM is associated with stressed or 
overpopulated livestock, thus leading to the immunocompromised state. Thus 
reducing the size of stocks and applying flagellin to fish showing early signs of 
disease may stimulate a protective immune response and reduce mortality rates. In 
this way, excessive loss of livestock may be prevented without significant financial 
losses for the aquaculturist. However, this is again purely speculative. 
 
4.13.2 Vaccine application   
Injection is an effective method for determining the protective properties of a 
vaccine, although it is costly, time consuming and impractical for large-scale 
immunizations. As stated earlier, administering vaccines by injection to large and/or 
valuable fish is still a plausible option. However, other methods of vaccine 
application would have to be considered if r-flagellin was to be administered on a 
large scale. As noted in a recent review by Plant and LaPatra (2011), coating or 
mixing feed with antigen can have the added advantage of being stress free for 
livestock and easier for applying to large numbers of fish. This method has a number 
of problems such as determining the protective dosage and ensuring that each fish 
receives an adequate amount of antigen can be problematic. Antigen may also be 
broken down by digestive enzymes in the lumen of the gut and consequently not 
have a demonstrable effect on the fish immune system (Plant and LaPatra, 2011). 
 
Whereas small, immunogenic peptides could probably withstand host digestive 
enzymes, it is unlikely that each fish would consume a similar amount of food. The 
only logical method of ensuring that each trout obtains enough of the recombinant 
antigen would be to significantly increase the amount added to feed. This poses a 
number of difficulties. Firstly, a large amount of recombinant protein or peptides 
would be required, thus increasing the overall cost of vaccine production. Secondly, 
large amounts of this product in feed may make it unpalatable for fish.   
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Taking into consideration all the methods outlined by Plant and LaPatra (2011), it is 
likely that vaccination via immersion would be the method of choice for applying 
the recombinant Y. ruckeri flagellin protein en masse. This form of vaccine delivery, 
which is shown diagrammatically in the appendix (Fig 5.9), has a number of features 
which make it superior over other methods. Unlike injection, immersion would limit 
the amount of stress imposed on livestock, is faster, and would not require personnel 
trained in fish injection. There is also the added advantage of being able to estimate 
the dose of antigen required for conferring protection. For example, the ability to 
reduce the volume of water to a certain level for a given number of fish would 
ensure each trout is sufficiently immunized. This method is currently used in 
vaccinating against a number of diseases, including ERM, and thus flagellin for 
convenience could be administered at the same time without further costs for the 
aquaculturist. In principle, the protein could be added directly to the vaccination 
tank without having to mix with feed. Furthermore, as the vaccine is proteinaceous 
in nature, it would be stable for a number of years either by freezing, lyophilisation 
or in liquid form following the addition of a preservative (e.g. sodium azide). Large 
amounts of vaccine could be produced at any one given time and stored indefinitely 
until required.   
 
In this study, as for vaccination, all challenges were performed by i.p. injection. 
Even though this method is again adequate for evaluating the protective properties 
of a given vaccine, it does not mimic natural infection. Injection also essentially 
bypasses the first line of defence (i.e. skin, antimicrobial peptides, and digestive 
enzymes) which presumably plays a major role in preventing infection. Thus, in 
addition to investigating administering flagellin via immersion, fish should be 
challenged by immersion.   
 
4.13.3 Vaccine structure 
As indicated in the results, it is likely that the conserved N- and/or C- terminal is 
contributing to protection. Some possible structures which could be considered are 
shown in the appendix (Fig 5.10). Constructs could be created using different primer 
sets to specifically overexpress immunostimulatory peptides which may reduce the 
amount of protein required to confer a protective immune response. Smith et al. 
(2003) has shown that a 13 amino-acid residue, which is conserved between 
different flagellin proteins and required for motility and proto-filament formation, 
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can sufficiently stimulate TLR5 recognition even at very low concentrations e.g. 10 
ng/ml. With further modifications it would seem that protection and/or immune 
stimulation could probably be achieved after modifying the vector construct. Thus 
there are potentially some exciting prospects regarding flagellin as a 
vaccine/immunostimulant. 
 
4.14 Vaccine failure and EX5 outbreaks 
Although flagellin is effective in preventing ERM when used as a sub-unit vaccine, 
and whereas the non-motile phenotype has probably not arisen due to a selection 
pressure on flagellin, it does not explain as to why EX5 isolates originally caused 
disease in rainbow trout previously vaccinated against this disease. A possible 
explanation using data generated in this work, while still not conclusive evidence, 
may be put forward to explain why this strain of Y. ruckeri caused disease.  
 
Like Austin et al. (2003), this study confirmed that vaccinating fish with a serotype 
O1 strain can offer some levels of protection 28 days post-vaccination against 
challenge with a serotype O1 Y. ruckeri isolate. However, it was shown that fish 
vaccinated with a serotype O1 strain were susceptible to infection with EX5 cells. In 
this respect, data from these vaccine/challenge experiments represent the so-called 
“vaccine failure” of the monovalent (= serotype O1) strain in adequately protecting 
against EX5 infection first described by Austin et al. (2003). Moreover, both work 
in this study and that by Austin et al. (2003) demonstrated that vaccination with an 
EX5 strain did not confer high levels of protection against challenge with an EX5 
strain.  
 
On the other hand, in contrast to Austin et al. (2003), vaccination studies using the 
EX5 strain as a vaccine showed that trout were sufficiently protected against 
challenge with a serotype O1 (YR1) Y. ruckeri strain (RPS = 95%). This shows that 
inactivated EX5 cells can effectively stimulate a protective immune response against 
a serotype O1 isolate. However, EX5 themselves have a greater tolerance towards 
such a response, suggesting that they are able to withstand the effects of the immune 
system and persist within the host. 
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4.14.1 Link between virulence and vaccine-induced protection 
The serotype O1 Y. ruckeri isolate (BA19), which was used in this study to create a 
flagellin devoid strain (BA19/Tn-RL27), is the strain used in the original (= 
monovalent) ERM vaccine which consequently failed to protect against EX5 isolates 
(Professor. B. Austin, University of Stirling, personal communication). An attempt 
to obtain a fresh culture from the vaccine manufacturers was unsuccessful, although 
the BA19 strain was available within as a lyophilised culture from 1983 and 
remained viable when grown in vitro. This strain was originally obtained from 
rainbow trout displaying signs of ERM in the UK during the 1960s and has 
presumably been used in the vaccine formulation until the recent outbreak of EX5 
strains in vaccinated livestock. It should also be noted that this strain originally 
conferred excellent levels of protection (RPS > 95%) against challenge with the 
serotype O1 strain (Section 1.17.1).  
 
Interestingly, work in this study using the serotype O1 (BA19) isolate showed it to 
be completely avirulent for rainbow trout since challenging naïve fish with this 
isolate (i.e. 1 x 10
5
, 10
6
, 10
7
, 10
8
, 10
9
 cells/ml; N = 5 x 5) did not induce any 
mortalities 2 weeks post-challenge (100% survival). Evidently the BA19 strain has 
moved from being virulent to avirulent since it was previously sourced from 
diseased fish (above). Why this Y. ruckeri strain has lost virulence remains 
unknown, however, routine sub-culturing in vitro is known to have a detrimental 
effect on the pathogenicity of this organism. For example, fresh Y. ruckeri EX5 
isolates sourced directly from diseased rainbow trout were found to be highly 
virulent towards naïve fish as administering 1 x 10
5
 EX5 cells/fish resulted in 100% 
mortalities after 4 days post-challenge (Austin et al., 2003). In fact as few as 1 x 10
3
 
EX5 cells/fish could cause mortalities (Dr D. Austin, Heriot-Watt University, 
personal communication). However, even after passing through fish, EX5 isolates 
were reduced in virulence towards rainbow trout as 4 x 10
5
 cells/fish resulted in only 
52% mortalities after 2 weeks post-challenge (this study).  
 
It could be hypothesised that highly virulent/aggressive Y. ruckeri isolates sourced 
directly from naturally infected fish are adapted for growth and persistence in vivo. 
For example, it is now widely accepted that one of the selective pressures or 
regulators of virulence in vivo is iron and temperature limitation (Tobback et al., 
2007). As the majority of iron is bound within host cells as protein-iron complexes 
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(e.g. haemoproteins), pathogenic bacteria must produce virulence factors such as 
siderophores, haemolysins, proteases and iron-regulated outer membrane proteins 
(IROMPs) in order to obtain this essential nutrient (Tobback et al., 2007). Research 
to date has shown that when Y. ruckeri is cultured in vitro in nutrient rich media 
(e.g. TSB or NB) at the optimum temperature of growth (i.e. 28ºC), production of 
these molecules is significantly repressed, sometimes even to undetectable levels 
(Tobback et al., 2007). An important observation in this study, although not directly 
quantified, found that EX5 strains grew better at very low temperatures (i.e. 4ºC) 
compared to the serotype O1 (BA19) strain. Moreover, the EX5 strain was far more 
efficient in growing under iron and/or temperature limiting (16ºC) condition 
compared to the serotype O1 (BA19) isolate. Nonetheless, the serotype O1 (BA19) 
could be “trained” to grow under virulence-inducing conditions, although a potential 
increase in pathogenicity for fish was not investigated. It is conceivable that 
continuously culturing/sub-culturing serotype O1 (BA19) bacteria on nutrient rich 
media has effectively removed any selection pressure that lends towards a virulent 
phenotype. In some cases it is possible to regain or increase virulence of Y. ruckeri 
strains via multiple passages through fish. It is worth noting, however, that while 
iron and temperature are considered to be influencing factors of virulence for Y. 
ruckeri in vivo, it is highly probable that other unknown environmental cues are 
influencing virulence gene expression. This is considered by many authors to be the 
ultimate downfall in in vitro experimentation for this fish pathogen (Tobback et al., 
2007).  
 
Understanding why certain fish vaccines confer better levels of protection against 
different forms of bacterial pathogens is often a contentious area of debate, 
principally because the roles of the innate and/or humoral immune system have not 
been definitively clarified within the literature. However, it is now becoming 
apparent from recent publications that vaccination with inactivated bacteria (or 
attenuated live forms of the pathogen) can result in the upregulation of genes (e.g. 
pro-inflammatory cytokines) which are associated with innate immunity (Section 
1.18.1). It is likely that protection observed in this study is associated with this 
aspect of the immune system since challenge was performed 28 days post-
vaccination, a time period which is insufficient for antibody production in rainbow 
trout (Raida et al., 2011b). Furthermore, the use of flagellin in this work as a 
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component of a sub-unit vaccine confirms the involvement of the innate immune 
system in protection towards bacterial challenge. 
 
Assuming that the innate immune system is stimulated upon vaccination, it suggest s 
that PAMPs produced by Y. ruckeri, which are present within the inactivated whole-
cell vaccine preparation, are involved in conferring protection. In this respect, 
PAMPs required for virulence are in themselves recognised by the innate immune 
system. Thus the avirulent serotype O1 (BA19) strain, which is possibly not 
expressing the same amount and/or combination of PAMPs required to stimulate a 
robust immune response, does not result in significant levels of protection against 
bacterial challenge. A similar situation has been observed for Helicobacter pylori 
whereby routine sub-culturing on solid media has resulted in the loss of antigenic O 
side-chain expression. If work by Tinsley et al. (2011b) is correct, then it is possible 
that serotype O1 (BA19) isolates are not producing a component of LPS which is 
required for stimulating an innate immune response. Conversely, highly virulent 
EX5 isolates could be expressing these immunostimulatory molecules which are, in 
themselves, required for virulence. It could be theorised that when inactivated EX5 
cells are used as a vaccine, PAMPs produced by these strains result in the 
stimulation of the innate immune system which can subsequently protect against 
bacterial challenge. This explanation would fit results outlined in this study, 
although published research has yet to prove that this is in fact the case. 
 
As discussed earlier, EX5 Y. ruckeri cells are able to resist the immune responses of 
fish vaccinated with the monovalent vaccine. Even fish vaccinated with the EX5 
strain are still, to some extent, susceptible to infection. This form of resistance to an 
immune response is indicative of serum resistance; an aspect of virulence which is 
associated with Y. ruckeri pathogenicity (Section 1.9.1). It has been suggested that 
serum resistance is an essential requirement for virulence by pathogenic serotype O1 
strains in vivo (Section 1.9.1). Interestingly, although this aspect of virulence is not 
fully understood, it is possible that serum resistance is associated with LPS. It could 
be theorised that extensive vaccination has driven the development of highly 
aggressive, serum resistant EX5 isolates.  
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4.15 EX5 and OmpA overexpression 
Upon fractionating WCPs by SDS-PAGE, it was strikingly clear that a 30 to 40 kDa 
protein was overexpressed by EX5 isolates. Although this protein was not unique to 
this Y. ruckeri strain (different serotypes were also expressing this protein), they did 
not reach the levels of overexpression observed by EX5 strains. This result was also 
observed by Wheeler et al. (2009), who separated crude OMPs by SDS-PAGE, 
although the identity of the protein was not established. Of note, Davies et al. (1990) 
also described a strain with an overexpressed protein of 30 to 40 kDa, although 
motility and/or virulence for this strain particular isolate was not stated. 
 
In order to identify this protein, WCPs were purified and separated by 2D SDS-
PAGE. It was evidently clear that four major protein spots within the region of 30 to 
40 kDa were overexpressed by EX5 strains when compared to other serotype O1 
isolates. Analysis of these protein spots following trypsin digests/Maldi-ToF mass 
spectrometry indicated that they were similar to outer membrane protein A (OmpA) 
of Y. enterocolitica. 
 
The overexpression of OmpA was interesting insofar as this protein has been shown 
to have a role in virulence for a number of pathogens belonging to the 
Enterobacteriaceae (Krishnan and Prasadarao, 2012). For example, clinical isolates 
of pathogenic E. coli K1 require OmpA to resist against serum killing and aid in the 
attachment/invasion of host tissues (Krishnan and Prasadarao, 2012). It could be 
postulated that OmpA may compensate for the lack of flagellin production in 
establishing attachment and/or invasion of fish tissues. EX5 is also able to cause 
disease in fish vaccinated with the monovalent vaccine, suggesting that it is capable 
of resisting an immune response. Indeed, it has been established that resistance to 
serum-mediated killing by Y. ruckeri is important for virulence (Section 1.9.1). It is 
conceivable that OmpA overexpression by EX5 might be contributing to serum 
resistance, particularly since all the molecules involved in this aspect of virulence 
are currently unknown. Furthermore, OmpA overexpression by EX5 may also aid in 
establishment and/or maintenance of biofilms as these structures are potentially a 
source of re-infection and persistence within the environment (Coquet et al., 2002a, 
Coquet et al., 2002b).  
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To ascertain what role OmpA might have in virulence for Y. ruckeri EX5 cells 
towards rainbow trout, an attempt was made to disrupt the gene encoding this outer 
membrane protein (ompA). Since the transconjugation system described by Metcalf 
et al. (2002) was optimised for creating Y. ruckeri transconjugants, and as it was 
successfully used to screen for a non-motile serotype O1 (BA19/Tn-RL27) mutant, 
an attempt was made to screen for a Y. ruckeri EX5 transconjugant carrying a 
transposon within the ompA gene (ompA::Tn-RL27). Unlike the previous screening 
process, which employed a specific phenotype to isolate a transconjugant, screening 
for a transposon within a specific gene initially posed a problem. However, both the 
transposon flanking/sequencing primers TPNRL17-1 and TPNRL13-2 were readily 
available, as were the ompA forward (OMPA-F) and reverse (OMPA-R) primers. 
Therefore, pooled transconjugants could theoretically be screened by PCR and 
detected using Southern blotting/hybridization with a DIG-labelled PCR probe. 
Unfortunately, out of 4800 transconjugants, none contained the Tn-RL27 transposon 
within the ompA gene.  
 
One possible explanation as to why the transposon screening process failed to isolate 
a transconjugant of interest is that the ompA gene is not a region which is susceptible 
to insertion (i.e. “hot-spot”). The isolation of a non-motile Y. ruckeri strain carrying 
a transposon within the same site as that of the non-motile transconjugant isolated 
by Evenhuis et al. (2009) would reinforce this theory. Another explanation is that 
the OmpA protein is physiologically essential for maintaining bacterial stability, and 
upon its disruption results in the loss of viability. The latter explanation would seem 
unlikely, particularly since viable E. coli strains with mutations in the ompA gene 
can be readily obtained (Krishnan and Prasadarao, 2012). It is also possible that Y. 
ruckeri transconjugants which carry a transposon within the ompA gene are reduced 
in their ability to compete with other strains during the conjugation stage and 
therefore not obtainable following this process. It does suggest that this conjugation 
system is insufficient or unable to produce the mutant of interest. Future attempts at 
creating disruptions in the Y. ruckeri ompA gene should be carried out using site-
directed mutagenesis in a bid to better understand the role of this protein in 
virulence towards fish. 
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4.16 Relationship between Y. ruckeri and other Yersinia spp. 
The question as to the correct placing of Yersinia ruckeri within the genus Yersinia 
has long been debated. Discussions over the correct genus for this organism can be 
linked back to initial work carried out by Ewing et al. (1978). A broad study by 
Kotetishvili et al. (2005) using MLST showed that Y. ruckeri was genetically distant 
to all other Yersinia spp. and may even substantiate a new genus. However, DNA 
sequencing in this study has highlighted a close phylogenetic relationship between 
Y. ruckeri and Y. enterocolitica. For example, BLAST analysis of two previously 
unidentified Y. ruckeri ORFs (fliC and ompA) most closely resemble and shared a 
high level of identity (>85%) to homologues within the Y. enterocolitica genome 
(flaA and ompA). While it cannot be assumed outright that Y. ruckeri is genetically a 
Yersinia spp. based on two genes alone, it does indicate that  there are some genetic 
similarities between Y. ruckeri and Y. enterocolitica. Work should again be taken up 
on definitively allocating this species within a new genus or maintaining it as a 
Yersinia spp. 
 
4.17 Concluding remarks 
Y. ruckeri is a successful pathogen of fish and one which will undoubtedly continue 
to cause disease in salmonids, particularly rainbow trout. While some consider the 
current bivalent vaccine to be superior over the monovalent vaccine, research into 
developing new and/or novel methods of control should not stop. As was the case 
with the monovalent vaccine, it is likely that the over application of the bivalent 
vaccine, coupled with the intensification of aquaculture, will drive the evolution of 
highly aggressive Y. ruckeri strains which can resist vaccination. Thus, novel 
vaccines will be required to prevent disease in the near future. Results from this 
study suggest that flagellin may be a potential vaccine candidate against ERM, 
although long-term research will have to be carried out before any attempts are made 
to commercialise this vaccine. Nonetheless, current data are promising, and research 
in the near future regarding this fish pathogen will undoubtedly be exciting in fields 
of both microbiology and immunology.   
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4.18 Conclusions 
 
1.  Y. ruckeri EX5 isolates are non-motile and do not produce detectable 
 flagellin under any of the standard conditions used to cultivate the 
 pathogen. 
   
2. The genome of the EX5 strain carries the gene encoding flagellin ( fliC), 
indicating that the organism was once motile. 
 
3. Flagellin is not the main immunostimulatory molecule in the monovalent 
 vaccine. It would seem unlikely that extensive vaccination against a 
 motile (i.e. flagellin-producing) strain exerted a selection pressure for a non-
 motile phenotype.   
 
4. Y. ruckeri flagellin is an effective sub-unit vaccine against a flagellin-
 producing serotype O1 and flagellin-devoid EX5 Y. ruckeri strain. 
 
5. The ORF encoding Y. ruckeri flagellin (fliC) was successfully cloned, and 
 shown to be 1,284 bp long. Flagellin from this species was predicted to 
 encode a 46.77 kDa protein (452 amino acids) which shares a high level of 
 identity (82%) with flagellin from Y. enterocolitica. 
 
6. Recombinant flagellin (r-flagellin) could be over-expressed to give relatively 
 high yields (40 mg/L) and purified as insoluble inclusion  bodies or soluble 
 flagellin when passed through an IMAC column.  
 
7. Recombinant r-flagellin was safe for use in fish at very high 
 concentrations (200 µg/fish) without any detrimental effects on fish health. 
 Evidence suggests that this protein may actually stimulate health and increase 
 appetite.  
 
8. Virulent EX5 Y. ruckeri strains are associated with the overexpression of 
 outer membrane protein OmpA. 
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Table 5.1: Composition of media used to cultivate bacterial strains. All media were 
autoclaved (121
º
C; 15 min) and cooled (~ 50
º
C) before use. 
Media Composition (grams per Litre)    
 
Liquid media: 
Columbia broth  Biopeptone  10.0 g 
 Dextrose  2.5 g 
 Ferrous sulphate  0.02g  
 Heart infusion powder  3.0 g  
 L-Cysteine hydrochloride  0.1 g 
 Magnesium sulphate  0.1 g 
 NaCl 5.0 g
 Peptone 10.0 g
 Sodium carbonate  0.6 g 
 Tris (Hydroxymethyl) aminomethane  0.83 g 
 Tris (Hydroxymethyl) aminomethane-HCl 2.86 g 
 Final pH: 7.3  
 
Luria-Bertani broth NaCl 10.0 g 
(LB) Tryptone 10.0 g 
 Yeast extract 5.0 g 
 Final pH: 7.2 
 
Nutrient broth D-glucose 1.0 g 
(NB) NaCl 6.0 g 
 Peptone 15.0 g 
 Yeast extract 3.0 g 
 Final pH: 7.5 
 
Tryptone soya broth Dextrose 2.5 g  
(TSB) Dipotassium phosphate  2.5 g 
 Enzymatic digest of casein 17.0 g 
 Enzymatic digest of soybean meal  3.0 g 
 NaCl  5.0 g
 Final pH: 7.3  
 
Solid media: 
Luria-Bertani agar LB 25.0 g 
(LA) Bacteriological agar No 1 10.0 g 
 Final pH: 7.2 
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Nutrient agar NB 25.0 g 
(NA) Bacteriological agar No 1 10.0 g 
 Final pH: 7.5 
 
Tryptone soya agar TSB 30.0 g 
(TSA) Bacteriological agar No 1 10.0 g 
 Final pH: 7.3 
 
 
 
 
Table 5.2: Susceptibility of selected bacterial isolates towards a range of antibiotics.  
 
 Bacterial strains  
 Y. ruckeri  E. coli     
Antibiotic BA19 R1 BW2020767/pRL27 S17λ pir/pLM1 
 
M13 Ring:  
Chloramphenicol (25 μg) S S S   S  
Erythromycin (5 μg)  R R R   R 
Fusidic acid (10 μg)  R R R   R 
Oxacillin (5 μg)  R R R   R 
Novobiocin (5 μg)  R R R   R 
Penicillin G (1 unit)  R R R   R 
Streptomycin (10 μg) S S I   R 
Tetracycline (25 μg)  S S S   S 
 
M26 Ring: 
Ampicillin (25 μg)  S S S   S 
Chloramphenicol (50 μg) S S S   S 
Colistin sulphate (100 μg) S S S   S 
Kanamycin (30 μg)  S S R   S 
Nalidixic acid (30 μg)  S S S   S 
Nitrofurantoin (50 μg) I I S   S 
Streptomycin (25 μg) S S I   R 
Tetracycline (100 μg) S S S   S 
Gentamicin (50 μg)  S S S   R  
 
Key: S = Sensitive; I = Intermediate sensitivity; R = Resistant. 
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Figure 5.1: Restriction plasmid map of the pET-38-b vector (Novagen) used in this 
study to clone the Y. ruckeri flagellin gene (fliC).  
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Figure 5.2: Plasmid map of the pRL27 vector used in this study to create Y. ruckeri 
transconjugants. Graphics were designed using SerialCloner (V2.1).  
 
 
 
 
 
 
 
 
 
 
tetR´ 
tetA 
Transposase 
aph  
Inverted repeats 
traJ 
RP4 ori 
pRL27 
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Figure 5.3: Determination of minimum inhibitory concentrations (MICs) for 
bacterial isolates towards nitrofurantoin. Optical density values for each 
concentration of nitrofurantion used in this work for the E. coli donor 
(BW2020767/pRL27) ( ) and Y. ruckeri host strains serotype O1 (BA19) ( ) and 
EX5 (R1) ( ) is shown. Data represented above are from the mean of five different 
growth experiments.   
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Figure 5.4: Large scale screening for non-motile serotype O1 (BA19) Y. ruckeri 
transconjugants. Cultures were stab inoculated from liquid cultures onto motility 
media (Columbia broth + 0.3% [w/v] agar) using a multi-well replicator. Two 
potentially non-motile mutants are clearly visible (indicated).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: Lipase production and secretion by Y. ruckeri strains on TSA plates 
supplemented with 1% (v/v) Tween 20. Single colonies were streaked onto these 
plates before incubating at 28°C for 48 h. Lipase production by the motile serotype 
O1 (BA19) Y. ruckeri strain is visible (A), whereas the phenotype is not observable 
for both the EX5 isolate (B) and non-motile serotype O1 (BA19/Tn-RL27) 
transconjugant (C).  
C A B 
+ 50 μg/ml kanamycin 
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ATTTTAAAGACACGCAGTGGCAGGTACTTGCCGGTCCGATCCTGATATTAATGATTCTGTCGATGATG
GTTTTGCCATTACCGCCGTTCATTCTGGATCTGTTGTTTACCTTTAACATCGCACTGTCCATCATGGT
ATTGCTGGTCGCGATGTTTACCAAACGCACGCTGGAATTTGCTGCATTCCCGACCATTTTGTTGTTTT
CCACCTTATTACGTCTATCctgtctcttatacacatctcaaccATCATCGATGAATTCGAGCTCGGTA
CCCCCCCATGTCAGCCGTTAAGTGTTCCTGTGTCACTCAAAATTGCTTTGAGAGGCTCTAAGGGCTTC
TCAGTGCGTTACATCCCTGGCTTGTTGTCCACAACCGTTAAACCTTAAAAGCTTTAAAAGCCTTATAT
ATTCTTTTTTTTCTTATAAAACTTAAAACCTTAGAGGCTATTTAAGTTGCTGATTTATATTAATTTTA
TTGTTCAAACATGAGAGCTTAGTACGTGAAACATGAGAGCTTAGTACGTTAGCCATGAGAGCTTAGTA
CGTTAGCCATGAGGGTTTAGTTCGTTAAACATGAGAGCTTAGTACGTTAAACATGAGAGCTTAGTACG
TGAAACATGAGAGCTTAGTACGTACTATCAACAGGTTGAACTGCTGATCTTCAGATCCTCTACGCCGG
ACGCATCGTGGCCGGGGTTCGAAATCGATGAGCTCGGGGGGGGGGGGGAAAGCCACGTTGTGTCTCAA
AATCTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACAT
AAACAGTAATACAAGGGGTGTTatgagccatattcaacgggaaacgtcttgctcgaggccgcgattaa
attccaacatggatgctgatttatatgggtataaatgggctcgcgataatgtcgggcaatcaggtgcg
acaatctatcgattgtatgggaagcccgatgcgccagagttgtttctgaaacatggcaaaggtagcgt
tgccaatgatgttacagatgagatggtcagactaaactggctgacggaatttatgcctcttccgacca
tcaagcattttatccgtactcctgatgatgcatggttactcaccactgcgatccccgggaaaacagca
ttccaggtattagaagaatatcctgattcaggtgaaaatattgttgatgcgctggcagtgttcctgcg
ccggttgcattcgattcctgtttgtaattgtccttttaacagcgatcgcgtatttcgtctcgctcagg
cgcaatcacgaatgaataacggtttggttgatgcgagtgattttgatgacgagcgtaatggctggcct
gttgaacaagtctggaaagaaatgcataagcttttgccattctcaccggattcagtcgtcactcatgg
tgatttctcacttgataaccttatttttgacgaggggaaattaataggttgtattgatgttggacgag
tcggaatcgcagaccgataccaggatcttgccatcctatggaactgcctcggtgagttttctccttca
ttacagaaacggctttttcaaaaatatggtattgataatcctgatatgaataaattgcagtttcattt
gatgctcgatgagtttttctaaTCAGAATTGGTTAATTGGTTGTAACACTGGCAGAGCATTACGCTGA
CTTGACGGGACGGCGGCTTTGTTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATC
TTCCCGACAACGCAGACCGTTCCGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAAC
AAAGCTCTCATCAACCGTGGCTCCCTCACTTTCTGGCTGGATGATGGGGCGATTCAGGCCTGGTATGA
GTCAGCAACACCTTCTTCACGAGGCAGACCTCAGCGCCCCCCCCCCCCCGAGCTCTTAATTAATTTAA
ATCTAGAGTCGACCTGCAGGCATGCAAGCTTCAGggttgagatgtgtataagagacagGCTCAACGTA
GCCTCAACCCGTATCATCCTGATGGATGGCCATACCGGTGCCGCAGCAGCTGGGCGGGTCGTTGAAGC
CTTTGGCCACTTCCTGGTCGGCGGCAACTTCGCCATCGGTATAGTGGTATTTATCATTTTGGTGGTGA 
 
Figure 5.6: DNA sequence of the Tn-RL27 insert within the flhA gene of the non-
motile serotype O1 (BA19/Tn-RL27) Y. ruckeri transconjugant. Regions highlighted 
in grey correspond to the flhA gene. Inverted repeats (underlined, lower case) are 
shown, as is the transposon-encoded aminoglycoside phosphotransferase (aph) gene 
(lower case, italics, underlined) and OriR6K replication site (italics). The 
sequencing primers tpnRL17-1 (italics, underlined) and tpnRL13-2 (underlined) are 
also included.     
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A 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCGGT
CATTAACACTAACAGCCTGTCTTTGCTGACCAGACACCTGAACAAATCCCAGGGCTCTTTAGGCACCG
CCATTGAGCGTTTGTCTTCCGGTCTGCGCATCAACAGCGCTAAAGATGATGCAGCGGGTCAGGCGATT
GCCAACCGTttcacctctaacatcaacggCCTGACTCAGGCAGCACGTAACGCCAACGACGGTATTTC
ACTGTCTCAGACCGCTGAAGGCGCGTTGGGCGAAATCAACAACAACCTGCAACGTGTCCGTGACCTGA
CCGTGCAGGCGCAGAACAGCTCTAACTCTGCCTCTGATATCGATTCCATCCAGTCTGAAGTTAACCAG
CGTATGGAAGAAATCAACCGCGTCACCAAACAAACCGATTTCAACGGCATTAAAGTCTTGGATAACCG
CACGGCAGCCAACGCGGAATATGCTTTCCAGGTGGGTTCGCAAGATGCCCAGAAAATCAATATCGAAA
TTGGTTCAAGCGCGGGCTGGAACCTGGCGACTGCCGGTGCCGGTGGTACTTCATCTGATGTGGTGAAC
GATTCTACTCAGATTAGTAAAGCTAAAGAAACGGTAGTGCAAACGCTGTCAGGGAAAACTGAAGCACA
GATCAACACCGCACTGACCAAATTTACGACTGACGTTAAGGCGGCAACCGATGCTGCCGGTGTAGTCA
CGGCAAAAGGGGCGTTAACCACGGCTCTGGGTTTAAAAGCGGATGCCGATTTAGGTACCGCCGTCAGC
TCCGCTGCGTTTGGTACTGATTTAAGCGTCGACCAGATCGCTGGCGTGAAAAGTGGTGTTTACAGCGC
TGCAATTAACGGGGCAAATTACGCTACAGCAAAAACTGAAGCTGAAGTTAGCGCTGCTCAAGCGGGTG
CTAAAACTGCTGGTGCGATGGTTAACGGTAACTTCCGTTCCGTTGAAGCCAAAGGTTTTGACGTATTG
AAAGGTAACGTGACGggcggcgcaacgggtacagcAACGGGTACAACCCCACTGGCTGATATCGATGC
GGCATTGAAAGCGGTTGATTCTCAGCGCAGTTCACTGGGTGCGTCCCAGAACCGTTTTGAATCTACCA
TCACTAACCTGAACAACACCGTGAACAACTTGACTTCAGCCCGTAGCCGTATCCAAGATGCGGATTAC
TCTACCGAAGTATCCAACATGAGCCGTGCGCAGATCCTGCAACAAGCCGGGACTTCTGTTATGGCTCA
GGCTAACCAGGTTCCACAGACTGTCTTGTCTCTGCTGCGTCTCGAGCACCACCACCACCACCACTGA 
B 
MGSSHHHHHHSSGLVPRGSHMAVINTNSLSLLTRHLNKSQGSLGTAIERLSSGLRINSAKDDAAGQAI
ANRFTSNINGLTQAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQ
RMEEINRVTKQTDFNGIKVLDNRTAANAEYAFQVGSQDAQKINIEIGSSAGWNLATAGAGGTSSDVVN
DSTQISKAKETVVQTLSGKTEAQINTALTKFTTDVKAATDAAGVVTAKGALTTALGLKADADLGTAVS
SAAFGTDLSVDQIAGVKSGVYSAAINGANYATAKTEAEVSAAQAGAKTAGAMVNGNFRSVEAKGFDVL
KGNVTGGATGTATGTTPLADIDAALKAVDSQRSSLGASQNRFESTITNLNNTVNNLTSARSRIQDADY
STEVSNMSRAQILQQAGTSVMAQANQVPQTVLSLLRLEHHHHHH* 
 
Figure 5.7: Open reading frame (ORF) of the cloned flagellin (fliC) gene from Y. 
ruckeri (A) and the deduced amino-acid sequence (B). Annealing sequences for the 
forward FLA-F (bold, underlined) and reverse FLA-R (underlined) primer are shown 
(A). In addition, annealing sites for sequencing primers FLG-L (lower case) and 
FLG-R (lower case, underlined) are also included. DNA sequences encoding the 
histidine (H) tags are highlighted (A), as are the predicted H-tags in the protein 
sequences (B).  
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A 
ATGAAAAAGACAGCTATCACGCATAGCAGTGCACTGGCTGGTTTCGCTACAGTAGCGCAAGCCGCACC
GAAAGATAACACCTGGTACACTGGTGGTAAACTGGGCTGGTCCCAGTTCCATGATGTCGGTACCGGTT
CAGACATTAGCAACGACGGTCCAACTCATAAGAGTCAACTGGGTGCTGGTGCATTCGTCGGTTACCAA
GCGAACCAGTATCTTGGCTTCGAAATGGGATATGACTGGCTGGGCCGTATGCCTTACAAAGGCGATAC
TGTTAACGGCGCTTTCaaagcacaaggcgttcagttGGCTGCTAAACTGAGCTACCCAATTGCTCAAG
ATCTGGACCTGTACACTCGTCTGGGTGGTATGGTTTGGCGTGCAGACGCTTCAGTAAACGAACCAAGT
ACAAACAGCCACGCAAGCGCTCACGATACTGGTGTTTCTCCGTTGGCCGCTGTTGGTCTTGAGTACGC
AGTAACCAAAAACTGGGCTACTCGTCTGGATTACCAATGGGTTAACAACATCGGTGACCGTGGTACCG
TTGGTGCTCGTCCAGATAACGGTATGCTGAGCGTAGGTGTTTCTTACCGTTTCGGTCAAGATGATGCT
ATCGTTCCAGTTGTTGCTCCAGCTCCAGCTCCAGCTCCAGTTGTTGATACCAAGCGTTTCACACTGAA
ATCTGACGTGCTGTTTGCTTTCAACAAAGCAACTCTGAAACCAGAAGGCCAGcaagcgctggatcaac
tgtaTTCTCAGTTGAGCTCTATCGATCCTAAAGACGGTTCTGTTGTAGTTCTGGGCTTCGCTGACCGT
ATCGGTCAAGCTGCTCCTAACTTGAAACTGTCTGAAAACCGCGCTCGCAGCGTTGTAGAGTACCTGGT
AGCTAAAGGTATCCCTGCAGACAAGATCTCTGCTCGTGGTATGGGTCAAGCAGATCCAGTTACAGGTA
ACACCTGTTGGTAGCTAAAGGTATCCCTGCAGACAAGATCTCTGCTCGTGGTATGGGTCAAGCAGATC
CAGTTACAGGTAACACCTGTGACAACGTGAAACCACGTGCTGCCCTGATCGAATGTCTGGCACCAGAT
CGTCGCGTAGAGATCGAAGTGAAAGGCATCAAAGAAGTTGTGACTCAGCCACAGGCTTAA 
B 
MKKTAITHSSALAGFATVAQAAPKDNTWYTGGKLGWSQFHDVGTGSDISNDGPTHKSQLGAGAFVGYQ
ANQYLGFEMGYDWLGRMPYKGDTVNGAFKAQGVQLAAKLSYPIAQDLDLYTRLGGMVWRADASVNEPS
TNSHASAHDTGVSPLAAVGLEYAVTKNWATRLDYQWVNNIGDRGTVGARPDNGMLSVGVSYRFGQDDA
IVPVVAPAPAPAPVVDTKRFTLKSDVLFAFNKATLKPEGQQALDQLYSQLSSIDPKDGSVVVLGFADR
IGQAAPNLKLSENRARSVVEYLVAKGIPADKISARGMGQADPVTGNTCW* 
 
Figure 5.8: Sequence of the Y. ruckeri ompA gene (A) and the predicted protein 
sequence encoded by this ORF (B). Annealing sites for primers OMPA-F 
(underlined) and OMPA-R (bold, underlined) are shown. Sequencing primer 
annealing sites for OMPA-F1 (bold, lower case) and OMPA-R1 (lower case, 
underlined) are also included.  
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A B C 
Vaccination chamber 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: Diagrammatic representation of a prospective technique for 
administering recombinant flagellin to rainbow trout on a commercial scale. A: 
Naïve fish (average weight = 2 to 4 grams) are pumped from an early stage rearing 
tank into a vaccination chamber. B: The water level is reduced to a specific volume 
before the addition of a concentrated r-flagellin preparation. At this time, other 
bacterins and/or virus preparations could be applied. C: Water levels are increased 
before pumping vaccinates into a sterilized rearing tank.  
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A 
MGSSHHHHHHSSGLVPRGSHMAVINTNSLSLLTRHLNKSQGSLGTAIERLSSGLRINSAKDDAAGQAI
ANRFTSNINGLTQAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQ
RMEEINRVTKQTDFNGIKVLDNRTAANAEYAFQVGSQDAQKINIEIGSSAGWNLATAGAGGTSSDVVN
DSTQISKAKETVVQTLSGKTEAQINTALTKFTTDVKAATDAAGVVTAKGALTTALGLKADADLGTAVS
SAAFGTDLSVDQIAGVKSGVYSAAINGANYATAKTEAEVSAAQAGAKTAGAMVNGNFRSVEAKGFDVL
KGNVTGGATGTATGTTPLADIDAALKAVDSQRSSLGASQNRFESTITNLNNTVNNLTSARSRIQDADY
STEVSNMSRAQILQQAGTSVMAQANQVPQTVLSLLRLEHHHHHH* 
B 
HHHHHHSSGLVPRGSHMAVINTNSLSLLTRHLNKSQGSLGTAIERLSSGLRINSAKDDAAGQAIANRF
TSNINGLTQAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQRMEE
INRVTKQTDFNGIKVLDNRTAANAEYAFQVGSQDAQKINIEIGSSAGWNLATAGAGGTSSHHHHHH* 
C 
HHHHHHVNGNFRSVEAKGFDVLKGNVTGGATGTATGTTPLADIDAALKAVDSQRSSLGASQNRFESTI
TNLNNTVNNLTSARSRIQDADYSTEVSNMSRAQILQQAGTSVMAQANQVPQTVLSLLRLEHHHHHH* 
D 
HHHHHHSSGLVPRGSHMAVINTNSLSLLTRHLNKSQGSLGTAIERLSSGLRINSAKDDAAGQAIANRF
TSNINGLTQAARNANDGISLSQTAEGALGEINNNLQRVRDLTVQAQNSSNSASDIDSIQSEVNQRMEE
INRVTKQTDFNGIKVLDNRTAANAEYAFQVGSQDAQKINIEIGSSAGWNLATAGAGGTSSSSSSVNGN
FRSVEAKGFDVLKGNVTGGATGTATGTTPLADIDAALKAVDSQRSSLGASQNRFESTITNLNNTVNNL
TSARSRIQDADYSTEVSNMSRAQILQQAGTSVMAQANQVPQTVLSLLRLEHHHHHH* 
 
 
Figure 5.10: Potential proteins/peptides derived from the recombinant Y. ruckeri 
flagellin protein sequence which could be used to refine the r-flagellin vaccine. A: 
Full amino-acid sequence of the Y. ruckeri r-flagellin protein used as template. B: 
N-terminal amino-acid sequence which is highly conserved between the Y. ruckeri 
flagellin protein and that of other Enterobacteriaceae flagellins. C: C-terminal 
amino-acid sequence which is similarly conserved among different flagellin 
proteins. D: Conserved N- and C- terminal fusion protein linked by a serine linker 
peptide (S). All proteins contain the Histidine tag (H) at the N- and C- terminal as 
they would be expressed using pET28-b vector and purified by passing through an 
IMAC column. 
 
